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Abstract 
In the United Kingdom (UK), an estimated 107,800 people were living with HIV in 
2013, of whom 55% were heterosexual men and women. Black African men and 
women accounted for the majority of heterosexuals living with HIV in the UK in 2013. 
In this PhD by prospective publication my research question is “How is the 
epidemiology of heterosexually-acquired HIV infection evolving, particularly among 
black Africans, in England, Wales and Northern Ireland?”. I conducted a quantitative 
analysis of national surveillance datasets and undertook literature searches. Most of my 
analysis was based on data from the three national HIV surveillance systems which 
constitute the HIV and AIDS Reporting System (New HIV Diagnoses database; Survey 
of Prevalent HIV Infections Diagnosed; CD4 Surveillance Scheme). I published the 
results of my analyses in six peer-reviewed papers between 2007 and 2014.  My key 
findings were as follows: over the last decade an increasing proportion of black African 
heterosexuals born abroad but diagnosed with HIV in the UK acquired HIV whilst 
living in the UK; outward migration from the UK may explain why some black African 
heterosexuals were lost to follow-up from HIV care; the proportion of black African 
heterosexuals diagnosed late with HIV has not changed substantially; the uptake of HIV 
testing among black African heterosexuals has increased over time but remains low 
compared with that among MSM. To minimize the risk of HIV transmission and to 
maximise the benefits of earlier detection my key recommendation is to promote regular 
HIV testing among black African women and men in a range of healthcare and 
community settings in E,W&NI, particularly in primary care. 
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1. Introduction 
Summary 
In this chapter I provide a background to the research and analysis conducted for my 
thesis. I summarise the epidemiological characteristics of the Human Immunodeficiency 
Virus and comment on research focusing on heterosexually-acquired HIV in England, 
Wales and Northern Ireland. I describe the proposed structure of the doctoral thesis 
which will include six papers published in peer-reviewed journals. 
1.1 Background to my thesis 
My involvement in HIV epidemiology began in 2002 when I joined the HIV and STI 
Department of the Public Health Laboratory Service (later to become the Health 
Protection Agency and then Public Health England) as an HIV scientist. Until that time, 
the majority of HIV diagnoses had been among men who have sex with men (MSM) 
(1). However, in my first year as an HIV scientist, in 2002, the HIV surveillance team 
(of which I was a member) observed there had been an increase in HIV diagnoses 
among heterosexuals since 1999 (1). This increase triggered my interest in the 
epidemiology of heterosexually-acquired HIV in the United Kingdom (UK). Prior to 
describing the proposed structure of my doctoral thesis I provide background 
information on the epidemiology of HIV in England, Wales and Northern Ireland 
(E,W&NI). 
1.1.1 Early years of the HIV epidemic in E,W&NI 
In July 1982, the first cases of AIDS were reported in the UK. Since these initial 
reports, 133,767 people have been diagnosed with HIV in E,W&NI (up to the end of 
2013) (1).  
In the early years of the HIV epidemic (1980s) in the UK, HIV diagnoses were 
predominately among MSM, people who inject drugs (PWIDs), and recipients of blood 
and blood products (figure 1.1). The introduction during the 1980s of needle and 
syringe programmes, and opiate substitution therapy, were successful in maintaining 
HIV diagnoses among PWIDs at a low level (2). The introduction in 1985 of the routine 
screening of blood donations for HIV greatly diminished the risk of transmission from 
blood transfusions and blood products (3, 4). Among MSM, however, an average of 
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1,570 men were diagnosed with HIV every year in E,W&NI between 1985 and 1998 
(range: 1,302 in 1988 to 1,755 in 1991) (figure 1.1). During that period of time MSM 
accounted for the majority of new HIV diagnoses reported annually in E,W&NI.  
Figure 1.1: HIV diagnoses among adults (aged ≥15 years at diagnosis) in E,W&NI 
by probable route of infection, 1982 to 2012  
 
Source: Public Health England (1) 
In these early years, the potential for HIV transmission through heterosexual sex in the 
UK was unclear. It was questioned whether “AIDS” in the UK would remain confined 
to PWIDs and MSM (5), and whether HIV could actually be transmitted between two 
heterosexual partners through sexual contact (6). However, early evidence for the sexual 
transmission of HIV between heterosexual partners emerged in other European 
countries and in sub-Saharan Africa. 
Among confirmed “AIDS” cases in France in 1982, some people were identified for 
whom the only risk factor was living in Equatorial Africa (ie there was no history of 
homosexual contact, nor travel to the USA or Haiti) suggesting that heterosexual 
contact was the route of transmission (7). In Belgium in 1984, HIV infection was 
reported among previously healthy patients originating from Central Africa for whom 
there was no evidence of an underlying immunosuppressive disease and no history of 
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blood-product transfusion, homosexuality, or intravenous-drug abuse raising the 
possibility of heterosexual transmission (8). The authors of a study conducted in the 
Democratic Republic of the Congo (then known as Zaire) in 1983 argued that a new 
epidemiological stage of HIV/AIDS was emerging in Central Africa with significant 
transmission among large heterosexual populations, implicating heterosexual 
transmission (9). The authors of a survey conducted in Zambia in the early 1980’s also 
concluded that HIV infection was prevalent in Africa and was transmitted 
heterosexually (10). A study of female “prostitutes” in 1984 in Rwanda reported a high 
risk of HIV infection (then referred to as HTLV III) among these women (11). 
A study in Edinburgh between 1985 and 1986 reported a 15% HIV “infection rate” 
among persons with no HIV risk factors other than having had heterosexual sex with a 
PWIDs (12). In London, early evidence of HIV being acquired heterosexually was 
presented among attendees of a sexual health clinic in 1987 having routine serological 
tests for syphilis. Among heterosexual patients at the clinic HIV prevalence was 1% 
both among women (4/412) and men (4/377) (13). Two of the eight HIV-positive 
heterosexuals had a history of injecting drug use (13). However, the remaining six had 
no identifiable risk factors that would have warranted their inclusion in an HIV risk 
group (13). 
To gain a better understanding of risk factors for heterosexually-acquired HIV, 
heterosexuals reported to national HIV surveillance in E,W&NI were categorised as 
first or second generation transmission (14). First generation transmission was defined 
as having a partner who was infected by a route other than heterosexual transmission, 
mainly bisexual men and PWIDs. Second generation transmission was defined as 
having a partner who themselves acquired HIV heterosexually.  
Behavioural interviews were conducted among those assigned to the second generation 
transmission group for whom the only reported risk for infection was heterosexual 
contact in the UK with a partner who themselves acquired HIV heterosexually. The 
purpose of these interviews was twofold: (i) confirm risk information was correct; (ii) 
identify additional risk factors for HIV transmission. These interviews found that, as 
compared with heterosexuals in the general population, HIV-diagnosed heterosexual 
men assigned to the second generation transmission group had an earlier sexual debut, 
and diagnosed heterosexual men and women were significantly more likely to report 
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having never used a condom (15). The sub-categorisation of heterosexuals ceased in 
2002, and interviews with HIV-diagnosed heterosexuals who acquired their infection 
from a partner who themselves acquired HIV heterosexually ceased in 2011.  
Between 1986 and 1991, there was a steady increase in both the number of newly 
diagnosed persons acquiring HIV through first generation and second generation 
heterosexual transmission (14). The proportion of HIV diagnoses in E,W&NI 
attributable to the two heterosexual categories combined increased from 4% in 1986 to 
23% in 1991 (14). By 1996, this proportion had increased to 27% (16). 
Figure 1.1 shows the number of heterosexuals diagnosed annually with HIV in E,W&NI 
increased steadily from 35 in 1985 to 1,150 in 1998. Over this time period, 
heterosexuals accounted for one quarter (24%) of all adults (aged ≥15 years at 
diagnosis) newly diagnosed with HIV in E,W&NI (1).  
1.1.2 The HIV epidemic in E,W&NI from 1999 onwards  
Between 1999 and 2012, approximately six out of ten HIV diagnoses in E,W&NI were 
among heterosexuals (1). In 1999, the annual number of HIV diagnoses in E,W&NI 
among heterosexuals exceeded for the first time that among MSM (figure 1.1). Between 
1999 and 2004, diagnoses of HIV among heterosexuals increased rapidly from 1,489 to 
4,679 before declining year on year to 2,465 in 2012 (figure 1.1). During this same 
period of time, the number of MSM diagnosed with HIV increased steadily (from 1,387 
in 1999 to 2,814 in 2012) (figure 1.1). These contrasting trends resulted in the annual 
number of HIV diagnoses among MSM once again exceeding that among heterosexuals 
in 2012, the first time it had done so since 1998. 
The rapid increase in HIV diagnoses between 1999 and 2004 triggered my interest in 
heterosexually-acquired HIV. However, it was the difference between diagnosed 
heterosexuals and MSM that attracted my attention. Whereas the majority of MSM 
diagnosed with HIV in E,W&NI between 1999 and 2012 were of white ethnicity and 
were born in the UK, the overwhelming majority of heterosexuals diagnosed with HIV 
were of black African ethnicity and were born abroad, mainly in sub-Saharan Africa (1). 
It was this finding that first got me thinking about the potential impact of migration both 
to and from the UK on the evolving epidemiology of heterosexually-acquired HIV 
infection in E,W&NI.  
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1.1.3 HIV among heterosexuals in E,W&NI 
In the UK (Scotland included) in 2012, an estimated 98,400 people of all ages were 
living with HIV (including diagnosed and undiagnosed) (3). Of these, 52,900 (54%) 
were heterosexuals (31,700 women and 21,200 men). African born men and women 
accounted for the majority (60%; 31,800) of heterosexuals living with HIV in 2012 (3).  
The estimated 52,900 heterosexuals living with HIV in the UK in 2012, equates to a 
prevalence of <1.5 per 1,000 of the total population. However, in black Africans, among 
whom heterosexual sex is the predominant route of infection, the prevalence of HIV is 
elevated. Among black African women, the estimated prevalence in 2012 was 51 per 
1,000, and among black African men 26 per 1,000 (3). The estimated prevalence of HIV 
among black African women in 2012 was higher than that in MSM (47 per 1,000) (3).  
Among the estimated 31,700 heterosexual women living with HIV in 2012, 24% were 
undiagnosed (3). The corresponding figure among the 21,200 heterosexual men was 
30%. The level of undiagnosed HIV among heterosexual women and men in 2012 was 
higher than that among MSM (18%) or PWIDs (14%) (3).  
In 2012, 6,028 adults were newly diagnosed with HIV in E,W&NI (1). Among those for 
whom probable route of infection was reported, 45% were heterosexuals (1). Among 
heterosexuals newly diagnosed with HIV in 2012 in the UK, 57% of women and 65% 
of men were diagnosed late (diagnosed with a CD4 cell count <350 cells/mm3 and 
beyond the point treatment should have been commenced) (3). Among MSM the figure 
was 34%, while among PWIDs it was 64% (3). 
Elevated levels of undiagnosed HIV and late HIV diagnosis among heterosexuals are of 
public health concern. In relation to undiagnosed HIV, data from the United States of 
America (USA), suggests that nearly half of all new HIV infections derive from the one 
in five people living with HIV who remain undiagnosed (17). The proportion of 
infections resulting from people living with undiagnosed HIV is likely to increase as the 
quality of HIV care improves among those diagnosed (17). This is because the majority 
of people with diagnosed HIV in receipt of antiretroviral therapy achieve virological 
suppression (<50 copies/mL) within a year of beginning treatment (18). Those who 
achieve virological suppression can almost eliminate their risk of sexually transmitting 
HIV (19). In relation to late HIV diagnosis, among heterosexuals diagnosed with HIV in 
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England and Wales between 2000 and 2004, those diagnosed very late (CD4 cell count 
<200 cells/mm3) were nine times more likely to die in the year following diagnosis than 
those diagnosed earlier (20). 
1.2 Research on heterosexually-acquired HIV infection in E,W&NI 
In 2008 I submitted my application for a research degree to City University London to 
examine the epidemiology of heterosexually-acquired HIV in E,W&NI in greater detail. 
As part of my application, I conducted a literature search on the epidemiology of 
heterosexually-acquired HIV in E,W&NI. My search highlighted a gap in the literature 
as little had been published on this subject prior to the submission of my application. 
I was only able to identify three papers published in peer-reviewed journals up to 2008 
which focused on the epidemiology of heterosexually-acquired HIV in E,W&NI. In 
2003, a paper describing the epidemiology of HIV infection among African 
communities in the UK (the majority of whom acquired HIV heterosexually) was 
published (21). In 2005, a research letter presenting the annual number of heterosexuals 
diagnosed with HIV in the UK was published (22), and a year later a paper on late HIV 
diagnosis and mortality among heterosexuals in England and Wales was published (20).  
The relative absence of published papers on HIV among heterosexuals in E,W&NI may 
have been explained by research having focused on the group most likely to acquire 
HIV in the UK, namely MSM. Until recently it was thought the overwhelming majority 
of heterosexuals acquired their HIV infection abroad (23, 24). On the other hand, among 
MSM, the rate of HIV transmission within the UK has been and remains high (3). In the 
years leading up to my registration for a PhD, a substantial body of research on HIV 
among MSM in the UK had been published (25-34). In comparison, relatively little had 
been published on HIV among heterosexual men and women in the UK.  Clearly there 
was a gap in the research literature which further motivated me to examine the 
epidemiology of heterosexually-acquired HIV in E,W&NI. 
1.3 Research question and objectives 
The overarching research question of my thesis is “How is the epidemiology of 
heterosexually-acquired HIV infection evolving, particularly among black Africans, in 
England, Wales and Northern Ireland?”. To answer this research question, I have 
formulated six objectives. My objectives are to:  
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1. analyse epidemiological data and undertake literature searches to highlight who is at 
risk of heterosexually-acquired HIV in E,W&NI;  
2. consider challenges in accurately ascertaining epidemiological trends in 
heterosexually-acquired HIV, and design new methods to improve precision;  
3. explore the quality of HIV care provided to HIV-diagnosed heterosexuals in 
E,W&NI by examining key indicators of care available from routine HIV 
surveillance data; 
4. examine the impact of migration on the heterosexual transmission of HIV in 
E,W&NI and consider whether a “home-grown” epidemic has developed among 
both heterosexuals born abroad and those born in the UK;  
5. conduct research into HIV tuberculosis co-infection among heterosexuals in 
E,W&NI and consider the role of testing for HIV in tuberculosis clinics and vice-
versa; 
6. investigate HIV testing trends among heterosexuals in E,W&NI and why high rates 
of undiagnosed HIV and late presentation persist in this group. 
In objective 4, “home-grown” refers to HIV infections acquired in the UK rather than 
abroad. Among persons born abroad, it also refers to HIV infections acquired post 
arrival in the UK rather than prior to arrival. 
1.4 The thesis 
I have written a PhD by prospective publication. My thesis includes six peer-reviewed 
papers published in national and international journals. I wrote and published five 
papers after I had registered for my PhD at City University London in 2009; one paper 
was published shortly before registration. My role and that of the co-authors of the six 
published papers is described in Appendix i. 
The papers are embedded in four chapters where I explore some of the issues raised by 
the papers. In addition to this Introduction and the four chapters, my thesis includes a 
Methods and a Conclusions chapter. In table 1.1, I provide a summary of the structure 
of the thesis and the six peer-reviewed papers. 
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Table 1.1: Structure of the thesis including the published papers  
Chapter title Peer-reviewed publication 
Chapter 1: Introduction - 
Chapter 2: Methods - 
Chapter 3: Trends in 
heterosexually-
acquired HIV in 
England, Wales and 
Northern Ireland 
Rice BD, Sinka K, Patel B, Chadborn T, Delpech V. The 
changing epidemiology of diagnosed prevalent HIV infections 
in England: greatest impact on the London environs. Epidemiol 
& Infect 2007; 135:151-158. 
Rice B, Elford J, Yin Z, Croxford S, Brown A, Delpech V. 
Trends in HIV diagnoses, HIV care and uptake of antiretroviral 
therapy among heterosexual adults in England, Wales and 
Northern Ireland. Sex Transm Dis 2014; 41(4): 257-265 
Chapter 4: Migration 
Rice BD, Elford J, Yin Z, Delpech D. A new method to assign 
country of HIV infection among heterosexuals born abroad and 
diagnosed with HIV in the UK. AIDS 2012; 26(15): 1961-1966. 
Rice BD, Delpech VC, Chadborn TR, Elford J. Loss to follow-
up among adults attending HIV-services in England, Wales and 
Northern Ireland. Sex Transm Dis 2011; 38(8):685-690. 
Chapter 5: HIV and 
tuberculosis co-
infection 
Rice BD, Elford J, Yin Z, Kruijshaar M, Abubakar I, Lipman 
M, et al. Decreasing incidence of tuberculosis among HIV 
diagnosed heterosexuals in England and Wales. AIDS 2013; 
27(7):1151–1157. 
Chapter 6: HIV testing 
Rice BD, Delpech V, Sadler KE, Yin Z, Elford J. HIV testing 
among black Africans living in England. Epidemiol & Infec 
2012; 141:1741–1748. 
Chapter 7: Conclusion - 
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1.4.1 Thesis outline 
Chapter 1: Introduction 
In this Introduction I present my research question and objectives, and describe the 
structure of my thesis. To provide background to the thesis, I present a summary of the 
epidemiology of HIV in E,W&NI between 1982 and 2012 and comment on research 
focusing on heterosexually-acquired HIV.  
Chapter 2: Methods 
Five of the peer-reviewed papers are based on the quantitative analysis of data collected 
through routine national HIV surveillance. For the sixth paper, data collected as part of 
a community-based survey are analysed. In the Methods chapter, I describe each of the 
datasets I use and explain my role in collecting, processing and analysing the data for 
my thesis. I discuss the strengths and weaknesses of the data and describe how data 
confidentiality is maintained.  
Chapter 3: Trends in heterosexually-acquired HIV in England, Wales and Northern 
Ireland 
In Chapter 3, I examine trends in heterosexually-acquired HIV in E,W&NI. The chapter 
includes two peer-reviewed published papers.  
The first of the two peer-reviewed papers, published in Epidemiology & Infection in 
2007, is called “The changing epidemiology of diagnosed prevalent HIV infections in 
England: greatest impact on the London environs” (35). In the paper, I explore the 
heterogeneous growth of the HIV epidemic in England between 1997 and 2004. I also 
present projections for the number of people living with HIV for the period 2005 to 
2007, based on observed trends between 1997 and 2004. The second paper, published in 
Sexually Transmitted Diseases in 2014, is called “Trends in HIV diagnoses, HIV care 
and uptake of antiretroviral therapy among heterosexual adults in England, Wales and 
Northern Ireland” (36). In the paper, I present overall trends in HIV diagnoses and 
quality of HIV care among heterosexual adults in E,W&NI between 1992 and 2011. For 
the period 2002 to 2011, I investigate trends among heterosexuals in late HIV 
diagnoses, first AIDS diagnosis, prompt integration into HIV care, uptake of 
antiretroviral therapy, and short-term mortality.  
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In the accompanying text I explore the accuracy of the epidemiological predictions I 
made in the first paper. I also investigate differences in late HIV diagnosis and quality 
of HIV care among heterosexuals reported in the second paper as well as examining an 
observed increase over time in average age at HIV diagnosis. 
Chapter 4: Migration  
The majority of heterosexual adults newly diagnosed with HIV in E,W&NI are born 
abroad (3). This raises several questions. What is the role of migration in shaping 
overall trends in HIV diagnoses among heterosexuals in E,W&NI? Has migration 
resulted in a wider “home-grown” epidemic developing among heterosexuals in 
E,W&NI? As well as inward migration, does outward migration influence the number 
of heterosexuals seeking HIV care annually? What are the challenges in accurately 
assessing the impact of migration on heterosexually-acquired HIV in E,W&NI? How 
best to define migrants and migration in relation to HIV? In Chapter 4 I consider these 
questions. 
Chapter 4 consists of two peer-reviewed papers plus accompanying text. The first of the 
two papers, published in AIDS in 2012, is called “A new method to assign country of 
HIV infection among heterosexuals born abroad and diagnosed with HIV in the UK” 
(24). In the paper, I introduce and apply a new technique for ascertaining where HIV 
was acquired among adults born outside of the UK. The second paper, published in 
Sexually Transmitted Diseases in 2011, is called “Loss to follow-up among adults 
attending HIV-services in England, Wales and Northern Ireland” (37). In the paper, I 
explore annual patterns of attendance at HIV services among HIV-diagnosed adults 
between 1998 and 2007. I focus on the extent to which HIV-diagnosed adults are lost to 
follow-up or attend services intermittently, and investigate predictors of loss to follow-
up. I put forward outward migration from the UK as one explanatory factor for loss to 
follow-up. 
In the accompanying text I explore different definitions of migration and migrants both 
in the general population and in relation to HIV. I examine the impact of inward and 
outward migration on the epidemiology of heterosexually-acquired HIV infection in 
E,W&NI, and consider whether a “home-grown” epidemic has developed among 
heterosexuals either born abroad or born in the UK. 
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Chapter 5: HIV and tuberculosis co-infection 
Globally, tuberculosis is the leading cause of illness and death among people living with 
HIV (38). In 2012, HIV-associated tuberculosis was estimated to have killed 320,000 
people worldwide (38). The highest rates of HIV-associated tuberculosis are seen in 
sub-Saharan Africa countries (38). In the UK, the majority of heterosexual men and 
women diagnosed with HIV are born in sub-Saharan Africa where the prevalence of 
both HIV and tuberculosis is high (3).  
Chapter 5 consists of a peer-reviewed paper plus accompanying text. The paper, 
published in AIDS in 2013, is called “Decreasing incidence of tuberculosis among 
heterosexuals living with diagnosed HIV in England and Wales” (39). As the title 
suggests, in the paper I report that the annual tuberculosis incidence rate among 
heterosexual adults living with diagnosed HIV in England and Wales has declined over 
time. Despite this decline the tuberculosis incidence rate in the study population remains 
significantly higher than in the general population of England and Wales. In the paper I 
highlight missed opportunities for earlier HIV testing. 
In the accompanying text I consider HIV tuberculosis co-infection in other European 
countries and reflect on the role of migration. I also investigate HIV TB service 
provision both in the UK and elsewhere in Europe. 
Chapter 6: HIV testing  
Rates of undiagnosed HIV and of late HIV diagnosis are elevated among black African 
heterosexual men and women in E,W&NI (3). This suggests that uptake of HIV testing 
is sub-optimal for this population group. Undiagnosed HIV is a driver of HIV 
transmission (17), and late presentation is a major risk factor for HIV-related morbidity 
and mortality (20).  
Chapter 6 consists of a peer-reviewed paper plus accompanying text. The paper, 
published in Epidemiology & Infection in 2012, is called “HIV testing in black Africans 
living in England” (40). In the paper, I present results from a community-based cross-
sectional survey of HIV prevalence, sexual attitudes and lifestyles among black African 
adults attending commercial and social venues in London, Luton, and the West 
Midlands in 2004 (41). I present the percentage of participants having tested for HIV in 
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the previous 24 months or having ever tested. In the paper, I also explore the association 
between perceived risk of HIV and HIV testing.  
In the accompanying text I report on HIV testing among black Africans since 2004 in 
this country. I also explore late HIV diagnosis and undiagnosed HIV among black 
Africans, and investigate barriers to, and triggers for, HIV testing among this group. 
Chapter 7: Conclusions 
In the final chapter of my thesis, I summarise the findings from my six peer-reviewed 
published papers and the accompanying text in Chapters 3, 4, 5 and 6. I describe what I 
have discovered that is new and discuss the public health importance and impact of my 
research. I also describe the methodological innovations introduced through my 
research, and discuss the strengths and limitations of my analysis. Finally, I make 
recommendations based on the research contained in my published papers and thesis 
chapters. 
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2.  Methods 
Summary 
This thesis is based on an analysis of quantitative data collected through routine national 
surveillance in E,W&NI and a community-based survey in England. Throughout this 
chapter I place emphasis on three national HIV surveillance systems which underpin the 
majority of my analysis. The three systems are the New HIV Diagnoses database, the 
Survey of Prevalent HIV Infections Diagnosed and the CD4 surveillance system. These 
three systems constitute the HIV and AIDS Reporting System.  
In this chapter, I provide a description of each of the datasets I utilised and provide 
details on the providers of these data. I outline ethical issues, discuss data 
confidentiality, and explore the strengths and limitations of using surveillance data for 
my analysis. I describe my role in relation to HIV surveillance data management and 
analysis and in developing and introducing new surveillance methodologies. Finally, I 
provide details of the literature reviews I conducted.  
2.1 HIV and AIDS Reporting System in E,W&NI 
Most of my analysis is based on data from the HIV and AIDS Reporting System 
(HARS). The HARS consists of three national surveillance systems: (i) the New HIV 
Diagnoses database; (ii) the Survey of Prevalent HIV Infections Diagnosed (SOPHID); 
(iii) the CD4 Surveillance Scheme (42). 
Data from HARS are used at the local, regional and national level in E,W&NI to 
monitor trends in the epidemiological characteristics of adults newly diagnosed with 
HIV and adults seen for HIV-related care. The data are also used to monitor trends in 
the diagnosis of AIDS defining illnesses and deaths (HIV and non HIV-related) in HIV-
infected adults. The data are utilised by health professionals (including HIV clinicians, 
public health specialists, and researchers), and HIV professional bodies, charities, and 
governmental / non-governmental organisations (including the British HIV Association, 
the All-Party Parliamentary Group on HIV and AIDS, the Terrence Higgins Trust, and 
the National AIDS Trust).  
Health professionals and organisations at the local, regional and national level in 
E,W&NI use HARS data for the following purposes: evaluate the impact of HIV testing 
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strategies; assess the quality of HIV care; design strategies to reduce HIV transmission 
and HIV-associated morbidity and mortality; determine the prevalence of diagnosed 
HIV; support the commissioning of HIV treatment, care, and prevention services; 
predict demands on local health and social services. The HARS is hosted at Public 
Health England. 
2.1.1 Public Health England 
Public Health England (PHE) is an executive agency of the Department of Health 
formally established in April 2013 (43). Prior to April 2013, the Health Protection 
Agency (HPA) was responsible for the national surveillance of HIV in E,W&NI. The 
HIV and STI Department of PHE is the national centre for the surveillance of HIV and 
other sexually transmitted infections in E,W&NI (42). The aims of the HIV and STI 
Department include describing trends in the prevalence and incidence of HIV, 
monitoring the transmission of HIV in at risk populations, and providing information 
for planning, targeting and evaluating prevention activities aimed at reducing risk 
behaviours and interrupting the transmission of HIV. 
2.1.2 New HIV Diagnoses database 
The New HIV Diagnoses database was established in 1982. The database receives 
voluntary and confidential reports of new HIV diagnoses, first AIDS diagnoses, and 
deaths in HIV-infected adults. Data are collected during two six monthly reporting 
periods (January to the end of June and July to the end of December). The variables 
collected are listed in table 2.1. 
The database is a dual reporting system. Reports are received from sites where adults 
test for HIV and laboratories conducting HIV diagnostic testing. In 2011, 296 
laboratories, genito-urinary medicine clinics, GP practices and other services where 
HIV testing takes place in E,W&NI reported to the New HIV Diagnoses database.  
28 
 
Table 2.1: HIV and AIDS Reporting System - data variables (as of end 2013) 
Information collected 
New HIV Diagnoses  SOPHID CD4 Surveillance Laboratory Clinic 
Date of HIV diagnosis in the UK* x x     
Place of HIV diagnosis in the UK* x x   
Place where last seen for HIV care*    x  
Postcode of residence**    x  
Clinic ID x x x  
Laboratory ID x   x 
HIV sub-type x x   
Previous HIV test history x x   
Reason for test   x   
Pregnant at HIV diagnosis   x   
Symptoms   x   
CD4 cell count   x x x 
Date of CD4 cell count   x x x 
Viral load   x x  
Date of viral load   x x  
Sex* x x x x 
Date of birth (from which age is 
derived)* x x x x 
Soundex code* *** x x x x 
Initials x x x  
Probable route of HIV infection** x x x  
Probable country of HIV 
infection**   x   
Ethnicity** x x x  
Country of birth   x   
Year of arrival in the UK   x   
AIDS diagnosis   x x  
AIDS indicator disease   x   
Date of AIDS   x x  
Date of death   x x  
Cause of death   x   
Antiretroviral therapy    x  
Date started ART     x   
* Mandatory fields required for a report to be entered and on which follow-up is conducted if 
missing 
** Key fields on which follow-up is conducted if missing 
*** A soundex code is a four character coding of an adults surname (the initial letter 
followed by three numbers) 
29 
 
Testing laboratories are encouraged to report new HIV diagnoses using either the 
laboratory report paper form or the Microsoft Excel laboratory report worksheet 
(forwarded via secure email on a six monthly basis). Sites conducting HIV testing (for 
example, genitourinary medicine clinics, infectious disease units, primary care services, 
and private healthcare facilities) are encouraged to report new HIV diagnoses, first 
AIDS diagnoses, and deaths in HIV-infected adults using either the clinician HIV report 
paper form or the Microsoft Excel clinician report worksheet. The laboratory and 
clinician HIV report forms are presented in Appendix ii. 
Having entered all reports received to the end of June or December on the system, the 
New HIV Diagnoses dataset is archived. Data entry is suspended and validations are 
conducted to create a dataset representing all diagnoses to the end of the reporting 
period. 
2.1.3 Survey Of Prevalent HIV Infections Diagnosed 
The SOPHID is a cross-sectional survey of all adults with diagnosed HIV infection who 
attend for HIV-related care within the National Health Service (NHS) in E,W&NI in a 
calendar year. The survey began in 1995 and is funded by the Department of Health and 
the London Specialised Commissioning Group. The survey is run twice a year (January 
to the end of June and July to the end of December) in London, Brighton, Hastings and 
Eastbourne, and annually (January to the end of December) in the rest of E,W&NI. 
Following the end of a survey period, reports of adults seen for HIV-related care are 
forwarded to PHE in electronic batches using the Microsoft Excel SOPHID report 
worksheet (forwarded via secure email). In 2011, 216 sites providing HIV care (for 
example, NHS HIV outpatient clinics and infectious disease units) reported to SOPHID. 
In table 2.1 I list the variables collected. The annual cross-sectional surveys are linked 
to create a cohort of adults seen for HIV care. I describe the method for linking surveys 
in section 2.6.1. In Appendix ii, I present the SOPHID metadata file. 
2.1.4 CD4 Surveillance Scheme 
The CD4 Surveillance Scheme monitors national trends in immunosuppression among 
HIV-infected adults. This is done through the collection and analysis of CD4 cell counts 
reported to PHE by laboratories across E,W&NI which perform CD4 T-lymphocyte 
counts and are registered with the National External Quality Assessment Scheme for 
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Leukocyte Immunophenotyping (44). Data are reported electronically bi-annually, 
quarterly, or monthly to suit individual laboratories using the Microsoft Excel CD4 
surveillance report worksheet. In 2011, 64 laboratories reported to the CD4 Surveillance 
Scheme. The variables collected through CD4 surveillance are listed in table 2.1. 
2.1.5 Data linkage within HARS 
In all three national surveillance systems no names are collected or held. Instead, a 
soundex code in combination with sex and date of birth provides a unique identifier for 
each adult reported to HIV surveillance. A soundex code is a four character coding of an 
adults surname (the initial letter followed by three numbers) (45). The code is created 
by applying an algorithm that encodes the first three consonants after the initial letter to 
numbers ranging between one and six (for surnames that contain less than three 
consonants zeros are added). The unique identifier is used to link records within and 
between the three national surveillance systems, a process that is integral to routine data 
processing and management. As I indicate in table 2.1, soundex code, sex and date of 
birth are all mandatory fields (fields that must be completed for a record to be entered 
on to HARS).  
2.2 Additional data sources 
I used two additional datasets held at PHE for my analysis: (i) Enhanced Tuberculosis 
Surveillance; (2) Mayisha II study. I also used information from national death 
registrations and the Index of Multiple Deprivation. 
2.2.1 Enhanced Tuberculosis Surveillance 
Enhanced Tuberculosis Surveillance commenced at the beginning of 1999 in England 
and Wales, and the start of 2000 in Northern Ireland. The main objective of Enhanced 
Tuberculosis Surveillance is to provide detailed demographic, clinical and 
microbiological information on pulmonary and extra pulmonary tuberculosis diagnoses 
in E,W&NI (46). Testing sites (for example, tuberculosis clinics, chest clinics, primary 
care services, and private healthcare facilities) are encouraged to report all new 
diagnoses of tuberculosis via a web-based system. Information is received from all 
tuberculosis diagnosing sites in E,W&NI, and the data are held at PHE. 
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To promote data quality, an annual data audit is undertaken based on criteria suggested 
in the 2007 Department of Health TB Toolkit for planning, commissioning and 
delivering high-quality services in England (47). Local and national data audits and 
evaluations are conducted on data quality, system user satisfaction, and mechanisms for 
implementing data quality improvement. The completeness of key fields is regularly 
reviewed. 
Key fields include name, date of birth, sex, place of diagnosis, ethnicity, country of 
birth, previous tuberculosis treatment history, start of tuberculosis treatment, previous 
diagnosis of tuberculosis, sputum smear status (pulmonary cases only), site of disease, 
and treatment outcome. For my analysis of HIV and tuberculosis co-infection, the 
following Enhanced Tuberculosis Surveillance fields were used: surname (converted by 
the tuberculosis surveillance team at PHE to a soundex code); date of birth; sex; place 
of tuberculosis diagnosis; date of tuberculosis diagnosis.  
2.2.2 Mayisha II study 
The Mayisha II study was a community-based survey of sexual attitudes and lifestyles 
among black African communities in England (London, Luton, and the West Midlands) 
conducted by the HPA (now PHE) in 2004 (41, 48, 49). The study was supported by a 
grant from the Medical Research Council, and approved by the Trent Multi-centre 
Research Ethics Committee, following a successful feasibility and acceptability pilot 
study in 2004 (49). Fieldwork was conducted in community-identified social and 
commercial venues (including bars, clubs, universities, churches, shops, barbers, 
hairdressers and community events) in London, Luton, and the West Midlands between 
August and December 2004.  
The study consisted of a cross-sectional community-based survey and a nested 
qualitative study. For my analysis, I focused on the community-based survey. The 
survey included an anonymous self-completion questionnaire (available in English and 
French) of 24 questions relating to demographics, health service use, and sexual 
behaviour and attitudes, and an optional oral fluid sample (using an OrasureTM device) 
for anonymous testing for HIV antibodies. Samples were forwarded to, stored and 
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The following fields from the Mayisha II study were included in my analysis: current 
HIV status (as reported by the participant and confirmed by a laboratory test result); 
HIV test history (whether previously tested for HIV and, if so, when and where the test 
was conducted); sex; age; country of birth; length of time living in the UK (for 
participants born abroad); highest level of formal education achieved; condom use at 
last sexual intercourse; number of sexual partners in the past 12 months; if ever 
diagnosed with a sexually transmitted infection other than HIV; perceived risk of 
catching HIV. Variable completion in the Mayisha II study was high. 
2.2.3 National death registrations 
Deaths among people living with diagnosed HIV are reported directly by clinics to the 
New HIV Diagnoses database and SOPHID. These reports are supplemented by 
national death registrations from the Office of National Statistics (ONS) (50). The ONS 
is the executive office of the UK Statistics Authority, an independent body operating at 
arm's length from government as a non-ministerial department, directly accountable to 
Parliament (51). National death registrations are received from the ONS via monthly, 
quarterly and annual files.  
Monthly files, which are received by PHE soon after the end of the month, include 
deaths where HIV and/or AIDS were recorded on the death certificate. Monthly files 
also include causes of death that are unusual in non HIV-infected individuals (for 
example Kaposi’s sarcoma or Pneumocystis pneumoni). 
Quarterly files, which are received by PHE soon after the end of the quarter, contain all 
deaths in persons aged ≤60 years reported that quarter, regardless of when the death 
occurred. This means that adding together four quarterly files in a year does not equate 
to the number of deaths in a given year (for example, some deaths occurring in 2011 
will not be reported until 2012 or later, while some deaths for earlier years will have 
been reported during 2011).  
Annual files contain all deaths in persons aged ≤60 years occurring within a calendar 
year. To ensure annual files are accurate and include underlying cause of death (a field 
not included in the quarterly file), there is an eighteen month reporting delay. 
Underlying cause of death is not part of the public death certificate and may be used to 
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record HIV status for persons where the family has objected to such information being 
made public.  
Augmenting deaths reported directly to the two national HIV systems with ONS death 
registrations (through data linkage on soundex code, sex and date of birth) helps ensure 
deaths among HIV-infected patients who have died in the community and/or of a non-
HIV-related event are also identified. The Births and Deaths Registration Act (1836) 
makes it a legal requirement for all deaths to be registered in the UK (52). 
2.2.4 The Index of Multiple Deprivation 
The Index of Multiple Deprivation (IMD) is part of the English Indices of Deprivation 
(53). The English Indices of Deprivation is calculated by The Department for 
Communities and Local Government, a UK ministerial department which has calculated 
local measures of deprivation in England since the 1970s (54).  
In 2010, the English Indices of Deprivation used 38 separate indicators organised across 
seven distinct domains of deprivation. These indicators were subsequently combined, 
using appropriate weights, to calculate the IMD. The IMD is used to rank every Lower 
Layer Super Output Area (LSOA) in England according to their relative level of 
deprivation (an LSOA is an aggregation of postcodes and typically contains a 
population of around 1500 people; LSOAs were developed by the ONS to produce areas 
of consistent size and stable boundaries) (55). Adults seen for HIV care in England, and 
reported to SOPHID, are assigned to an LSOA based on their postcode of residence. 
According to their LSOA, adults are assigned an IMD score. 
2.3 Ethical issues and data confidentiality 
For all PHE surveillance systems strict attention to confidentiality is maintained at 
every stage of data collection, analysis and storage. The HIV systems held at PHE are 
designed to directly support the public health surveillance of HIV infection in E,W&NI. 
Therefore, it is required that all fields collected within these systems add value to 
surveillance outputs. Limited patient identifiers are collected to aid the identification 
and removal of duplicate records and to link records across surveys and systems.  
The NHS Trusts and Primary Care Trusts (Sexually Transmitted Diseases) Directions 
2000 (56), enables PHE to collect HIV data without consent for surveillance and 
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prevention services from NHS trusts. Through National Information Governance Board 
for Health and Social Care approval under section 251 (57), PHE is legally covered to 
collect HIV data without consent from outside of trusts. The Patient Information 
Advisory Group approved the 2001 application from the Public Health Laboratory 
Service (predecessor to the HPA and PHE) for the use of patient data (including HIV 
data) without consent (58). Approval is renewed each year by the National Information 
Governance Board for Health and Social Care through the section 251 annual review 
process.  
Statutory Instrument 2002 No. 1438 in The Health Service (Control of Patient 
Information) Regulations 2002 provides the legal basis for the handling of HIV data 
(59). Public Health England is registered under the Data Protection Act 1998 
(registration number Z7749250) to handle data for diagnostic, public health and other 
purposes (60). All records are kept securely in compliance with the Caldicott Guidelines 
(61). All PHE staff have a legal duty to keep patient information confidential.  
All personal health information is stored at PHE on secure servers and all databases are 
password protected. Access to disaggregate HARS data is strictly limited to those 
directly involved in the collation of the data. 
2.4 Strengths and limitations of HIV surveillance data for my thesis 
The majority of my analysis is based on data from HARS. There are both advantages 
and disadvantages in using established, pre-collected data to answer my research 
question. 
In E,W&NI, HIV care through the NHS is open access and free at point of contact, and 
all NHS sites providing HIV care, and all HIV diagnostic laboratories, are encouraged 
to report to HARS. Recognising the need for clinician co-operation, regular contact is 
made with reporting sites, and both routine and bespoke site-specific outputs are made 
available by PHE. Recognising the need for clinicians to focus on the medical needs of 
their patients the collection of risk behaviour information in HARS is kept to a 
minimum.  
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2.4.1 Advantages of using HARS data 
An evaluation by internal and external stakeholders conducted in 2007 and 2008 of all 
HIV and STI national surveillance systems in E,W&NI considered the utility of HARS 
data. The evaluators concluded that the three components of HARS provided important 
and vital HIV statistics used to describe the HIV epidemic in the UK, and that the data 
were both comprehensive and valid (62).  
Comprehensive 
Only laboratory confirmed cases of HIV are reported to the New HIV Diagnoses 
database. For a record of a newly diagnosed adult to be included in the database their 
site and date of diagnosis, soundex code, sex, and date of birth must be present. To 
reduce underreporting, both laboratories and clinics are encouraged to report a new 
diagnosis of HIV, and reporting sites that either have not reported, or have reported 
fewer patients than might be expected based on previous reports, are identified and 
contacted. To further minimise underreporting, SOPHID records identified as new HIV 
diagnoses during the specified year are linked to the New HIV Diagnoses database. 
Records in SOPHID without a match in the New HIV Diagnoses database are added to 
the latter system. 
SOPHID receives data from all NHS sites providing HIV care. For a record of an adult 
seen for HIV care to be included in SOPHID their site and date seen for care, soundex 
code, sex, date of birth, and place of residence must be reported. Reporting to SOPHID 
is directly linked to funding allocation of local HIV services. Non-reporting NHS sites 
that might be providing HIV-related care are identified and contacted. Sites that either 
have not reported, or have reported fewer patients than might be expected based on 
previous reports, are subsequently contacted. 
All laboratories carrying out CD4 cell counts in E,W&NI registered with the National 
External Quality Assessment Scheme for Leucocyte Immunophenotyping are invited to 
participate in the CD4 surveillance scheme (44). The NEQAS list is regularly checked 
to identify and invite new laboratories carrying out CD4 cell counts. 
The reporting of a first AIDS diagnosis at time of an HIV diagnosis is likely to be 
comprehensive as HIV and AIDS diagnoses can be reported to the New HIV Diagnosis 
database jointly via the same electronic or paper form. The reporting of deaths among 
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HIV-infected persons is also likely to be comprehensive as notifications reported 
directly by clinics to the New HIV Diagnoses database and SOPHID are supplemented 
by death notifications from the ONS.  
Valid 
All HIV data received by PHE are checked for duplicate records and missing or 
inaccurate information. Through routine data linkage within and between the New HIV 
Diagnosis database and SOPHID duplicate records are identified and removed from 
final amalgamated datasets. Missing and inaccurate information are identified through 
routinely run validation checks.  
Validation checks are applied to individual records (for example, sex is male if route of 
infection is sex between men), and to records pertaining to the same adult reported over 
time to a single system (for example, ethnicity is consistently reported over time). 
Validation checks are also applied to records pertaining to the same adult reported to 
two or more systems (for example, if an adult is reported as having died to the New 
HIV Diagnoses database a validation check is conducted to see whether they were 
subsequently reported to SOPHID as having been seen for HIV care). 
Data linkage within and between the national surveillance systems is conducted to 
populate missing information (for example, probable route of infection is reported to 
SOPHID but not to the New HIV Diagnoses database) and update inaccurate 
information where possible (for example, an adult reported to multiple annual SOPHIDs 
was reported as white to all but one survey). Where information is still missing or 
inaccurate, follow-up is undertaken with clinicians, health advisors, or data managers 
for all key / mandatory fields (see table 2.1). 
Available 
The data, which underpin the majority of my analysis, are not only comprehensive and 
accurate but also readily available for analysis. It would not have been feasible for me, 
singlehandedly, to assemble a comparable dataset for the purpose of my thesis. 
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2.4.2 Disadvantages of using HARS data 
Fixed variables with limited range 
To promote reporting and encourage clinician co-operation the HARS dataset is kept to 
a minimum (see table 2.1 for a list of variables collected). To facilitate regular reporting 
from all HIV diagnostic sites and sites providing HIV care across E,W&NI the HARS 
dataset is standardised and fixed. The HARS data I use for my analysis are therefore 
limited and inflexible. Although the data facilitate simple trend analysis at the national 
and sub-national level they do not provide insight or context for these trends. 
Overestimating heterosexually-acquired HIV 
Information on probable route of HIV infection has been described as being key to 
understanding the epidemiology of HIV (63). In relation to describing how the 
epidemiology of heterosexually-acquired HIV infection is evolving in E,W&NI, 
accurate information on probable route of HIV infection is crucial. The assignment of 
route of infection through surveillance, however, has been accused of both 
underestimating and overestimating heterosexual HIV transmission.  
The potential for underestimation arises from the rigid and cautionary approach to 
assigning heterosexually-acquired HIV (6, 64, 65). The potential for overestimation 
arises from some MSM being misclassified as heterosexuals due to social stigma (66, 
67). 
In E,W&NI, probable route of infection is assigned through national HIV surveillance 
according to a hierarchy of risk. Heterosexual sex is at the lowest level of this hierarchy. 
To illustrate how the hierarchy is applied we may consider a newly diagnosed adult 
male reported by a clinic as having injected drugs and having had unprotected sex both 
with men and women. Based on current estimates of HIV prevalence, the primary route 
of infection for this adult male would be sex between men. Injecting drug use would be 
his secondary factor and sex with a woman his third. In the USA, where probable route 
of HIV infection is also applied hierarchically, it has been argued that the rigidity of 
assignment results in heterosexual HIV transmission being underestimated (6). 
I would argue that it is unlikely that the figures I present in this thesis represent an 
underestimation of HIV diagnoses among heterosexuals in E,W&NI. The hierarchical 
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approach to HIV risk assignment would result in heterosexually-acquired HIV 
potentially being underestimated if it was applied regularly. In the seven years I was 
jointly responsible for coding probable route of infection on new HIV diagnoses reports 
I rarely applied hierarchical assignment in relation to potential heterosexual 
transmission. This was because few new HIV diagnoses reports presented heterosexual 
sex and one or more other probable route of infection.  
It is likely that the figures I present in this thesis represent an overestimation of HIV 
diagnoses among heterosexuals in E,W&NI because of misclassification. For example, 
in Italy, where probable route of HIV infection is also assigned according to a hierarchy 
of risk, national HIV surveillance data were linked to data from the Italian Cooperative 
Group on AIDS-Related Tumours (67). Comparing probable route of HIV infection 
between the two systems, a lower level of concordance was observed among 
heterosexual men than among PWIDs or MSM (67). The results of the study led to the 
proposition that there was a pervasive tendency for some men to conceal their having 
sex with other men leading to heterosexual transmission being overestimated (66). In 
Florida, an in-depth case review of 168 people reported in 1989 and 1990 as having 
acquired “AIDS” heterosexually resulted in 50 having their risk reclassified (68). The 
majority were reclassified as PWIDs or MSM (68).  
A potential explanation for why some PWIDs or MSM may be misclassified as having 
acquired HIV heterosexually is social stigma. It has been argued that the level of 
misclassification of route of infection among MSM will depend, in part, on the strength 
of social stigma in a country (67).  
As a marker of social stigma in the UK, 6% of 2,092 lesbian, gay and bisexual people in 
England, Scotland and Wales responding to an online interview in 2012 reported that 
they expected to be treated worse than heterosexual people when accessing routine or 
emergency hospital treatment (69). Among gay people from black and minority ethnic 
backgrounds the figure was 12% (69). Related to this, it has been suggested some 
healthcare workers in the UK assume all black and minority ethnic people are 
heterosexual (70). These findings suggest the misclassification of probable route of 
infection among MSM may be limited overall but higher among black and minority 
ethnic groups.  
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Exclusion of heterosexuals living with undiagnosed HIV 
Data from HARS relate only to persons diagnosed with HIV. In the UK, an estimated 
one in four heterosexuals living with HIV in the UK remain undiagnosed (3). Therefore, 
the numbers I present in this thesis relating to diagnosed heterosexuals systematically 
underestimate the true number of heterosexuals living with HIV. 
Underreporting of AIDS diagnoses 
In section 2.4.1, I suggested that the reporting of first AIDS diagnoses at the time of 
HIV diagnosis is likely to be comprehensive. Reports of first AIDS diagnoses 
subsequent to HIV diagnosis, however, are likely to be under-reported as no procedures 
are in place to encourage such reporting. 
2.5 My role in HIV surveillance and monitoring 
I have been employed within the HIV and STI department of PHE for two periods: 
April 2002 to May 2005 and September 2006 to the present day. During the first of 
these two periods I was the Lead Scientist for SOPHID. Between September 2006 and 
January 2011 I was Senior Scientist for New HIV Diagnoses. From January 2011 to the 
present day I have been a Principal HIV Scientist. 
2.5.1 Lead Scientist for SOPHID 
As Lead Scientist for SOPHID I was responsible for developing methodological 
changes concerning the surveillance of adults seen for HIV care. I was also responsible 
for designing and implementing audits of data quality, for maintaining the 
confidentiality of patient information, for coordinating all aspects of database 
management, and for disseminating results from the survey. I supervised a team of three 
scientists and administrators.  
I introduced a number of methodological changes to the system which improved data 
comprehensiveness and validity, and facilitated analysis for this thesis. The 
methodological changes I introduced included linking the annual cross-sectional 
surveys to create a cohort of adults seen for HIV care, establishing a new secure 
document gateway for transferring electronic data, and introducing enhanced and timely 
data quality checks. 
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2.5.2 Senior Scientist for New HIV Diagnoses 
In my role as Senior Scientist I oversaw all activities surrounding the national reporting 
of new HIV and AIDS diagnoses and deaths in HIV-infected individuals. I supervised a 
team of seven scientists and administrators. I introduced a number of methodological 
changes which facilitated analysis for this thesis. I introduced new methods of 
receiving, checking and conducting follow-up on new diagnoses to improve the quality, 
completeness and consistency of these data. I also introduced methodological changes 
to promote integration between the New HIV Diagnoses system and SOPHID.  
In addition to my responsibilities for HIV surveillance, I was responsible for the safe 
storage and handling of Mayisha II study data, and for outputs generated from these 
data. I was also responsible for a number of HIV and STI departmental surveillance 
audits, reviews and evaluations. In 2007 and 2008 I was the departmental lead for an 
evaluation conducted by internal and external stakeholders of all HIV and STI national 
surveillance systems. 
2.5.3 Principal HIV Scientist 
As a principal HIV scientist I am responsible for cross-system operational support and 
scientific leadership on the development and management of routine, integrated 
surveillance outputs, and for ensuring consistency in data analysis methodologies, data 
presentation policies and surveillance operating procedures. As a scientific lead for HIV 
prevention monitoring, I represent the UK on a number of international advisory 
groups. These include the Joint United Nations Programme on HIV/AIDS (UNAIDS) 
Monitoring and Evaluation Reference Group Indicator Working Group (71), and the 
European Centre for Disease Prevention and Control (ECDC) advisory group to monitor 
the Dublin declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia 
(72). As an advisory group member I helped successfully argue for the inclusion of 
migrants in the monitoring of the Dublin declaration. 
I am / have been a co-applicant or work package lead on a number of European wide 
projects. These include the ECDC tendered project “Migrant health: Sexual 
transmission of HIV within migrant groups in the EU/EEA and implications for effective 
interventions” (73), the ECDC tendered project “Revised HIV/AIDS surveillance in 
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Europe, including collection of data about country of HIV infection” (74), and the 
European Union project “Joint Action on Improving Quality in HIV Prevention" (75).  
2.6 My role in bespoke HIV data linkage and assigning country of HIV infection 
2.6.1 Creating a cohort of adults seen for HIV care using SOPHID 
I created with a colleague (Dr Valerie Delpech) a cohort of adults seen for HIV care 
using SOPHID. This was done by linking records across the 1998 to 2007 annual cross-
sectional SOPHIDs on full identifiers (soundex code, sex, date of birth, and postcode of 
residence), and by applying a deterministic matching algorithm written to take into 
consideration a variety of possible matches based on part identifiers (see table 2.2). 
Deterministic matching applies a series of rules. Records are assigned as matches or 
non-matches according to whether the requirements of one of these rules have been met. 
The algorithm presented in table 2.2 was subsequently amended to also consider an 
adults clinic identification number. The algorithm is now routinely applied to annual 
surveys.  
By linking the annual SOPHIDs to create a cohort of adults seen for HIV care it was 
possible to monitor, for the first time, patterns of attendance, loss to follow-up from 
care, and quality of HIV care provision. I explore these themes in Chapters 3 and 4 of 
this thesis. 
Table 2.2: Data linkage algorithm 
Full-matched 
identifiers 1 Full soundex, DOB and sex 
Part-matched 
identifiers              
(identify 
transcription error) 
2 Soundex initial, full DOB and sex 
3 Soundex numbers, full DOB and sex 
4 Full soundex, DOB month/year and 
sex 
5 Full soundex, DOB day/year and sex 
6 Full soundex, DOB day/month and sex 
7 Full soundex, DOB day/month of one 
record to month/day in another and sex 
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2.6.2 Data linkage between HIV and tuberculosis surveillance 
To link individual level data on persons living with diagnosed HIV (as reported to 
HARS) with individual level data relating to diagnoses of tuberculosis (as reported to 
Enhanced Tuberculosis Surveillance) the HIV and tuberculosis surveillance teams at 
PHE (including myself) developed and applied probabilistic matching. Probabilistic 
matching considers the frequency and uniqueness of data and accounts for complex 
typographical errors. Considering soundex code, sex, date of birth, country of birth and 
residential postcode, the probability of two or more records belonging to the same adult 
was expressed as a percentage. Based on this percentage, records were assigned as 
matches, possible matches or non-matches. Possible matches were subsequently 
reviewed by a member of the research team and assigned as matches or non-matches. 
Data linkage between the HIV and tuberculosis systems facilitated my analysis for 
Chapter 5. 
2.6.3 Assigning likely country of HIV infection 
To identify people most at risk of acquiring HIV heterosexually whilst living in the UK 
I developed a new method to assign likely country of HIV infection. Assignment was 
based on CD4 cell count at diagnosis and year of arrival in the UK (data available from 
the New HIV Diagnoses database), estimated year of HIV infection, and estimated CD4 
cell count at HIV infection. 
To estimate year of HIV infection, my colleagues Dr Valerie Delpech and Dr Zheng 
Yin and I applied multilevel linear models with random effects to the square root of 
CD4 cell counts from date of first count to date of last count for eligible adults 
diagnosed with HIV between 1996 and 2010. A proxy date of infection was calculated 
for each adult based on the mid-point between date of last negative HIV test and date of 
first HIV positive test. An individual’s CD4 cell count at infection was estimated by 
extrapolating the parameters of the multilevel linear models to the proxy dates of 
infection. I present the results of this analysis in Chapter 4 of this thesis. 
2.7 Data analysis 
For the purpose of this thesis I analysed, independently and combined, the New HIV 
Diagnoses, SOPHID, and CD4 surveillance datasets. I analysed Enhanced Tuberculosis 
Surveillance data in combination with merged HARS data. I analysed death 
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registrations as part of the New HIV Diagnoses database and IMD rankings as part of 
the SOPHID dataset. I analysed the Mayisha II dataset, which I cleaned and validated, 
independently. 
Throughout this thesis, I define an adult as aged ≥15 years. The only exception is when 
presenting data from the Mayisha II study where I define an adult as ≥16 years (41, 48, 
49). 
2.7.1 Univariate and multivariate analysis 
In this thesis, I applied multivariate logistic regression models to test for associations 
between variables. I include in multivariate logistic regression models explanatory 
variables found to be significantly associated with outcome variables in univariate 
analysis (either at the 95% or 99% level as stated in the published papers). 
2.7.2 Statistical tests  
I compared continuous variables using the Wilcoxon–Mann–Whitney test, and 
compared rates using the Pearson’s χ2 test. I used the Cochran-Armitage chi-square 
trend test for time-trend analysis. To model trends over time I applied a linear 
regression model. I applied longitudinal analysis of the trajectories of CD4 cell counts 
to model CD4 cell decline over time. Testing values and confidence intervals are, as 
indicated, either at the 95% or 99% level. I use STATA 8.2, 9.0, and 12.0 (Stata Corp., 
College Station, Texas, USA) for my analysis. Further information on my statistical 
analysis is included in each of the published papers. 
2.7.3 Geography 
Most of my analysis is based on data for E,W&NI (HARS; ONS national death 
registrations) or England only (MAYISHA II study; Index of Multiple Deprivation). 
Enhanced Tuberculosis Surveillance commenced at the beginning of 1999 in England 
and Wales, and the start of 2000 in Northern Ireland. To maximise the number of years 
included in the analysis for paper 5.1, I focused on England and Wales only. Much of 
the literature I identified in my computerised literature searches (see section 2.8) refers 
to the UK as a whole (i.e. includes Scotland). Where appropriate, in this thesis I refer to 
the UK, E,W&NI, England and Wales, or England only. 
 
44 
 
2.8 Literature review 
In each of the four chapters within which I embed my published papers I identified 
topics raised in the papers for further exploration To this end, I undertook a 
computerised literature search around these topics using Ovid MEDLINE and 
EMBASE by means of City University London’s Health and Society E-Resource 
Databases (76). I applied key terms to search article titles and abstracts for papers 
published in the English language. Research into HIV is fast moving and this has been 
particularly true since the widespread introduction of highly active antiretroviral therapy 
in the late 1990’s. It is for this reason that the majority of my computerised literature 
searches focus on papers published from 2000 onwards. Publications with relevant titles 
were selected for abstract screening. 
I conducted a review of the reference lists of key publications identified through my 
computerised literature searches. Publications of interest were obtained through title and 
/ or author searches using PubMed Central and Google Scholar (77, 78). To identify 
grey literature, I conducted manual Internet key word searches using Google. The 
literature searches I conduct for the purpose of this thesis are presented in Appendix iii. 
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3. Trends in heterosexually-acquired HIV in 
England, Wales and Northern Ireland 
Summary 
In this chapter, I explore trends over time in heterosexually-acquired HIV in E,W&NI. 
The two published papers in this chapter examined: (i) trends among adults living with 
diagnosed HIV in England between 1997 and 2004 and (ii) trends in HIV diagnoses and 
quality of HIV care among heterosexual adults in E,W&NI between 1992 and 2011. 
The first paper is called “The changing epidemiology of diagnosed prevalent HIV 
infections in England: greatest impact on the London environs” (35). In the paper I 
reported an increase in the number of HIV-diagnosed adults living in England between 
1997 and 2004 and highlighted differences in this trend across three regions (London; 
London environs; rest of England). I also presented projections for the number of 
people living with HIV for the period 2005 to 2007, based on the trends for 1997 to 
2004. 
The second paper is called “Trends in HIV diagnoses, HIV care and uptake of 
antiretroviral therapy among heterosexual adults in England, Wales and Northern 
Ireland” (36). In the paper, I reported an increase in the number of HIV diagnoses 
among heterosexual men and women in E,W&NI between 1992 and 2004, followed by 
a steady decline to 2011. I also presented evidence for improvements over time in the 
quality of HIV care among heterosexuals, and report an increase in average age at HIV 
diagnosis. 
In this chapter, I examine the accuracy of the epidemiological predictions I made in the 
first paper. In relation to the second paper, I examine differences in late HIV diagnosis 
and quality of HIV care by age, sex and other factors. I also investigate the increase 
over time in average age at HIV diagnosis.  
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3.1 Introduction 
As described in Chapter 1, approximately six out of ten HIV diagnoses in E,W&NI 
between 1999 and 2012 were among heterosexuals (1). In this chapter, I investigate 
trends over time in heterosexually-acquired HIV in E,W&NI. The chapter includes two 
papers which I published in peer-reviewed journals. In the first paper I examined trends 
in the number of HIV-diagnosed adults living in England between 1997 and 2004, and 
made epidemiological predictions for the period 2005 to 2007 based on these trends. In 
the second paper I explored observed trends in HIV diagnoses and quality of HIV care 
among heterosexual men and women in E,W&NI between 1992 and 2011. 
In this chapter, after summarising the key findings from the two papers I go on to 
explore the accuracy of the epidemiological predictions I made in the first paper. 
Considering the results presented in the second paper, I investigate differences in late 
HIV diagnosis and quality of HIV care by age, sex and other factors among 
heterosexuals. I also examine the increase over time in average age at HIV diagnosis. 
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3.2 The published papers 
3.2.1 Rice et al., Epidemiology & Infection 2007 
The changing epidemiology of diagnosed prevalent HIV infections in England: 
greatest impact on the London environs 
http://www.ncbi.nlm.nih.gov/pubmed/16753075  
Summary: Data from the 1997–2004 Surveys of Prevalent HIV Infections Diagnosed 
were analysed by three geographical areas of residence and treatment to describe the 
heterogeneous growth of the HIV epidemic in England and provide projections to 2007. 
Between 1997 and 2004, the number of diagnosed HIV-infected adults resident in 
England increased by 163 % (14 223 to 37 459). Within the ‘London environs’ the 
increase was 360 % (742 to 3411), within the rest of England 219 % (4417 to 14 088) 
and within London 120 % (9064 to 19 960). By 2004, the London environs had the 
largest proportion of infections acquired through heterosexual sex (and in particular 
women) and the most recently diagnosed population. Projections indicate over half of 
diagnosed HIV- infected adults will live outside London by 2007. The epidemiology of 
diagnosed HIV infection within the London environs is likely to be a predictor of future 
trends in England overall. 
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3.2.2 Rice et al., Sexually Transmitted Diseases 2014 
Trends in HIV diagnoses, HIV care, and uptake of antiretroviral therapy among 
heterosexual adults in England, Wales, and Northern Ireland 
http://www.ncbi.nlm.nih.gov/pubmed/24622638  
Aim: To examine epidemiological trends among heterosexual adults (Q15 years) in 
England, Wales, and Northern Ireland (E,W&NI) newly diagnosed as having HIV 
between 1992 and 2011, or seen for HIV care in 2011. 
Methods: Trend analyses of heterosexual adults newly diagnosed as having HIV in 
E,W&NI in 1992 to 2011 was performed, as well as univariate and multivariate 
analyses examining the late diagnosis of HIV, integration into care, AIDS, uptake of 
antiretroviral therapy, and mor- tality in 2002 to 2011. Data are as reported to the 
national HIVand AIDS Reporting System. 
Results: The number of heterosexual adults newly diagnosed as having HIV in 
E,W&NI  increased steadily between 1992 (731)  and 2004 (4676), before declining 
(2631 in 2011). Nonetheless, in 2011, hetero- sexuals accounted for 49% (2631/5423) 
of all newly diagnosed adults in E,W&NI. Of 38,228 heterosexual adults as having HIV 
between 2002 and 2011, 72% were black African, of whom 99% were born abroad. 
Over the decade, there was an increase in the percentage of HIV diag- nosed 
heterosexuals integrated into care within 28 days of diagnosis (61%Y78%) and in 
receipt of antiretroviral therapy within 1 year of diagnosis (45%Y52%) and a decline in 
the percentage with AIDS (16%Y7%; all, P G 0.01). Late HIV diagnoses (CD4 G350 
mm3) among heterosexuals exceeded 60% in all years. 
Conclusions: Our analyses highlight the impact of migration on the epidemiology of 
heterosexually acquired HIV in E,W&NI. Although there was evidence of an 
improvement in clinical care over time, con- tinued high rates of late diagnosis suggest 
that current testing policies are failing among heterosexuals. 
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3.3 Research findings from my published papers 
The first published paper in this chapter is called “The changing epidemiology of 
diagnosed prevalent HIV infections in England: greatest impact on the London 
environs” and was published in the journal Epidemiology and Infection in 2007 (35). In 
this chapter, it is referred to as paper 3.1. In the paper, I described how the number of 
HIV-diagnosed adults living in England increased between 1997 and 2004, and 
highlighted differences between three regions (London, London environs, and the rest 
of England). The London environs comprised nine 2001 health authorities, eight of 
which bordered London (Buckinghamshire, Hertfordshire, North Essex, South Essex, 
West Kent, East Surrey, West Surrey and Berkshire). The ninth health authority was 
Bedfordshire, and was included due to its proximity and links to London. In paper 3.1, I 
also presented projections for the number of people living with HIV for the period 2005 
to 2007, based on trends from 1997 to 2004 (the last year for which data were 
available). 
In paper 3.1 I reported a 360% increase between 1997 and 2004 in the number of HIV-
diagnosed adults resident in the London environs. In the rest of England and London, 
increases of 219% and 120% were reported (respectively). Differences in trends among 
heterosexuals diagnosed with HIV mainly explained these differing patterns. By the end 
of 2004, the London environs had the largest percentage of diagnosed adults who 
acquired HIV heterosexually, and the largest percentage increase in the number of 
diagnoses among black Africans. 
Applying a linear progression model to the observed data between 1997 and 2004, I 
predicted in paper 3.1 that the number of HIV-diagnosed heterosexuals living in London 
would exceed the number of diagnosed MSM resident in the capital in 2005. This 
phenomenon had already been observed in the London environs and the rest of England. 
I also predicted that half of all diagnosed adults would be living in the London environs 
and the rest of England by 2007 (in 2004, 47% of diagnosed adults in England were 
living in these two areas combined). Finally, I predicted that the epidemiology of 
diagnosed HIV infection within the London environs would be a predictor of future 
trends in England overall. 
The second paper in this chapter is called “Trends in HIV diagnoses, HIV care and 
uptake of antiretroviral therapy among heterosexual adults in England, Wales and 
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Northern Ireland” and was published in the journal Sexually Transmitted Diseases in 
2014 (36). In this chapter, it is referred to as paper 3.2. In the paper, I presented time 
trends in HIV diagnoses among heterosexuals in E,W&NI for the period 1992 to 2011. I 
also explored late HIV diagnosis, first AIDS diagnosis, prompt integration into HIV 
care, uptake of antiretroviral therapy, and short-term mortality for the period 2002 to 
2011. These are considered to be proxies for the uptake of HIV testing and the quality 
of HIV care. 
Following an increase between 1992 and 2004 in the number of heterosexuals 
diagnosed with HIV in E,W&NI, I reported in paper 3.2 a steady decline in diagnoses 
between 2005 to 2011. Behind this overall decline was a reduction in the number of 
diagnoses among black Africans, the majority of whom were born in sub-Saharan 
Africa.  
In paper 3.2 I presented evidence for HIV care among heterosexuals improving over 
time. The percentage of heterosexuals in the study population diagnosed with AIDS 
declined between 2002 and 2011. Over the same time period, the percentage of 
heterosexuals promptly integrated into care or starting antiretroviral therapy within one 
year of HIV diagnosis increased. The decline between 2010 and 2011 in table 2 of paper 
3.2 in the percentage of heterosexuals starting antiretroviral therapy within one year of 
HIV diagnosis is due to the analysis being conducted only to the end of 2011. For the 
majority of persons diagnosed in 2011 uptake of antiretroviral therapy was monitored 
for less than 12 months. 
Despite a slight decline over time (which was not statistically significant), the 
percentage of heterosexuals reported in paper 3.2 as diagnosed late with HIV (CD4 cell 
count <350 cells/ml) between 2002 and 2011 remained high at 64%. In the paper, a late 
HIV diagnosis was shown to be strongly associated with short-term mortality (a death 
within one year of HIV diagnosis). This finding highlights the need for improved HIV 
testing strategies among heterosexuals in E,W&NI.  
In paper 3.2, I also presented evidence of median age at HIV diagnosis increasing 
between 1992 and 2011. Among men median age at diagnosis increased from 33 to 41 
years, and among women from 28 to 36 years.  
51 
 
In the remaining part of this chapter I assess the validity of my predictions in paper 3.1 
on future epidemiological trends. Considering the results presented in paper 3.2, I 
investigate differences in late HIV diagnosis and quality of HIV care by age, sex and 
other factors. I also explore the increase over time in age at HIV diagnosis. I finally 
make recommendations based on papers 3.1 and 3.2 and the analysis in this chapter. 
3.4 Literature search 
The two published papers in this chapter raised a number of issues which I described in 
the previous section. Using the methods I described in Chapter 2 (section 2.8), I 
conducted computerised and manual literature searches in relation to these topics. The 
main topics were: (i) utility of surveillance data to predict HIV trends; (ii) quality of 
HIV care; (iii) late HIV diagnosis; (iv) older age at HIV diagnosis. Appendix iii lists 
details of the searches conducted for this chapter. The identified papers provide the 
foundation for the rest of this chapter. 
3.5  Predicting future epidemiological trends 
In paper 3.1, I extrapolated national HIV surveillance data for England for the period 
2001 to 2004 to provide estimates for 2005 to 2007. Ten years later, it is possible to 
look back and reflect on the accuracy of my estimates. At the time of this analysis the 
SOPHID cohort did not exist and therefore I was not able to follow individuals over 
time. 
3.5.1  Reasonable approximations 
Two predictions which I made in paper 3.1 were more or less borne out. In paper 3.1 I 
predicted an increase in the number of heterosexuals living with diagnosed HIV in 
England from 18,554 in 2004 (observed figure) to 28,053 in 2007. The number of 
heterosexuals living with diagnosed HIV in England did in fact increase between 2004 
and 2007 (as I had predicted) but the actual number in 2007 was 26,520 rather than the 
28,053 I predicted (1). Why did my predicted number slightly exceed the actual 
number? 
The predictions presented in paper 3.1 were based on the assumption that observed 
trends in the number of people seen for HIV care up to 2004 would continue. Overall 
trends in the number of people seen for HIV care are influenced by the annual number 
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of new HIV diagnoses. My predictions for the years 2005 to 2007 were mainly based on 
the observed increase in HIV diagnoses up to 2004 continuing. However, as I 
highlighted in paper 3.2, between 2004 and 2011 there was a year on year decline in the 
number of new HIV diagnoses among heterosexuals in E,W&NI. This decline led to a 
slower rate of increase than I had predicted in the annual number of heterosexuals living 
with diagnosed HIV in England. This slower rate of increase resulted in the observed 
number of heterosexuals living with HIV in 2007 falling slightly short of my predicted 
figure, although the difference was small. 
I also predicted in paper 3.1 that half of all HIV-diagnosed adults in England would be 
living outside London by 2007. The number of HIV-diagnosed adults living outside of 
London actually exceeded the number living in London a year earlier, in 2006 (1). My 
prediction was based on HIV diagnoses continuing to increase in both areas up to 2007 
but with the rate of increase being faster outside of London. Figure 3.1A shows the 
number of HIV diagnoses among heterosexuals in London actually declined from 2003 
onwards. A decline in diagnoses was also observed outside of London but not until two 
years later, in 2005 (see figure 3.1A). The earlier decline in diagnoses among 
heterosexuals in London resulted in the number of HIV-diagnosed adults living outside 
of London exceeding the number living in London one year earlier than I predicted. 
In paper 3.2, I highlighted another potential reason for a divergence between the 
predicted and observed rates of increase. In paper 3.2, the majority of heterosexuals 
diagnosed with HIV were shown to be born abroad, mainly in sub-Saharan Africa. In a 
recent London School of Economics report, it was suggested that between 2001 and 
2011 “poor-country” migrants, including those from Africa, were increasingly settling 
in towns on the outskirts of London as settlement within the boroughs of London was 
becoming ever more financially difficult (79). Also, in 1999 a system of relocating 
asylum seekers across the UK was introduced (80). It is therefore probable that the 
voluntary or involuntary movement of foreign born HIV-diagnosed heterosexuals from 
London to elsewhere in England influenced the observed trends. As neither residency 
status nor reason for moving residence is collected through national HIV surveillance it 
was not possible to consider the voluntary or forced movement of diagnosed people in 
my analysis for paper 3.1 
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Figure 3.1: HIV-diagnosed heterosexuals and men who have sex with men by place 
of diagnosis and residence, 2002 to 2012  
A. Newly diagnosed adults by area of diagnosis
B. Diagnosed adults seen for HIV care by area of residence
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Source: Public Health England (1) 
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3.5.2 Imprecise approximations 
Two predictions I made in paper 3.1 were not borne out. In the first of these two 
predictions I forecast the number of HIV-diagnosed heterosexuals residing in London to 
exceed the number of diagnosed MSM in 2005. Figure 3.1B highlights how the 
observed number of diagnosed heterosexuals resident in London actually remained the 
same or lower than the number of MSM in all years up to 2012 (2005:10,345 
heterosexuals versus 10,421 MSM; 2012: 14,697 heterosexuals versus 15,552 MSM) 
(1).  
In the second prediction I forecast that, as seen in the London environs, heterosexuals, 
black-Africans, and females would account for an increasing percentage of the HIV-
diagnosed population in the rest of England, excluding London. In fact, between 2005 
and 2012, the annual percentage of diagnosed adults living in England outside of 
London who acquired HIV heterosexually, were black African, or were female 
remained more or less constant (heterosexually-acquired: 56% in 2005 and 59% in 
2012; black African: 40% in 2005 and 36% in 2012; female: 37% in 2005 and 35% in 
2012) (1). 
I suggested in paper 3.1 that my predictive model was particularly sensitive to changes 
in the pattern of in-migration of HIV-infected people from high prevalence countries. 
The results I present in paper 3.2 support this suggestion. In paper 3.2, I reported the 
majority of heterosexuals newly diagnosed with HIV in E,W&NI to be black African, 
female, and born in sub-Saharan Africa. I also reported a decline in diagnoses between 
2004 and 2011 which almost certainly reflects corresponding changes in migration to 
the UK. A decline in diagnoses among people arriving in the UK from high HIV 
prevalence countries would translate in to fewer diagnoses among black African and 
female heterosexuals and explain why my two predictions above were not borne out.  
3.5.3 Challenges in predicting future trends 
I highlight mixed success for the predictions I made in paper 3.1. I am not alone in 
failing to predict accurately the future course of HIV. In 1993, it was predicted that the 
heterosexual transmission of HIV in the UK would increase steadily but at a rate lower 
than that among MSM and PWIDs (81). In fact, between 1993 and 2003, the annual 
number of HIV diagnoses among heterosexuals in E,W&NI increased rapidly, among 
55 
 
MSM diagnoses increased steadily, and among PWIDs they decreased (1). In 1986, it 
was claimed in a book entitled “The AIDS Cover Up” there would be 64 million people 
infected with HIV in the USA by 1990 (82). At the end of 2010, an estimated 872,990 
persons were living with diagnosed HIV infection in the USA, of whom approximately 
one in four probably acquired their infection through heterosexual sex (83).  
It has been argued that the utility of HIV surveillance to predict the future course of 
HIV epidemics among heterosexuals is limited due to the long latency period of 
infection and misclassification of risk (84). I disagree with this argument. The latency 
period of HIV can be accounted for by basing predictive models on observed trends in 
diagnoses, preferably over many years, and monitoring changes in the percentage of 
people diagnosed late. In addition, the potential impact of misclassification of risk is 
likely to be small. In Chapter 2 (section 2.4.2), I suggested that the misclassification of 
risk through national HIV surveillance in E,W&NI was limited. In the UK context, I 
would argue that changing patterns of migration and health boundary changes limit the 
utility of surveillance data for predicting the future course of heterosexually-acquired 
HIV.  
Paper 3.2 highlighted the impact of migration on trends of HIV diagnoses among 
heterosexuals in E,W&NI. Despite acknowledging in paper 3.1 the potential impact of 
migration on predicted trends I did not apply an adjustment for migration patterns in my 
analysis. The reason for this was two-fold. At the time of conducting the analysis for 
paper 3.1 it was not clear there would be a subsequent decline in HIV diagnoses and 
that this decline would be associated with changing migration patterns. Also, any 
adjustment would require accurate national and regional estimates of migration patterns 
both to and from the UK. Such data are not easily available as I discuss in Chapter 4. 
There is evidence not only of foreign born people arriving in the UK already infected 
with HIV, but also acquiring HIV post arrival (24). Predictive models of heterosexually-
acquired HIV could be improved if we better understood reasons for ongoing 
heterosexual transmission of HIV in high prevalence countries from which people 
migrate to the UK, and the extent to which these remain present after arrival in the UK. 
Explanations for the ongoing heterosexual transmission of HIV in parts of sub-Saharan 
Africa from which people migrate to the UK include unequal gender relations, 
resistance to sexual behaviour change, and regionally specific sexual behaviours and 
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practices (85, 86). In relation to sexual behaviours and practices, male circumcision (87-
90), concurrent sexual partnerships (91-93), and Herpes Simplex Virus2 prevalence (87, 
94, 95), have been put forward to explain differential rates of heterosexual HIV 
transmission in sub-Saharan Africa. I think it would be fair to say that there remains 
little consensus on why rates of heterosexually-transmitted HIV differ so greatly 
between countries and populations in sub-Saharan Africa. 
The utility of surveillance data in predicting the future course of heterosexually-
acquired HIV is also limited by changes to health boundaries. Between 2002 and 2014, 
there were three major changes to the geographical structure of the NHS. In 2002, 
health authorities were replaced with primary care trusts and strategic health authorities 
(96). In 2006, many of these trusts and authorities were combined to create larger health 
geographies (96). Finally, in 2013, primary care trusts and strategic health authorities 
were abolished and replaced with clinical commissioning groups, NHS area teams, and 
NHS commissioning regions (96, 97). 
On each occasion health boundaries are amended, national HIV surveillance data are 
mapped to the new geographies. Mapping to both the previous and new geographies is 
conducted by linking the postcode of an HIV-diagnosed person’s residence and site of 
HIV care to the Office of National Statistics postcode directory. Once mapping has been 
completed, older geographies are discarded. As a consequence, it was not possible to 
explore recent trends in the London environs, and thereby verify the accuracy of my 
predictions in paper 3.1, as this area was defined by 2001 health authority boundaries 
which have since been abolished.  
3.6 Late HIV diagnosis and quality of HIV care 
As described in Chapter 2 (section 2.6.1), I created with my colleagues a cohort of 
adults seen for HIV care by linking annual cross-sectional SOPHIDs. The creation of a 
cohort of diagnosed persons facilitated the development of measures of late HIV 
diagnosis and quality of HIV care. Currently, seven measures of the uptake of HIV 
testing and quality of HIV care are used in the UK. These seven measures are generally 
(3)referred to as quality of HIV care indicators and are as listed in table 3.1.  
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Table 3.1: Quality of HIV care indicators in the UK 
Indicator Monitoring Measure 
Late diagnosis Timeliness of diagnosis CD4 cell count <350 cells/ml 
within 3 months of diagnosis 
Linkage to care Prompt integration into 
care 
CD4 cell count taken within 2 
weeks, 1 month and 3 months of 
diagnosis 
Retention in care 
among new patients Retention in care 
Seen for care after 12 and 24 
months of diagnosis 
Retention in care 
among all patients Retention in care 
Seen for care in current and 
previous year 
Viral load outcome Effectiveness of ART 
after initiating treatment 
Viral load <50 copies/ml within 
12 months of commencing ART 
ART coverage 
Those in need of 
treatment in receipt of 
treatment 
CD4 cell count <350 cells/ml and 
in receipt of ART 
CD4 outcome 
Immune status of adults 
regardless of treatment 
status 
CD4 cell count ≥350 cells/ml 
after 12 months in care 
Source: Amended from Aghaizu et al., 2013(3) and Delpech et al., 2013 (98) 
Quality of HIV care indicators, it has been argued, enable necessary service 
enhancements by identifying where gaps in care provision are most pronounced (99). 
Several of the quality of HIV care indicators presented in table 3.1 have been revised 
and incorporated into British HIV Association quality standards to promote equity of 
access to care in the UK and to ensure people living with HIV can access the care they 
need (100). 
In paper 3.2, I examined three of the indicators presented in table 3.1. These were: (i) 
late HIV diagnoses; (ii) linkage to care; (iii) ART coverage. I also examined first AIDS 
diagnosis and short-term mortality as markers of late HIV diagnosis and quality of 
subsequent HIV care. 
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3.6.1 Late HIV diagnosis 
A late diagnosis of HIV is associated with increased risk of morbidity and mortality (3, 
20, 101-106). In paper 3.2, I report a small decline between 2002 and 2011 in the 
percentage of heterosexual adults diagnosed late (CD4 cell count <350 cells/ml) from 
66% to 61%. This decline was statistically significant (p<0.01) in univariate but not in 
multivariate analysis. Despite this slight decline, heterosexuals remain more likely to be 
diagnosed late with HIV compared to MSM. In 2012, six out of ten heterosexuals 
diagnosed with HIV in the UK were diagnosed late compared to one in three MSM (3).  
In paper 3.2, late diagnosis was shown to be associated with male sex, older age, non-
white ethnicity, and being born or probably acquiring HIV abroad. How can we explain 
these differences? 
The successful provision of HIV screening through antenatal services may partly 
explain the observed difference in late diagnosis by sex. In 2012, 98% of pregnant 
women attending antenatal services in the UK agreed to have an HIV test (107). This 
high rate of screening ensures the majority of HIV-undiagnosed pregnant women 
attending antenatal services are identified prior to giving birth. Among heterosexual 
men there is no equivalent setting for the systematic offer of an HIV test. 
The authors of a clinic-based study conducted in the USA between 2002 and 2004 
concluded that  low perceived risk for HIV infection by both patients and health 
providers potentially explained elevated rates of late HIV diagnosis among older 
patients (108). It has been argued that persons who present late in general have a low 
perceived risk of infection (109). In the USA, a low rate of HIV risk perception both 
among older adults and HIV service providers has been linked with a reduced number 
of opportunities for HIV testing among persons aged 50 years or above and, therefore, a 
higher level of late diagnosis in this group (110). 
The majority of HIV-diagnosed heterosexuals of black African ethnicity and / or born 
abroad acquire their infection prior to arrival in the UK (24). Therefore, the associations 
between late diagnosis and non-white ethnicity and being born or probably acquiring 
HIV abroad may be due, in part, to some individuals among these groups arriving in the 
UK with established (but undiagnosed) infection. Other potential explanatory factors 
include migrant groups in the UK having poor access to healthcare services due to a 
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range of issues, including a lack of information and fears over privacy  (111-115), HIV 
positive black Africans delaying testing due to them not suspecting their positive status 
(113), symptom misrepresentation (116), and missed opportunities for earlier diagnosis 
in setting such as primary care (101) and tuberculosis services (117, 118) (see sections 
5.6.2 and 6.7.2). Another likely explanatory factor for the reported association is the 
considerable level of stigma attached with HIV in African communities in the United 
Kingdom. Stigma has been reported as a major barrier to accessing HIV testing and 
other HIV services (114, 115, 119, 120). In section 6.7.1, I discuss how testing 
strategies targeted at black African communities in the UK may create stigma. 
Similar associations with late HIV diagnosis to those presented in paper 3.2 have been 
reported elsewhere. Among adults attending two south London hospitals for HIV care 
between 1998 and 2000, black Africans were more likely to present with a lower CD4 
cell count than whites and black Caribbeans (121). Among heterosexuals diagnosed in 
England and Wales between 2000 and 2004, a very late diagnosis (CD4 cell count <200 
cells/ml) was shown to be associated with increased age at diagnosis, and acquiring 
HIV abroad (20). In France (122), Greece (123), and Spain (124), a late diagnosis has 
been associated with acquiring HIV heterosexually. In Greece a late HIV diagnosis has 
also been associated with being born outside of Greece, and increased age at diagnosis 
(123). In Spain, older age, male sex, and being born abroad were predictive factors for a 
late HIV diagnosis (124).  
3.6.2 Linkage to care and ART coverage 
The percentage of newly diagnosed heterosexuals in E,W&NI promptly integrated into 
HIV care (having a CD4 cell count measured within 28 days of HIV diagnosis), or in 
receipt of antiretroviral therapy within one year of diagnosis, is shown in paper 3.2 to 
have increased over time. Prompt integration into care is reported in the paper to be 
associated with recent year of diagnosis, being aged 35 years or above at diagnosis, and 
white ethnicity. Receipt of antiretroviral therapy within one year of diagnosis is reported 
to be associated with recent year of diagnosis, being aged 35 years or above at 
diagnosis, female sex, and late diagnosis. How might we account for these differences? 
The association between recent year of HIV diagnosis and the two quality of care 
indicators most probably reflects changes to guidelines for the treatment of HIV-
infected adults and associated improvements in clinical practise. In 2008, British HIV 
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Association treatment guidelines recommended HIV-diagnosed adults started treatment 
at a higher CD4 cell count than was previously recommended (from 200 cells/ml to 350 
cells/ml) (125). To implement this recommendation it was required that a CD4 cell 
count at diagnosis be conducted among both symptomatic and asymptomatic adults 
newly diagnosed with HIV, and that an increased percentage of these adults start 
antiretroviral therapy within one year of diagnosis. 
The associations between older age at diagnosis and the two quality of care indicators 
(prompt integration into care and receipt of ART) may be explained by the fact that 
heterosexuals aged 35 years or above are more likely to be diagnosed late than those 
aged less than 35 years (reported in paper 3.2). As persons diagnosed late are in greater 
need of timely referral pathways and treatment than those diagnosed promptly a greater 
proportion of older adults, as compared with younger adults, would be fast tracked.  
The association between white ethnicity and prompt integration into HIV care may be 
explained by the finding that white adults in England are more likely than black African 
adults to be diagnosed with HIV in a GUM clinic with integrated services (126). The 
majority of adults diagnosed with HIV outside of a GUM clinic or other HIV services 
will require referral to these services, thereby resulting in some delay. 
The association between female sex and being in receipt of ART within one year of 
diagnosis is harder to interpret as females were less likely than males to be diagnosed 
late. The finding may be linked to the role of antenatal services in promoting prompt 
HIV diagnoses and, where required, treatment among women. 
3.6.3 AIDS defining illnesses and deaths 
Among HIV-diagnosed heterosexuals both the number of AIDS diagnoses (a diagnosis 
of an AIDS defining illness) and deaths are reported in paper 3.2 as having declined 
between 2002 and 2011. Among heterosexuals who died, two-thirds died within one 
year of HIV diagnosis (referred to as short-term mortality). 
In paper 3.2, an AIDS diagnosis was shown to be associated with earlier year of HIV 
diagnosis, male sex, older age at HIV diagnosis, and being born and probably acquiring 
HIV abroad. The associations between AIDS diagnosis and male sex, older age, and 
being born and probably acquiring HIV abroad are most likely explained by late 
diagnosis, for which the same associations were presented in section 3.6.1. Although 
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over nine in ten heterosexuals with an AIDS diagnosis were diagnosed late, a late 
diagnosis was not included as an explanatory variable for AIDS diagnosis in paper 3.2 
as both are markers of severe immunosuppression. The association between an AIDS 
diagnosis and year of diagnosis probably reflects improvements in quality of HIV care 
over time. In recent years, improvements in prompt entry into HIV care and in 
maintaining a high CD4 count have been linked with better clinical outcomes (98). 
Short-term mortality was shown in paper 3.2 to be strongly associated with late HIV 
diagnosis and not receiving antiretroviral therapy within one year of HIV diagnosis. 
These associations are probably explained by the fact that the predicted life expectancy 
of a person diagnosed with HIV is relatively high if they are diagnosed promptly and 
have access to a wide range of antiretroviral drugs (127). Persons diagnosed late are 
more likely to die shortly after diagnosis before they can begin antiretroviral therapy 
(20, 127). Short-term mortality was also reported in paper 3.2 to be associated with 
male sex and older age at HIV diagnosis. The strength of the association between short-
term mortality and age at diagnosis increased with age. It is likely that this finding is 
partly explained by higher overall deaths rates in the general population among older 
age groups (128). The association between male sex and short-term mortality is difficult 
to interpret.  
The results I presented in paper 3.2 are similar to the results of previous analysis of HIV 
surveillance data. In England and Wales between 2000 and 2004, one third of 
heterosexuals diagnosed very late with HIV also had an AIDS diagnosis (20). Among 
heterosexuals diagnosed with a CD4 count ≥200 cells/ml the figure was 4% (20). 
Among the heterosexuals diagnosed very late, the percentage who died within a year of 
their diagnosis was nine times higher than among those diagnosed earlier (20). 
In paper 3.2, I linked the decline in AIDS diagnoses and deaths with improvements in 
clinical HIV care. A previous analysis of mortality trends among HIV-diagnosed 
persons in England and Wales between 1999 and 2008 also linked the observed 
reduction in deaths among heterosexuals with enhancements in clinical care (129). This 
analysis however, highlighted the need for further enhancements. Despite the decline in 
deaths, the mortality rate among HIV-diagnosed heterosexuals in 2008 was reported to 
be five times higher than that in the general population (129). 
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3.6.4 Reducing late HIV diagnosis and improving quality of HIV care 
In paper 3.2, I reported mixed success in reducing late HIV diagnosis and improving 
quality of HIV care among heterosexuals in E,W&NI over time. Although I reported a 
slight decline between 2002 and 2011 in the percentage of heterosexual adults 
diagnosed late, in 2012 six out of ten heterosexuals were diagnosed beyond the point 
treatment should have commenced. This proportion is unacceptably high and remains 
almost double that among MSM. 
On the other hand, I also presented evidence of success in paper 3.2. I reported increases 
over the study period in the percentage of newly diagnosed heterosexuals in E,W&NI 
promptly integrated into HIV care or in receipt of antiretroviral therapy within one year 
of diagnosis. I also reported a reduction in the number of HIV-diagnosed heterosexuals 
diagnosed with an AIDS defining illness or having died between 2002 and 2011.  
The authors of a recent study based on national HIV surveillance data concluded that 
the UK NHS provides high quality HIV care, and that there was no evidence of health 
inequalities in relation to access to, and retention in, HIV care (98). However, they did 
find elevated rates of late diagnosis among black Africans. The authors concluded that 
this was largely a result of adults of sub-Saharan origin having acquired HIV prior to 
arriving in UK (98). The authors of the study highlighted how their findings were in 
sharp contrast to similar studies conducted in the USA (98). In the UK, it was estimated 
that of the 96,000 people living with HIV in 2011 (diagnosed and undiagnosed) half had 
an undetectable viral load (<50 copies/ml) (130). In the USA, of the estimated 1.1 
million people living with HIV in the USA in 2011 only one quarter were estimated to 
have achieved viral suppression (131). Poorer quality HIV care in the USA as compared 
to the UK may be explained by differences in national healthcare provision. In the UK, 
HIV care through the NHS is free and open access whereas in the USA HIV care is 
largely provided by private organisations. It has been suggested that one of the reasons 
for a low rate of retention in HIV care among people of black ethnicity in the USA is a 
lack of health insurance (132). 
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3.7 Increase in median age at HIV diagnosis 
In paper 3.2, I reported median age at HIV diagnosis among heterosexuals as having 
increased over the study period. Between 1992 and 2011, median age at diagnosis 
increased from 33 to 41 years among men and from 28 to 36 years among women.  
Over the same period of time during which median age at HIV diagnosis increased, the 
number of HIV diagnoses among heterosexuals born abroad, specifically in sub-Saharan 
Africa, declined (36). As compared to the overall population, a greater proportion of 
migrants to the UK are of working-age (16 to 59 years for women and 16 to 64 years for 
men) (133). If, on average, migrants are younger than the general population, a 
reduction in the number of migrants and in the number of diagnoses among migrants 
would lead to an increase in median age among the remaining population diagnosed 
with HIV.  
Based on additional analysis of the data I described in paper 3.2, in table 3.2 I present 
median age at HIV diagnosis among heterosexuals by year and ethnicity. Median age at 
diagnosis is shown in table 3.2 to increase not only among black Africans, of whom the 
majority are born abroad, but also among people of white, black Caribbean and other 
ethnicity. The majority of people of white or black Caribbean ethnicity were born in the 
UK. This increase in median age at diagnosis among all ethnic groups suggests the 
impact of reduced migration on median age at diagnosis is modest, if it exists at all. 
Table 3.2:  Median age at diagnosis among heterosexual adults (aged ≥15 years at 
diagnosis) in E,W&NI by ethnicity, 2002 to 2011 
  
Year of HIV diagnosis 
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 
Black African 32 33 33 33 33 35 35 36 37 37 
White 35 36 36 37 36 39 38 39 40 40 
Black Caribbean 32 32 32 34 35 32 37 39 42 43 
Other ethnicity 31 32 31 33 33 34 35 35 36 37 
Source: Additional analysis of data presented in Paper 3.2 
A more likely explanation for the increase in median age at diagnosis is a rise of HIV 
transmission among older adults. In a previous analysis of national HIV surveillance 
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data, the overall number of HIV diagnoses in E,W&NI among older adults (aged 50 
years or above) was shown to have more than doubled between 2000 and 2007 (104). 
Of the increasing number of older adults diagnosed with HIV, it was estimated half 
acquired their infection when aged 50 years or over (104). It has been proposed that an 
increase in HIV infection among older adults is due to an ageing population, an 
increased number of older adults starting new sexual relationships, and poor risk 
perception (110, 134, 135). 
Between 1985 and 2010, the median age of the UK population increased from 35.4 
years to 39.7 years (136). Over this same time period, the percentage of the UK 
population aged 65 years or over increased from 15% to 17% (136). Although this 
percentage growth appears modest, it represents an increase of 1.7 million people aged 
65 years or over (136). An increase in the number of older adults in the population will 
lead to an increase in the number of older people at risk of heterosexually-acquired HIV 
if sexual risk behaviour remains constant, or increases, in this group. 
It has been suggested that an overall increase in sexually transmitted infections among 
older adults in the UK may, in part, be associated with an increasing number of older 
adults leaving long-term relationships (135). In the USA, an increase in HIV diagnoses 
among older adults has been linked with a high number of widowed and divorced 
people commencing new sexual relationships (134). In Sweden, it has been suggested 
that an observed increase in sexual activity in older people may partly be due to the 
general population having more positive attitudes to sexuality in later life (137). 
In relation to older men in countries such as the UK and USA, a greater number may 
now be capable of vaginal or anal intercourse due to the availability of erectile 
dysfunction medications (134, 135). In relation to older women, they may be more 
likely than younger women to have unprotected sex due to the greatly reduced chance of 
pregnancy (134). Age-related thinning and dryness of vaginal tissue may also increase 
the risk of HIV infection among sexually active older women (134). Unfortunately, 
evidence for on-going risk of HIV transmission among older adults is not presented by 
ethnic group.  
Another potential explanation for older adults being at increased risk of acquiring HIV 
is risk perception. In the USA, it has been suggested that although older adults visit their 
65 
 
doctors frequently, they are less likely than younger adults to discuss sexual habits 
(134).  
3.8 Recommendations  
In papers 3.1 and 3.2, I explored trends in HIV diagnoses. In paper 3.1 I highlighted the 
diverse growth of the HIV epidemic between regions of England, and in paper 3.2 
presented trends in HIV diagnoses and quality of HIV care among heterosexual adults 
in E,W&NI. 
Based on the analysis of paper 3.1, I recommended local services be responsive to 
increases and changes in their diagnosed HIV-infected population as described by 
national surveillance. Since 2008, the British HIV Association has recommended HIV 
testing be expanded beyond specialised sexual health services in local areas where 
national surveillance data show diagnosed HIV prevalence (based on SOPHID data) to 
exceed two per 1,000 population aged 15-59 years (138). 
In section 3.5.3 I highlighted how changing migration patterns and health boundaries 
present challenges when predicting the future course of diagnosed HIV. These 
challenges can be overcome by exploring methods to adjust for inward and outward 
migration, and by assessing at which geographical level estimates remain both robust 
and useful for the planning of HIV services.  
To minimize the risk of on-going transmission of HIV within the UK, I argue in paper 
3.1 for sustained HIV prevention activities among heterosexual men and women from 
countries with a high HIV prevalence. In paper 3.2, I conclude that the results presented 
underscore the need for targeted HIV prevention strategies and making available to 
black Africans the routine offer of an HIV test in a range of healthcare and community 
settings, as recommended in the National Institute for Health and Clinical Excellence 
guidance on HIV testing in 2011 (139). 
Research conducted in this country has highlighted on-going heterosexual HIV 
transmission within the UK among African communities (23, 24). Based on this 
evidence, the National AIDS Trust called for a holistic HIV prevention strategy to 
reduce HIV incidence amongst black African men and women in the UK (140). In 
addition to HIV testing, it was suggested that a holistic HIV prevention strategy include 
the promotion of free or affordable condoms and lubricant, health promotion and 
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outreach work, methods to address risks associated with travel to and from countries of 
origin (see section 4.8.1), and the engagement of faith groups (140). 
Evidence is presented in paper 3.2 for improvements over time in the quality of HIV 
care received by heterosexuals. Caution, however, should be exercised when 
interpreting these results as they relate to diagnosed heterosexuals only. Had both 
diagnosed and undiagnosed heterosexuals been considered, the percentage promptly 
integrated into care or in receipt of ART would have been substantially lower. This 
point should be made clear when quality of care indicators are presented. The issue of 
undiagnosed HIV among heterosexuals is discussed in Chapter 6. 
In section 3.7, I suggested the increase in median age at HIV diagnosis among 
heterosexuals is associated with a rise of HIV transmission among older adults, which 
in turn, is due to an aging population having increased sexual relationships. Research 
into strategies to reduce HIV transmission among older adults is warranted.  
In an editorial accompanying the publication of paper 3.2, two recommendations were 
put forward in light of the paper’s findings (141). Firstly, the authors of the editorial 
argued for widespread and, where appropriate, repeated HIV testing to facilitate prompt 
initiation of antiretroviral treatment among those diagnosed positive (141). I believe the 
British HIV Association recommendation for expanded HIV testing in local areas where 
diagnosed HIV prevalence exceeds two per 1,000 adult population strikes the right 
balance between widespread and targeted HIV testing strategies. In relation to repeat 
testing, to reduce late HIV diagnoses among heterosexuals I believe further research is 
warranted into the frequency of testing. This research should include community and 
provider engagement, an examination of the frequency with which the target population 
engage with healthcare and community settings where HIV testing is offered, the 
likelihood that a person who previously tested HIV negative will acquire HIV infection 
(i.e. the incidence), and the cost effectiveness (for example, cost per infection averted, 
cost per life year gained and cost per quality-adjusted life year gained). Future research 
should also take into account HIV-related stigma and how best to make testing facilities 
both accessible and acceptable to heterosexual men and women in this country. 
Secondly, the authors of the editorial recommended the use of HIV surveillance data to 
monitor interventions, justify the deployment of prevention strategies available, and 
make predictions on future benefit (141). I support this recommendation. 
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Comprehensive and validated surveillance systems can provide routine and accurate risk 
information which may be used to develop, deploy and monitor prevention and 
treatment strategies. 
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4. Migration 
Summary 
In this chapter, I consider the challenges we face in accurately assessing the impact of 
migration on the epidemiology of heterosexually-acquired HIV in E,W&NI. For the 
purposes of this chapter I apply the United Nations Educational, Scientific and Cultural 
Organisation (UNESCO) definition of migration as the “crossing of the boundary of a 
political or administrative unit for a certain minimum period of time” or the “territorial 
relocation of people between nation-states” (142). The two published papers in this 
chapter examine: (i) country of HIV infection among migrants living in the UK and (ii) 
retention in HIV care in E,W&NI.  
The first paper is called “A new method to assign country of HIV infection among 
heterosexuals born abroad and diagnosed with HIV in the UK”. The paper highlighted 
difficulties in accurately ascertaining where heterosexual adults who were born abroad 
and diagnosed with HIV in E,W&NI actually acquired their infection (the majority were 
born in sub-Saharan Africa and were of black African ethnicity) (24). To address these 
difficulties, I developed a new method for ascertaining likely country of HIV 
acquisition among heterosexual adults born abroad.  
The second paper is called “Loss to follow-up among adults attending HIV-services in 
England, Wales and Northern Ireland”. In the paper, I examined annual patterns of 
attendance at HIV services in E,W&NI (37). I identified two phenomena previously not 
reported at the national level. These were: (i) permanent loss to follow-up to HIV 
services and (ii) intermittent attendance at services. Outward migration from the UK 
was put forward as a partial explanation for loss to follow-up. 
Both papers relied on a definition of migration which has been adopted by PHE. In this 
chapter, I explore different definitions of migration and migrants both in the general 
population and in relation to HIV. I highlight the importance of applying clear and 
meaningful definitions when ascertaining the impact of migration on heterosexually-
acquired HIV. I also examine the impact of migration on the heterosexual transmission 
of HIV in E,W&NI and consider whether a “home-grown” epidemic has developed 
among heterosexuals either born abroad or born in the UK. I then go on to examine the 
possibility that outward migration from the UK has contributed to people being lost to 
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follow-up. Finally I describe the impact of the two published papers to date and make 
some recommendations.  
4.1 Introduction 
In Chapters 1 and 3 I highlighted that the majority of heterosexual adults newly 
diagnosed with HIV in E,W&NI were born abroad. Most of the heterosexual adults born 
abroad originated from sub-Saharan Africa. In this chapter I examine the impact of 
migration on the epidemiology of heterosexually-acquired HIV in E,W&NI. The 
chapter includes two papers which I published in peer-reviewed journals. The first paper 
examined the country of HIV infection among migrants while the second paper 
considered retention in HIV care in E,W&NI. In this chapter, after summarising the key 
findings from the papers I go on to conduct a detailed examination of definitions of 
migration and migrants. I also consider challenges in assessing the impact of migration 
on heterosexually-acquired HIV in E,W&NI. Finally I consider the impact of my papers 
and the two new methods I developed for describing the epidemiology of 
heterosexually-acquired HIV in E,W&NI. 
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4.2 The published papers 
4.2.1 Rice et al., AIDS 2012 
A new method to assign country of HIV infection among heterosexuals born 
abroad and diagnosed with HIV in the UK 
http://www.ncbi.nlm.nih.gov/pubmed/22781226  
Objective: To apply a new method to ascertain likely place of HIV infection among 
persons born abroad and diagnosed with HIV in the United Kingdom (UK). 
Design: Analyses of heterosexual adults born abroad, diagnosed with HIV in the UK 
between 2004 and 2010, and reported to the national HIV diagnoses database. 
Methods: Year of infection was ascertained by applying an estimated rate of CD4-cell 
count decline between an individual’s CD4-cell count at diagnosis and estimates of 
CD4-cell count at infection. A person was classified as having probably acquired HIV 
while living in the UK if estimated year of infection was later than reported year of 
arrival in the UK. 
Results: Of 10,612 heterosexual adults born abroad included in the analyses, 85% 
(9065) were of black-African ethnicity. We estimate that 33% (26%-39%) of persons 
acquired HIV whilst living in the UK. This percentage increased from 24% (16%-39%) 
in 2004 to 46% (31%-50%) in 2010 (p < 0.01). The estimate of 33% is three times 
higher than national estimates of HIV acquired in the UK based on clinic reports (11%) 
(p< 0.01). 
Conclusions: Assigning place of HIV infection using routinely available clinical and 
demographic data and estimated rates of CD4-cell decline is feasible. We report a high 
and increasing proportion of persons born abroad who appear to have acquired their 
HIV infection whilst living in the UK These findings highlight the need for continued 
targeted HIV prevention efforts, particularly among black-African communities. 
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4.2.2 Rice et al., Sexually Transmitted Diseases 2011 
Loss to Follow-Up among adults attending Human Immunodeficiency Virus 
services in England, Wales, and Northern Ireland 
http://www.ncbi.nlm.nih.gov/pubmed/21844719  
Aim: To assess the extent to which human immunodeficiency virus (HIV)-diagnosed 
adults attending HIV-services in England, Wales, and Northern Ireland are lost to 
follow-up or attend services intermittently.  
Methods: A cohort of HIV-diagnosed adults was created by linking records across the 
1998 to 2007 national annual Survey of Prevalent HIV Infections Diagnosed. The 
records were also linked to the national HIV and acquired immune deficiency syndrome 
New Diagnoses Database (n = 61,495) and to Office for National Statistics death 
records. Patterns of HIV-service attendance were analyzed. 
Results: On average, 90% of adults attending HIV-services in any one year attended the 
following year. Nearly 5% of adults attending services in any one year were lost to 
follow-up, a further 4% subsequently attended services intermittently, whereas less than 
2% died. Cumulatively, 19% of adults seen for HIV care between 1998 and 2006 were 
lost to follow-up by the end of 2007. Factors associated with loss to follow-up included 
being the following: female; aged 15 to 34 years; black-African or “other” ethnicity; not 
on antiretroviral therapy; recently diagnosed; and infected outside the United Kingdom. 
Conclusions: Although the majority of HIV-diagnosed adults in England, Wales, and 
Northern Ireland attended HIV-services regularly, cumulatively nearly 1 in 5 adults 
were lost to follow-up between 1998 and 2007. Innovative strategies focusing on those 
most likely to drop out of regular care should be developed to maintain regular service 
engagement and to ensure optimal care. 
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4.3 Research findings from my published papers 
The first published paper included in this chapter is called “A new method to assign 
country of HIV infection among heterosexuals born abroad and diagnosed with HIV in 
the UK” and was published in the journal AIDS in 2012 (24). In this chapter it is 
referred to as paper 4.1. In the paper, the importance of knowing where HIV was 
acquired was highlighted. Recognising limitations in the existing method for assigning 
likely country of HIV acquisition based on clinic HIV reports, in paper 4.1 I introduced 
a new method of assignment among heterosexual adults born abroad and diagnosed 
with HIV in E,W&NI between 2004 and 2010. The overwhelming majority of the study 
population were of black African ethnicity. The new method utilised routinely available 
clinical and demographic data to establish whether an HIV-diagnosed heterosexual adult 
who was born abroad acquired HIV before or after their arrival in the UK. A year of 
HIV infection was calculated for each adult in the study population by applying 
ethnicity and age specific rates of CD4 cell decline between their CD4 cell count at 
diagnosis and estimated CD4 cell count at infection. Adults were classified as having 
probably acquired HIV while living in the UK if their estimated year of infection was 
later than their reported year of arrival in UK.  
According to the new method, over the study period one third of heterosexual adults 
born abroad acquired HIV whilst living in the UK. This proportion increased from just 
below one quarter in 2004 to nearly a half in 2010. This estimate of one third of foreign-
born adults acquiring HIV whilst living in the UK was three times higher than the 
national estimate based on clinic reports. A recommendation was made in the paper for 
the new method to be applied in other countries where there are a high number of HIV 
diagnoses among migrant populations. 
The second published paper included in this chapter is called “Loss to follow-up among 
adults attending HIV-services in England, Wales and Northern Ireland” and was 
published in the journal Sexually Transmitted Diseases in 2011 (37). In this chapter I 
refer to it as paper 4.2. In paper 4.2 I explored annual patterns of attendance at HIV 
services in E,W&NI at the national level for the first time. I also investigated factors, 
other than death, associated with HIV-diagnosed adults no longer accessing HIV care or 
accessing care intermittently. 
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Nine out of ten adults attending HIV services in any one year between 1998 and 2006 
were shown to also attend services the following year. However, on average nearly 5% 
of adults attending HIV services in any one year were reported as lost to follow-up from 
care. An additional 4% of adults were reported as subsequently attending services 
intermittently, while fewer than 2% were reported as having died. Cumulatively, 
between 1998 to 2006, one in five adults attending HIV-related services in E,W&NI 
was lost to follow-up. Nonetheless, the vast majority of adults diagnosed with HIV in 
the UK continued to engage with services during the study period. 
I suggested in the paper that outward migration from the UK may partially explain loss 
to follow-up. This suggestion was based on analyses showing adults of black African 
ethnicity, those who acquired HIV outside the UK, those not in receipt of antiretroviral 
therapy, and those recently diagnosed with HIV in the UK, as the groups most likely to 
be lost to follow-up. Although these associations provided some evidence of emigration 
contributing to loss to follow-up, it was not possible to judge the extent to which this 
was the case in the published paper. 
Both papers relied on a definition of migration which has been adopted by PHE. In this 
chapter, I will explore different definitions of migration both in the general population 
and in relation to HIV. I go on to highlight the importance of applying clear and 
meaningful definitions when ascertaining the impact of inward and outward migration 
on heterosexually-acquired HIV in E,W&NI. 
4.4 Literature search 
Using the methods I described in Chapter 2 (section 2.8), I conducted computerised and 
manual literature searches in relation to the topics raised in the two published papers in 
this chapter. The topics were as follows: (i) heterosexually-acquired HIV and migration 
(ii) challenges of HIV surveillance; (iii) CD4 decline; (iv) HIV, migrants and migration; 
(v) HIV and migration in Europe; (vi) HIV and migration in the USA. Appendix iii lists 
details of the searches conducted for this chapter. The identified papers provided the 
foundation for the rest of this chapter. 
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4.5 Different ways of defining migrants in the general population 
To understand the different ways migrants may be characterised in relation to HIV, it is 
useful to first consider national and international definitions of migrants and migration. 
The European Union’s European Foundation for the Improvement of Living and 
Working Conditions broadly defines migrants as persons moving across borders to live 
and work (143). The United Nations Educational, Scientific and Cultural Organisation 
(UNESCO) describes migration as the “crossing of the boundary of a political or 
administrative unit for a certain minimum period of time” or the “territorial relocation 
of people between nation-states” (142). The United Nations also characterises migrants 
according to the length of time they migrate. Long-Term International Migration 
(LTIM) is defined as “A person who moves to a country other than that of his or her 
usual residence for a period of at least a year… so that the country of destination 
effectively becomes his or her new country of usual residence.” (144). 
The European Migration Network, coordinated by the European Commission, provides 
a list of different types of migrants and reasons for migration (145). A similar list is 
provided by UNESCO where migrants are categorised according to their motives or 
legal status. Table 4.1 presents the European Migration Network and UNESCO 
categories.  
Table 4.1: Types of migrants and reasons for migration 
European Migration Network types of migration and migrants
UNESCO types of migrants
Migrants  - Environmentally-driven; Forced; Highly qualified; Illegally resident / staying; Irregular; Labour; 
Long-term; Second generation; Short-term; Transit; Worker
Temporary labour / guest worker migrants; Highly skilled and business migrants; Irregular / undocumented / 
illegal migrants; Refugees / asylum seekers / people forced to move due to external factors; Family reunion / 
family reunification migrants; Return migrants
Migration  - Economic; Exploitative; Family; Forced; Illegal; Irregular; Labour; Legal; Managed; Permanent; 
Spontaneous; Temporary
 
Source: European Migration Network, 2014 (145) and UNESCO, 2013 (142) 
No single definition of migrants or migration is applied within the UK. The ONS 
International Passenger Survey (IPS) and Labour Force Survey (LFS) are two of the 
main sources of information on migration in the UK (146-148). Both apply different 
definitions of migrants and different methods for quantifying migration. 
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The IPS, in combination with data from the Home Office and Irish Central Statistics 
Office, reports on long-term international migration, with the definition of LTIM being 
the same as that of the United Nations (146, 147). The survey captures information on 
passengers travelling into or out of the UK via major routes and includes questions on 
reason for migration and country of birth. The LFS measures the number of people 
resident in the UK who were born abroad or have non-British nationality (146, 147). 
Approximately 53,000 private households are sampled quarterly and the sample is 
weighted to ONS population estimates so that it is representative of the general 
population.  
The University of Oxford’s Migration Observatory suggests that the term migrant is 
often unclear in public debate and is often conflated with ethnicity, religion and 
immigration status (149). This lack of clarity is not helped by national and international 
bodies applying different, and often subjective, definitions of migrants and migration. 
Several of the definitions described above could be labelled as subjective as they rely on 
self-definition. For example, estimates of LTIM via the IPS are based on how long a 
respondent intends to stay in the UK rather than on their actual length of stay. 
4.6 Different ways of defining migrants at risk of HIV 
A sound epidemiological variable has been described as one that differentiates 
populations in some underlying characteristic relevant to health (150). In relation to 
HIV, a definition should highlight the risk among migrants whilst ensuring xenophobia 
and stigmatisation are not promoted. This final point is of particularly importance given 
the propensity of the UK media to present migrants in a poor light. Headline such as 
“Where Britain’s New Hetero AIDS Cases Began” (151), “Asylum seekers with killer 
diseases exploit legal loophole to avoid deportation” (152), “Aids infected asylum-
seekers overwhelm-UK hospitals” (153), and “The secret threat to British lives” (154) 
provide evidence for the need to think carefully how best to define migrants in relation 
to HIV research.  
The literature search conducted for this chapter identified several definitions of migrants 
which may provide a foundation for public health action in relation to heterosexually 
acquired HIV and, if applied sensitively, avoid negative stereotyping. These include 
country of birth, ethnicity, nationality, second-generation migrant, and long-term 
international migrant. Each of these are considered below. 
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4.6.1 Country of birth 
Historical, economic and socio-political ties have facilitated the movement of people to 
the UK from a wide range of countries. A large number of people arrive in the UK from 
the Indian sub-continent, where there are concentrated HIV epidemics, sub-Saharan 
Africa, where many countries have generalised HIV epidemics (HIV prevalence ≥1% in 
the general population), and other European Union countries, within which HIV 
prevalence varies greatly (155, 156). Therefore, when presented along with national 
HIV prevalence estimates, country of birth can provide a crude assessment of risk. Even 
then, data presented by country of birth can mask variations in HIV risk across sub-
populations within countries. 
4.6.2 Ethnicity 
Ethnicity based on skin colour has been described as subjective, imprecise, and 
unreliable (150). Collecting information on ethnicity has been labelled complex due to 
the subjective, multifaceted and changing nature of ethnic identification, which is often 
self-defined, and due to changing social and political attitudes (157). Recognising the 
complexities of collecting information on ethnicity in the UK, the ONS provides 
guidance on how to request, harmonise and present such data (157).  
In 1991 a question on ethnic group was introduced to the UK census. It has been 
suggested that it was introduced, in part, to measure success in tackling social 
inequalities among the UK population according to ethnicity highlighted by sample 
surveys in the 1980’s (158). It had originally been planned that a question on ethnicity 
would be introduced in the 1981 census (158, 159). Its introduction was postponed 
following an unsuccessful trial in 1979 (159). Ethnicity has now been requested in the 
past three UK censuses (1991, 2001 and 2011), and on all three occasions both the 
instructions and the categorisation of ethnicity have differed slightly (160). Assignment 
of ethnic group in the census is based on self-classification and reflects the group an 
individual see themselves belonging to (161). It has been highlighted that the census 
question on ethnic group does not necessarily reflect an individual’s place of birth 
(161).  
In relation to health research, concern has been raised over the potential for ethnicity 
data to be misused or misinterpreted (162), or result in stereotyping and exploitation 
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(163). There is also concern that ethnicity-based research provides ammunition to 
claims that ethnic minorities are a burden on society (85), and that it transforms ethnic 
minorities into statistical categories which reinforce stereotypes (164). There is also 
concern that research into ethnicity and health often applies a comparative approach 
where the white population is used as a standard against which diseases that are more 
common in ethnic minority groups are compared (165). It has been argued that this 
approach may mask preventable diseases among ethnic minority groups because they 
are less common than among the white population (165). 
In support of the use of ethnicity data, it has been argued that to reduce health 
inequalities and target HIV prevention activities in the UK it important that ethnicity, 
alongside country of birth, be collected through HIV surveillance (162, 166). By 
acknowledging ethnic disparities, it has been suggested communities would be 
empowered to act against HIV (163).  
Ethnicity was included in the HIV surveillance system in E,W&NI in 1992. The 
following broad categorisation of ethnicity was applied: white; black African; black 
Caribbean; black other; Indian sub-continent; other/mixed; not known. In 2014, the 
categorisation of ethnicity in HIV surveillance was widened to meet NHS Information 
Standards Board data standards (167). Ethnicity is now categorised as follows: White 
(British; Irish; any other white background); Mixed (white and black Caribbean; white 
and black African; white and Asian; any other mixed background); Asian or Asian 
British (Indian; Pakistani; Bangladeshi; Any other Asian background); Black or Black 
British (Caribbean; African; any other black background); Other Ethnic Groups 
(Chinese; any other ethnic group; not stated). Discussions are on-going with regards 
how best to present data according to these categories.  
When considering how best to present data on ethnicity it should be noted that in the 
past it has been suggested that there should be a unified approach to HIV prevention 
among African communities in the UK to increase the potential for raising funds (168). 
Recently in France, it was similarly suggested nationality be more broadly categorised 
so that HIV prevention programmes consider sub-Saharan Africans as a single racial 
minority (169). Not all are in agreement with this homogenous approach. In 2003, HIV 
researchers in the UK were accused of obscuring heterogeneity within ethnicity groups 
by applying broad categorisations such as black African (85). The category of black 
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African will comprise people born in the UK, born in low or high HIV prevalence areas 
of Africa, or born elsewhere. 
4.6.3 Nationality 
Nationality is where a person holds citizenship of a national state. There are six types of 
British Nationality, and it is possible for a person to renounce their British nationality 
(170). It is also possible for a British citizen to be a national of one or more other 
countries (171). 
In the LFS, a migrant is defined as someone who reports having been born abroad, or 
being of non-British nationality (146). There is a preference to present LFS outputs by a 
person’s country of birth, as it tends not to change over time. A person’s nationality 
may change over time. For example, a person may arrive in the UK as a foreign 
national, but subsequently become a UK national.  
In France, where nationality is routinely collected through HIV surveillance, it has been 
acknowledged that a major limitation of this variable in studying the impact of 
migration on HIV is that foreign-born persons obtaining French citizenship will be 
assigned as French (172). The use of self-reported nationality in research has also been 
criticised as it may be based on a person’s social or cultural affinity (146), or a 
combination of their place of birth, culture, and personal histories (173). 
4.6.4 Second generation migrant 
Second-generation migrants are persons born within a country to parents of whom one 
or both arrived in the country as a migrant. In terms of HIV risk, sexual mixing between 
different ethnic groups (known as dissortative sexual mixing) in the Netherlands has 
been shown to be higher among second-generation “migrants” than first-generation 
migrants (174). This finding led the authors of the study to conclude that disassortative 
sexual mixing would increase as second-generation “migrants” reach adulthood and 
first-generation migrants give birth to more second-generation “migrants” (174). In the 
Netherlands this could increase the risk of HIV transmission within the country. 
In the UK migrants born in sub-Saharan Africa and / or of black African ethnicity are at 
an elevated risk (as compared to the general population) of being diagnosed with HIV. 
In combination with additional demographic and epidemiological information, such as 
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parent’s country of birth and ethnicity, generational information may help identify 
groups at risk of acquiring or living with HIV in the UK.  
4.6.5 Long-term international migrant 
Long-term international migrants are persons who arrive and effectively make the UK 
their country of usual residence. The categorisation of long-term international migrant 
relies on self-reporting or applying an arbitrary cut-off point based on number of years 
resident in the UK. I would argue that a simple categorisation as to whether a person is 
a long-term migrant or not provides little insight into the heterogeneity of HIV risk 
across migrant groups. However, it is likely that a migrant’s risk of acquiring HIV in the 
UK increases with their length of residence, therefore the number of years of residence 
in the UK may be valuable information.  
4.6.6 Combination of methods 
Applied alone, none of the variables described in sections 4.6.1 to 4.6.6 clearly 
differentiate populations at risk of HIV within the UK. Figures relating to persons 
arriving in the UK from Bangladesh and the Republic of South Africa illustrate the need 
for combining variables to characterise migrants at risk of HIV.  
A similar number of people born in Bangladesh (230,000) and South Africa (211,000) 
were resident in the UK in 2011 (155). However, during the decade 2003 to 2012, 46 
adults born in Bangladesh were diagnosed with HIV in E,W&NI compared to 2,126 
adults born in South Africa (1). National HIV prevalence estimates explain this 
difference. In Bangladesh estimated HIV prevalence among adults aged 15 to 49 years 
is <0.1% (175), whereas in South Africa it is 17.9% (176). Figures relating to South 
Africa also highlight the need to consider ethnicity when characterising migrants. 
Among women attending antenatal care clinics in South Africa, HIV prevalence ranges 
from 1.1% among white women to 31.4% among black women (177). During the 
decade 2003 to 2012, 284 white South Africans and 1,599 black South Africans were 
diagnosed with HIV in the UK (1). 
Alongside ethnicity and route of transmission, a recommendation was made in 2004 for 
HIV surveillance systems in Europe to include country of origin to describe HIV among 
migrants (178). In E,W&NI, country of birth and ethnicity are routinely collected 
through national HIV surveillance, as is route and likely country of HIV infection (see 
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table 2.1). Data completion of both ethnicity and country of birth exceeds 80% among 
heterosexuals diagnosed with HIV in E,W&NI (36). 
Heterogeneity in risk of living with or acquiring HIV can be highlighted when broad 
ethnicity categories, such as black African, are presented in combination with country or 
world region of birth. For example, by combining these two variables it has been 
possible to show that a greater number of black Africans born in Eastern Africa are 
diagnosed with HIV in E,W&NI than those born in other regions of Africa (36). 
Elsewhere, the practicality of combining country of birth with ethnicity has been 
highlighted. Driven by reports of elevated prevalence among people of black ethnicity 
in the USA, researchers highlighted the need to also consider country of birth by 
identifying higher rates of HIV among “foreign-born blacks” than “native-born blacks” 
(179, 180). 
4.7 Migrants at risk of HIV in Europe 
Migrants make up a significant and increasing proportion of people diagnosed with HIV 
in Europe (73, 181-187). Three quarters of European Union / European Free Trade 
Association countries consider migrants to be an important sub-population in their 
response to HIV (73). Despite this, no common definition of a migrant, or consistent 
approach to collecting information about migration, is applied across Europe. It has 
been suggested that most data relating to HIV among migrants is drawn from small 
studies, unrepresentative samples or questions added to other data collection exercises 
(188). 
To maximise the public health benefit of surveillance activities across Europe, in 2011 
it was recommended that comparable surveillance data be made available to improve 
the characterisation of migrant and ethnic minorities at risk of HIV in Europe (189). The 
European Centre for Disease Prevention and Control has designed a set of indicators to 
monitor and evaluate the HIV response among migrants from countries with generalised 
HIV epidemics (72, 73). For countries to adopt these indicators a combination of 
information on country of birth and national HIV prevalence estimates is required.  
Of 24 European Union / European Free Trade Association countries responding to a 
2012 questionnaire about surveillance systems for monitoring the sexual transmission of 
HIV, all but Latvia and Romania collected some data to describe the HIV epidemic 
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among migrant populations at the national level (73). Nineteen of the 24 countries 
collected the country of birth of newly diagnosed people (73). Sixteen countries 
collected nationality, three of which did not record country of birth (73).  
Although most European Union / European Free Trade Association countries collect 
information on HIV among migrants, there is variation in their approach. Take France 
and the Netherlands, for example. In France, nationality and HIV subtype are used to 
explore the impact of migration on HIV (172, 190, 191). In the Netherlands, 
combinations of country of birth, HIV prevalence estimates, ethnicity, and generation of 
migrant are used to characterise migration and HIV (174, 192-194).  
Although similar information is collected in the Netherlands as in E,W&NI, the 
application of this information differs. In the Netherlands country of birth has been used 
to assess the impact on HIV transmission of people specifically arriving from Surinam 
and the Netherlands Antilles (174, 192). It has also been used to distinguish differences 
between first and second generation migrants (174). In E,W&NI, where information on 
generation is not routinely available, country of birth is usually presented in aggregate 
form to identify people born in world regions where the prevalence of HIV is high, 
primarily sub-Saharan Africa (24, 37).  
Until there is a standardised approach to characterising HIV among migrants in Europe 
it will remain difficult to compare the impact of migration on HIV, and the response to 
this, between European countries. Following their 2011 recommendation for 
comparable surveillance data to be collected based on country of birth, the ECDC in 
2013 reiterated the need for countries to collect and submit standardised data to enable 
cross border linkages to facilitate a more complete picture of HIV among migrants 
(195). 
4.8 Heterosexual transmission of HIV among migrants living in E,W&NI or 
elsewhere in Europe 
In 2011, an estimated 12% (7,509,000/63,200,000) of the UK resident population was 
born outside of the UK (155). Of the sixty most common countries of birth (155), adult 
HIV prevalence, according to UNAIDS country profiles, exceeded 1% in twelve (196). 
Approximately 1.7% of the UK resident population (1,100,000 people) were born in one 
of these twelve countries, nine of which are in sub-Saharan Africa (155). The twelve 
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countries are as follows: Democratic Republic of Congo; Ghana; Jamaica; Kenya; 
Nigeria; Russia; South Africa; Tanzania; Thailand; Uganda; Zambia; Zimbabwe. 
It has been proposed that as disparities in control programmes expand between 
developed and developing nations, the impact of migration on the epidemiology of HIV 
in low prevalence countries will increase (197). The impact of migration, particularly 
migration from high HIV prevalence countries, is often discussed in terms of imported 
disease or burden. As early as 1991 there were reports of heterosexual HIV infections in 
London being “imported” (198). In 1995 the impact of “imported” HIV infections to the 
UK and of ethnic group “attributable” infection was discussed (199). As recently as 
2003, the UK Cabinet Office conducted a governmental inquiry into "imported” 
infections, examining the issue of testing people for HIV prior to or at the point of entry 
into the UK (200). 
However, when considering the impact of migration from high prevalence areas on HIV 
transmission among migrants within E,W&NI we must not simply assume all infections 
are “imported”. We need to gauge whether the conditions which facilitate HIV 
transmission in high prevalence countries remain present after migration and, among 
those diagnosed, gain robust estimates of where HIV was acquired. 
4.8.1 HIV transmission 
In paper 4.1, I estimated that nearly half of heterosexuals born abroad and diagnosed 
with HIV in 2010 acquired their infection while living in the UK. Conditions which 
facilitate transmission of HIV within populations include a high prevalence of infection 
(201), sexual risk behaviour (85, 86), assortative sexual mixing (169), and travel to 
home countries (202, 203). I will address the conditions for HIV transmission while 
living in the UK in turn. 
Many countries in sub-Saharan Africa have generalised HIV epidemics (156), and there 
is a body of evidence showing HIV prevalence among black Africans in the UK to be 
greatly elevated compared to that among the general population (3, 48, 204). In a group 
among whom HIV prevalence is elevated, sexual risk behaviour may include having 
unprotected sexual intercourse (particularly with persons of unknown HIV status), and 
having multiple sexual partners. In a study of sexual behaviour among black African 
heterosexuals living with HIV in London, one in seven reported unprotected intercourse 
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in the previous three months with one in twenty reported unprotected intercourse with a 
partner of unknown or negative HIV status (205). Among participants of a 
cross‐sectional community-based survey of Africans in England, the overwhelming 
majority of whom were born abroad, 22% reported having ever had a previous STI 
diagnosis (a proxy for sexual risk behaviour) (48). Nearly three quarters of Africans 
living in England reported having had one or more sexual partners in the previous year 
(41, 204). Further evidence is presented in section 4.8.2 for HIV transmission occurring 
among black Africans in E,W&NI. 
Among migrant groups there is evidence of assortative sexual mixing where persons 
have sexual contact with people who share their ethnicity or country of origin (174, 193, 
194, 206, 207). It is likely that sexual mixing among migrants groups increases the 
potential of transmission within these groups. For example, intra-African segregation of 
sexual networks has probably contributed to HIV transmission amongst sub-Saharan 
African migrants in France through sexual contact between people from African 
countries of low and high HIV prevalence (169). In paper 4.1, I highlighted how among 
black African heterosexuals born abroad and diagnosed with HIV in the UK the 
percentage acquiring their infection whilst living in the UK increased over time. 
However, it was not possible to assess how many of those acquiring HIV whilst living 
in the UK did so through sex with another person of black African ethnicity born 
abroad. Patterns of sexual mixing are discussed in greater detail in section 4.9. 
The conditions which facilitate HIV transmission in countries of origin may also persist 
after migration because of international travel. A cross-sectional survey of sub-Saharan 
African communities resident in inner London found 43% of men and 46% of women 
had visited their home countries within the previous five years (202). Among the men 
visiting their home country, over a third reported having had new sexual partnerships 
(202). A similar percentage (40%) of Surinamese and Antillean migrants in the 
Netherlands reported having visited their homeland during a five year period (192). Of 
those visiting their homeland, 47% of men and 11% of women had a local sexual 
partner (192). A subsequent study of migrants to the Netherlands found 60% of 
participants to have travelled to their homeland in the previous five years (203). Among 
these participants, approximately one in ten were identified as a potential bridge 
population for HIV transmission as they reported having unprotected sex with partners 
in both countries (203).  
84 
 
4.8.2 Likely country of HIV infection 
As far back as 1992, it was reported that the heterosexual transmission of HIV in the 
UK was increasing due to infections being acquired both abroad and in the UK (14). Of 
heterosexuals diagnosed with HIV in the UK between 1985 and 1996, an estimated six 
in ten probably acquired HIV in Africa (208). In 1997 black African men and women 
were singled out as being at particularly risk of “AIDS” in the UK (166).  
The extent to which HIV was being acquired heterosexually within the UK was unclear. 
This lack of clarity was mainly due to doctors assigning people diagnosed with HIV 
who reported unprotected sex both in Britain and an African country as having acquired 
HIV in Africa (209). This potential bias in assignment led to suggestions that the 
heterosexual transmission of HIV among African communities in the UK was being 
underestimated (21), and that national estimates of black Africans acquiring HIV within 
the UK were too low (23).  
As discussed in section 4.3, to reduce potential bias in assigning likely country of HIV 
infection I introduced in paper 4.1 a new method of assignment based on routinely 
available data. In paper 4.1, it was estimated that a third of heterosexual adults born 
abroad and diagnosed with HIV in E,W&NI between 2004 and 2010 acquired their 
infection whilst living in the UK. Among those of black African ethnicity, the figure 
was 31%. In another study among persons born or raised in Africa attending one of 
fifteen London centres for HIV care between April 2004 and February 2006, it was 
estimated that between a quarter to a third of all HIV-positive Africans currently 
resident in the UK acquired their infection in the UK (23).  
The results presented both in the 2009 Burns paper and paper 4.1 highlight the need to 
enhance targeted prevention efforts to reduce the transmission of HIV among black 
African communities living in the UK (23, 24). However, the results also highlight how 
a substantial number of Africans continue to arrive in the UK having already acquired 
HIV abroad. There have been calls for developed countries to invest not only 
domestically in infectious disease control programmes but also in developing countries 
from which migrants originate (210). Such an approach, in relation to tuberculosis, was 
shown to be cost effective in a USA based model (211). 
85 
 
Elsewhere in Europe only a small number of countries have considered likely country of 
HIV infection among migrants. Of 24 European countries responding to a survey on the 
surveillance of HIV and HIV transmission among migrants from countries with 
generalised HIV epidemics, only the UK, Norway, Denmark, and the Netherlands 
provided information on country of infection (73). Of these four countries, only the UK 
and Norway provided specific estimates on country of infection. United Kingdom 
estimates were those published in paper 4.1, whilst Norway reported 14% (22/152) of 
migrants diagnosed with HIV in 2011 as having acquired HIV via sexual transmission 
whilst resident in Norway (73).  
Denmark reported a small and stable proportion of migrants newly diagnosed with HIV 
as having probably acquired their infection in Denmark from another migrant (this was 
not quantified) and the Netherlands referred to published literature (73). In 2010, an 
estimated 40% of new HIV infections among African migrants to the Netherlands were 
acquired outside the Netherlands (193), thereby suggesting up to 60% were acquired 
within the Netherlands. This figure is comparable with my estimate for E,W&NI of 
43% of infections among black African heterosexuals born abroad being acquired in the 
UK in 2010. 
Research into country of HIV infection has also been conducted in Switzerland and 
Italy. Among persons of Asian or African nationality diagnosed with non-B HIV in 
Switzerland, an estimated one in five acquired their infection within Switzerland (212). 
Applying an HIV avidity test to estimate time of infection among HIV-positive “illegal” 
migrants and then comparing this to time of migration, the authors of a study in Italy 
reported six of 27 migrants to have acquired HIV in Italy and four to have acquired their 
infection prior to arrival (213). Country of infection could not be determined for 
seventeen of the 27 participants (213). 
Evidence of migrants having sexual relationships both in the UK and whilst travelling 
from the UK (see section 4.8.1) highlights some of the complexities in assessing, among 
those diagnosed, country of HIV infection. In recognition of this, in paper 4.1 people 
were assigned as having acquired HIV either before or after their arrival in the UK. The 
group assigned as having acquired HIV after arriving in the UK consists of people 
infected in the UK as well as those infected whilst travelling away from the UK (but 
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after first moving here). Both of these groups lend themselves to targeted HIV 
prevention activities within the UK. 
In summary, there is strong evidence of heterosexual transmission of HIV occurring 
within E,W&NI among black African migrants who live here. Data from other 
European countries also suggest that there is within-country transmission of HIV among 
migrants living there. 
4.9 Heterosexual transmission of HIV in the general population in E,W&NI or 
elsewhere in Europe 
In the general population, patterns of sexual mixing are an important determinant of 
HIV transmission (214). In section 4.8.1, I suggested assortative sexual mixing among 
migrants might increase the potential for transmission within these groups. Conversely, 
assortative sexual mixing might decrease the potential for HIV transmission between 
migrant and non-migrant populations.  
In the Netherlands, approximately four in ten sexually active migrants reported having 
had sexual contact with someone from another ethnic group, including “indigenous” 
Dutch (174). A low level of sexual mixing with the “Dutch” population has been put 
forward to partly explain why migrants, among whom HIV prevalence is elevated as 
compared to the general population, have had little impact on heterosexually-acquired 
HIV nationally (193, 194). In Israel the risk of HIV transmission between labour 
migrants and Israelis has been described as being limited as sexual contact between 
these two groups is rare (207).  
In addition to assortative sexual mixing other factors may reduce the potential for HIV 
transmission between migrant and non-migrant populations. In Denmark, primary 
infection rather than late presentation has been identified as fuelling HIV transmission 
among young MSM (215). If primary infection is a key determinant of transmission, 
then the potential impact of migration on HIV transmission among the general 
population, as well as among migrant groups, will be reduced. This is because many 
HIV-positive migrants will arrive after the period of highest infectivity. The potential 
impact of migration on HIV transmission in the general population is also likely to be 
limited by the relatively small size of the migrant population (194, 216). 
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Despite evidence that the heterosexual transmission of HIV will, most probably, remain 
concentrated among migrant groups, the heterosexual acquisition of HIV is often seen 
as being analogous to the spread of infection in the general population. This 
misconception may have arisen as a result of early national mass media campaigns, such 
as those in the UK (217) and Australia (218), suggesting everyone was potentially at 
equal risk of acquiring HIV. It may also be due to the situation in industrialised 
countries with concentrated epidemics, such as the UK, being confused with that in 
parts of sub-Saharan African where the heterosexual transmission of HIV has resulted 
in generalised epidemics. 
National and international bodies have been accused of exaggerating the potential for 
the widespread heterosexual transmission of HIV in industrialised countries to garner 
political and funding support. The Joint United Nations Programme on HIV/AIDS has 
been accused of overstating the potential for HIV transmission to highlight the need for 
generalised HIV prevention programmes (219). The United States Public Health Service 
has been similarly accused to secure increased research funds (220).  
It is important that the potential for HIV infection to spread in the general population is 
not overstated. This is particularly true in the context of HIV and migration. It has been 
suggested that fears relating to the spread of infectious diseases, such as HIV, have been 
conflated with those relating to migrants (221). Both in the UK (221) and the USA 
(222), it has been argued there is a strong association in the public mind between the 
spread of infectious diseases, such as tuberculosis and HIV, and foreigners and 
migration.  
This conflation between spread of disease and migration is a cause for concern. In 2003, 
in an article entitled “The secret threat to British lives”, it was reported that doctors 
feared African immigration might ignite a heterosexual epidemic in Britain (154). In 
2003 and 2004, several UK bodies, including the Conservative party, called for 
compulsory screening of migrants for HIV (221, 223). One commentator expressed a 
fear that such calls for immigration control could tarnish the UKs reputation for its 
rational, coherent, and effective public health policy response to HIV (223). 
In response to calls for greater action, including screening, the UK All-Party 
Parliamentary Group on HIV and AIDS established an inquiry in 2003 into the impact 
of the nationality and immigration system on people living with HIV (200, 223). Four 
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hearings were held where evidence was taken from HIV specialist clinicians, general 
practitioners, solicitors, community-based and national AIDS organisations, and 
migrants living with HIV (223). The inquiry found no supportive evidence for screening 
being an effective public health response. It was proposed that the screening of migrants 
could further stigmatise HIV and result in people actively avoiding testing (200, 223). It 
was recommended the Government oppose mandatory testing for HIV upon entry and 
instead promote HIV testing among migrants based on informed consent (200, 223). 
In summary, there is evidence that the heterosexual transmission of HIV in E,W&NI 
will, for the most part, remain concentrated among black African migrants who live 
here. Equally, it appears that heterosexually-acquired HIV will also remain concentrated 
among migrants in other European countries. 
4.10 Retention in care and outward migration from the UK 
When assessing the role of migration in shaping the HIV epidemic among heterosexual 
adults in E,W&NI outward migration needs to also be considered. In paper 4.2, 
retention in HIV care was investigated. In the paper, nine out of ten adults attending 
HIV services in a given year between 1998 and 2006 were shown to attend for care the 
following year. Cumulatively, almost one in five adults seen for HIV care between 1998 
and 2006 were reported as being lost to follow-up by the end of 2007. Nonetheless, the 
overwhelming majority continued to attend for care during the eight year study period. 
In paper 4.2, the following groups were most likely to be lost from HIV care: of black 
African or “other” ethnicity; female; aged 15 to 34; not on antiretroviral therapy at last 
report; recently diagnosed with HIV; acquired HIV in Africa or elsewhere in Europe; 
acquired HIV heterosexually. In the paper I suggested that the association between loss 
to follow-up and black African ethnicity, acquiring HIV abroad, and having been 
recently diagnosed was indicative of migrants leaving the UK soon after receiving an 
HIV diagnosis. Although country of birth was not analysed in paper 4.2, there is 
evidence for the overwhelming majority of black Africans diagnosed with HIV being 
born abroad (36), and the majority of diagnosed foreign-born people having acquired 
HIV abroad (24). 
Although there is no direct evidence for migrants leaving the UK following an HIV 
diagnosis, there is evidence for migrants, in general, leaving the UK. In 2012, almost 
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half of all migrants to the UK intended to stay for one or two years only (224). An 
estimated 209,000 former immigrants left the UK in 2012 (225). Former immigrants are 
those entering and leaving the UK as long-term international immigrants, and the figure 
of 209,000 was obtained from LTIM estimates in the IPS (see section 4.5) (225).  
Estimates produced by the IPS should be interpreted with caution. In 2012, large 
discrepancies between migration estimates based on the IPS and the 2011 Census for 
England and Wales were identified. The Census based mid-year population estimate 
was almost 500,000 higher than the estimate based on combined 2001 Census and IPS 
data (226). The reason identified for the underestimation was that IPS interviews were 
concentrated at principal airports, such as Heathrow and Gatwick, at a time when an 
increasing number of migrants were travelling to regional airports (226). One 
commentator suggested this methodological issue highlighted limitations in using 
survey data to estimate net migration and emphasised the need for better national 
migration data (224). To address the inadequate sampling design and coverage of the 
IPS, more regional UK airports are now included in the survey and an increased number 
of migration interviews are conducted at key regional airports, such as Luton and 
Stansted (226). 
Other studies have identified loss to follow-up from HIV care. Among HIV-positive 
individuals attending ten clinical centres in the UK who had one or more CD4 counts 
reported prior to April 2004, 44% were potentially lost to follow-up at least once 
(defined by the absence of a CD4 cell count for a year or more) (227). Of those lost to 
follow-up at least once, 40% were permanently lost to follow-up (227). This suggests 
approximately 18% of the study population were permanently lost to follow-up. The 
estimate of 18% of the study population being permanently lost to follow-up in the 
study by Hill was similar to my estimate of 19% in paper 4.2.  
Potential loss to follow-up in the study by Hill was associated with being non-white, 
having acquired HIV heterosexually or by ‘‘other’’ risk, and having had a greater 
number of previous episodes of loss to follow-up (227). Interestingly, being male was 
also found to be associated with potential loss to follow-up (227). In paper 4.2, 
permanent loss of follow-up was associated with being female. This difference may be 
due to the different definitions of loss to follow-up applied. In paper 4.2, loss to follow-
up was permanent (i.e. a person previously seen for HIV care was not seen again) 
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whereas, in the study by Hill persons were potentially lost to follow-up at least once if 
they didn’t have their CD4 cell count recorded for a year or more. The difference in 
results by sex may, therefore, indicate that males are more likely than females to return 
to care following a period of loss to follow-up.  
In paper 4.2, it was reported that annual estimates of retention in care would be made 
available in routine national surveillance outputs. A subsequent analysis of quality of 
HIV care during the first twelve months from HIV diagnosis, based on national 
surveillance data, investigated retention in care. Among 5,833 persons diagnosed with 
HIV in the UK in 2010, who were not reported as having died, 85% were seen for HIV 
care in 2011 (98). In paper 4.2, a higher percentage (90%) of adults attending services in 
a given year were shown to attend again the following year. Whereas the original study 
considered retention in care among all people seen for HIV care, the study by Delpech 
considered only persons newly diagnosed with HIV. In paper 4.2, a significantly lower 
rate of retention in care was found among those recently diagnosed. Two reasons for 
this were proposed. Some people, following an HIV diagnosis, may withdraw from HIV 
care until they are symptomatic, and some may leave the UK (see above in this section).  
In the study by Delpech, little variation was reported across groups of newly diagnosed 
adults in the percentage retained in care (98). This is in contrast to the study described 
in paper 4.2. It may be that the association between a recent diagnosis of HIV and loss 
to follow-up from care masks differences between sub-groups of newly diagnosed 
adults. 
Using the methods described in paper 4.2, a clinic-based audit was conducted among 
people seen for HIV care in 2010 but not 2011 (228). It was estimated that 2,132 were 
seen for care in 2010 but not 2011, and were not reported as having died. Of these, 964 
(45%) probably remained in the UK, 590 (28%)  had probably left the UK and for the 
remaining 578 (27%) their status was unknown (228). Of those who remained in the 
UK, it was reported that just over half (508/964; 53%) may have been wrongly assigned 
and were in care in 2011 and that a further 237 (25%) returned to care in 2012 (228). 
These findings lend support to the suggestion in paper 4.2 that permanent loss to follow-
up from HIV care was, in part, explained by outward migration from the UK. Another 
potential reason for not accessing care services while remaining in country is fear of 
stigma and discrimination(119, 229).  
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Retention in HIV care has also been explored in the USA, and has been shown to be 
much lower than in the UK. Of the estimated 1,148,200 persons living with HIV in 
2009, an estimated 82% had been diagnosed, 66% had been linked into care, and 37% 
were retained in care (230). Among people of black ethnicity diagnosed with HIV in 
2010 in the USA, an estimated 75% were linked to care and 48% were retained in care 
(132). It was suggested that reasons for a low rate of retention among people of black 
ethnicity include poverty, lack of health insurance, and stigma (132). Among all adults 
aged 19 to 64 years seen for HIV care in the USA between January and April 2009, six 
in ten had a low income, and almost two in ten had no health insurance (231).  
Another potential reason for loss to follow-up from HIV care in the USA was outward 
migration. The potential for HIV-diagnosed people leaving the USA has raised concern 
over continuity of care. Evidence of HIV-positive Mexicans returning to Mexico led to 
calls for a bi-national perspective to HIV training activities (232). If, as suggested in 
paper 4.2, outward migration partially explains loss to follow-up from HIV care in the 
UK, then continuity of care between countries is also of concern. The inclusion of a 
recommendation for research on bi-national approaches to continuity of HIV care in 
paper 4.2 would have been merited. No such recommendation was made. 
It was recommended in paper 4.2 that innovative strategies be developed to maintain 
regular service engagement among groups at increased risk of dropping out of regular 
care. In response to paper 4.2, clinicians at two London Hospitals reported on an audit 
of a newly implemented policy to identify patients lost to follow-up and to return them 
back into care (233). Patients who had not attended either clinic for a period of one year 
or more were identified and contacted by phone or post. Among those successfully 
contacted, a third returned to care within a median period of 15.5 days (233). 
4.11 Impact of the published research and recommendations  
In papers 4.1 and 4.2, the impact of migration on heterosexually-acquired HIV in the 
UK was addressed. Paper 4.1 highlighted the need for HIV prevention activities 
targeting migrant communities in E,W&NI, particularly those from sub-Saharan Africa; 
paper 4.2 highlighted the importance of developing strategies to maintain regular 
engagement with HIV services in E,W&NI. 
92 
 
When designing and implementing HIV prevention strategies it is important to 
understand which population groups are at risk of acquiring HIV in the UK through 
heterosexual contact. In paper 4.1, the number of people born abroad reported as having 
acquired HIV heterosexually whilst living in the UK was significantly higher than 
previously estimated. Confident that the revised estimates presented in paper 4.1 were 
robust, a recommendation was made for this new method of assigning likely country of 
HIV acquisition to be applied in other countries where the number of HIV diagnoses 
among migrant populations was high. For this to be viable, country of birth, CD4 cell 
count at diagnosis, and year of arrival in host country would be required among HIV-
diagnosed persons born abroad.  
Of 24 European Union / European Free Trade Association countries responding to a 
2012 questionnaire about HIV surveillance systems, nineteen reported collecting 
country of birth, twelve recorded date of arrival into their country, and seventeen 
collected CD4 count at diagnosis (73). Responding to the recommendation for the new 
method to be adopted by other countries, the ECDC identified Belgium, Denmark, 
France, Greece, Lithuania, Luxembourg, Malta, Romania and Slovakia as countries 
where it could potentially be applied to assign likely country of HIV acquisition (234). 
At an ECDC workshop on improving the monitoring of HIV among migrant 
populations in Europe held in Madrid October 2013, Sweden, Belgium, Portugal and 
Italy volunteered to use the new method (234). In January 2014, I co-organised a 
workshop in London where representatives of these four countries, ECDC, and PHE 
met to discuss the project. During the two day workshop the new method was applied to 
national datasets from Sweden, Italy and Belgium. The application of the method to 
non-UK datasets was shown to be feasible. At the annual meeting of the network for 
Sexually Transmitted Infections and HIV held in Dubrovnik, Croatia in May, 2014, the 
ECDC reaffirmed its commitment for the new method to be rolled out to all European 
countries where migrants are disproportionately affected by HIV (234). 
Further work is required to assess the level of disaggregation to which estimates of 
likely country of infection remain robust. To date estimates have only been presented by 
broad categorisations of sex, age, region of birth or ethnicity, and not by combinations 
of these variables. Additional analyses are also warranted to investigate whether 
published estimates of risk behaviour during foreign travel (192, 202, 203) may be 
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utilised to adjust estimates of likely country of infection. To better understand HIV 
transmission dynamics driving heterosexually-acquired HIV in the UK, research on 
assortative sexual mixing among migrant groups is merited, as is research on the 
potential association between increased dissortative sexual mixing and second 
generation migrants. 
In paper 4.2, it was recommended that annual estimates of loss to follow-up among 
HIV-diagnosed adults be made available, and that loss to follow-up be included as a 
quality of care indicator. To conduct the analyses presented in paper 4.2, we created a 
cohort of adults attending HIV services. Being able to observe patterns of care and 
treatment among a cohort of HIV-diagnosed adults facilitated the design and 
implementation of a national set of quality of care indicators (98). Retention in care (the 
flipside to loss to follow-up) is now routinely reported on as a quality of care indicator 
(98). 
It was also recommended in paper 4.2 that innovative strategies be developed to 
maintain regular service engagement among persons at increased risk of loss to follow-
up. For a sizeable proportion of the study population in a recent clinic based audit of 
people seen for HIV care in 2010 but not 2011, reason for loss to follow could not be 
determined (228, 235). Not knowing the reasons for people leaving HIV care makes it 
difficult to develop strategies to maintain regular service engagement. Following the 
publication of paper 4.2, a London study reported partial success in maintaining service 
engagement by directly contacting people lost to follow-up (see section 4.10) (233). To 
reduce HIV-related morbidity and mortality, further research is warranted to identify 
more effective methods for retaining people in HIV care.  
Paper 4.2 also highlighted the need for research into continuity of care among HIV-
diagnosed persons leaving the UK. It is likely that a sizeable proportion of people lost to 
care are returning to their country of origin. Research should, therefore, be conducted 
into bi-national approaches to ensure efficient and effective pathways of care among 
HIV-diagnosed people leaving the UK. 
 In this chapter I have presented numerous definitions of migrants and migration. It is 
essential that migrants are defined in a way that clearly highlights their varying risks for 
HIV. A workable definition of migrants at risk of HIV also needs to avoid reinforcing 
negative stereotypes that may promote stigma and discrimination.  
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In papers 4.1 and 4.2, I presented evidence for the utility of categorising migrants 
according to their ethnicity and country of birth. These two variables can be utilised 
through research and surveillance to highlight heterogeneity in risk of acquiring or 
living with HIV among migrants. Heterogeneity in risk is more readily highlighted by 
these two variables when combined with HIV prevalence estimates according to country 
of birth and / or ethnicity (see section 4.6.7). In future, information on ethnicity and 
country of birth should be combined with that on assortative sexual mixing to better 
understand existing and emerging patterns of risk among migrants. 
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5.  HIV and Tuberculosis co-infection 
Summary 
In this chapter, I explore HIV-tuberculosis co-infection among heterosexuals. The 
published paper included in this chapter is called “Decreasing incidence of tuberculosis 
among HIV diagnosed heterosexuals in England and Wales” (39). In the paper I 
highlighted how one in ten heterosexual adults living with diagnosed HIV in England 
and Wales between 2002 and 2010 were diagnosed with active tuberculosis. I also 
reported that the annual incidence rate of active tuberculosis in the HIV-positive study 
population declined between 2002 and 2010. Despite this decline the incidence of 
tuberculosis among HIV-diagnosed heterosexuals remained substantially higher than in 
the general UK population. 
In this chapter, I investigate HIV-tuberculosis co-infection in the UK and other 
European countries. I also explore HIV-tuberculosis service provision in these 
countries. 
5.1 Introduction 
The British HIV Association guidelines for the treatment of TB/HIV co-infection state 
that persons living with HIV and latent tuberculosis are much more likely than their 
HIV negative counterparts to progress to active tuberculosis (236). Among people 
living with HIV, tuberculosis is the leading cause of illness and death globally (38, 
237). In 2012, HIV-associated tuberculosis was estimated to have killed 320,000 people 
worldwide (38, 237). The majority of these deaths occurred in sub-Saharan Africa (38, 
237). 
In 2012, there were 6,364 HIV diagnoses and 8,751 reported cases of active 
tuberculosis in the UK (3, 46). Diagnoses of both infections were elevated among ethnic 
minority groups and persons born abroad, including those of black African ethnicity 
born in sub-Saharan Africa (3, 36, 46). In Chapters 3 and 4, I reported how the majority 
of heterosexuals diagnosed with HIV in E,W&NI were born in sub-Saharan Africa. As a 
consequence, HIV-tuberculosis co-infection is of particular importance for this 
population group. 
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This chapter includes a paper which I published in a peer-reviewed journal. In the paper 
I presented annual incidence rates of tuberculosis between 2002 and 2010 among 
heterosexual adults living with diagnosed HIV in England and Wales. By examining the 
relationship between the date of HIV diagnosis and the date of tuberculosis diagnosis, I 
highlighted missed opportunities for early HIV testing in tuberculosis settings and vice 
versa.  
In this chapter, after summarising the key findings from the paper, I go on to explore 
HIV-tuberculosis co-infection and service provision among heterosexual adults living in 
the UK and elsewhere in Europe. Unless I state otherwise, tuberculosis refers to active 
rather than latent infection. 
97 
 
5.2 The published paper: Rice et al., AIDS 2013 
Decreasing incidence of tuberculosis among heterosexuals living with diagnosed 
HIV in England and Wales 
http://www.ncbi.nlm.nih.gov/pubmed/23276802  
Objectives: To calculate annual tuberculosis incidence rates, and investigate risk 
factors for tuberculosis, among heterosexual adults living with diagnosed HIV in 
England and Wales. 
Design: Analyses of comprehensive national records of persons seen for HIV care 
between 2002 and 2010 linked to the national tuberculosis database (1999–2010) for 
England and Wales. 
Methods: Annual incidence rates of tuberculosis among heterosexual adults living with 
diagnosed HIV were calculated on the basis of the number of heterosexual adults seen 
for HIV care in a given year and the number, in that same year, with a first episode of 
tuberculosis at the time of, or subsequent to, their HIV diagnosis. 
Results: Between 2002 and 2010, almost one in 10 (4266/45 322) heterosexual adults 
living with HIV were diagnosed with tuberculosis, of whom the majority (92%) were 
diagnosed at the time of, or after, their HIV diagnosis; 84% (3307) were black African. 
The annual tuberculosis incidence rate decreased from 30 per 1000 in 2002 to 8.8 per 
1000 in 2010 (P < 0.01). The annual tuberculosis incidence rate among those not on 
antiretroviral therapy (ART) was significantly higher than among those using ART 
(2010: 36 versus 3 per 1000; P < 0.01). 
Conclusions: The annual tuberculosis incidence rate among heterosexual adults living 
with diagnosed HIV in England and Wales has declined significantly over the past 
decade. However, the 2010 rate remains significantly higher than in the general 
population. Our findings support routine HIV testing in tuberculosis clinics, screening 
for latent tuberculosis in HIV diagnosed persons, and the prompt initiation of ART 
where appropriate. 
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5.3 Research findings from my published paper 
My published paper in this chapter is called “Decreasing incidence of tuberculosis 
among HIV diagnosed heterosexuals in England and Wales” and was published in the 
journal AIDS in 2013 (39). In this chapter, I refer to it as paper 5.1.  
In paper 5.1, I described how one in ten heterosexual adults living with diagnosed HIV 
in England and Wales between 2002 and 2010 were diagnosed with tuberculosis. I 
reported that the annual incidence rate of tuberculosis among HIV-diagnosed 
heterosexuals declined from 30 per 1,000 in 2002 to nine per 1,000 in 2010. The 
incidence rate of tuberculosis in 2010 was elevated among the following groups of HIV-
diagnosed heterosexuals: aged 35 year and above at HIV diagnosis; male; born abroad; 
infected abroad; not on antiretroviral therapy; with a CD4 cell count <200 cells/ml at 
HIV diagnosis. 
I highlighted in paper 5.1 how the decline in the incidence of tuberculosis over time 
coincided with a decline in the overall number of heterosexuals in the UK acquiring 
HIV in sub-Saharan Africa and an increase in the uptake of antiretroviral therapy among 
persons diagnosed late. I also highlighted how, despite the decline in incidence over 
time, the rate in 2010 of nine tuberculosis cases per 1,000 HIV-diagnosed heterosexuals 
greatly exceeds the rate of 0.1 per 1,000 in the general UK population.  
I investigated in paper 5.1 the relationship between the date of HIV diagnosis and the 
date of tuberculosis diagnosis. Among those diagnosed with tuberculosis, I reported the 
majority to have been diagnosed simultaneously with HIV. However, I also reported 
that a substantial number of heterosexuals were diagnosed with tuberculosis more than 
six months after HIV, and a small number were diagnosed six or more months prior to 
HIV diagnosis. Diagnosis of tuberculosis more than six months after an HIV diagnosis 
represents a missed opportunity for the earlier diagnosis of tuberculosis. However, it’s 
possible that tuberculosis diagnosed more than six months after HIV diagnosis may not 
have been present at the time of the HIV diagnosis. In which case, this represents a 
missed opportunity for the prevention of tuberculosis which the patient acquired after 
being diagnosed with HIV infection. Conversely, the diagnosis of tuberculosis prior to 
an HIV diagnosis represents a missed opportunity for the early diagnosis of HIV (which 
almost certainly was present at the time of the tuberculosis diagnosis). 
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In this chapter I explore HIV-tuberculosis co-infection in the UK and elsewhere in 
Europe. Considering the evidence I presented in paper 5.1 of missed opportunities for 
earlier testing, and therefore earlier treatment, I also examine HIV-tuberculosis service 
provision in the UK and elsewhere in Europe. 
5.4 Literature search 
Using the methods I describe in Chapter 2 (section 2.8), I conducted a computerised and 
manual literature search in relation to two topics raised in the published paper in this 
chapter. These were: (i) the incidence of active tuberculosis among HIV-diagnosed 
heterosexuals in the UK and elsewhere in Europe; (ii) HIV-tuberculosis service 
provision in the UK and elsewhere in Europe. Appendix iii lists details of the searches 
conducted for this chapter. The identified papers provide the foundation for the rest of 
this chapter. 
5.5 HIV-tuberculosis co-infection in the UK and elsewhere in Europe 
The degree to which HIV-tuberculosis co-infection is seen as a public health priority 
differs between European countries dependent on burden of disease (238). Nonetheless, 
the World Health Organisation recommends the surveillance of tuberculosis among 
persons living with HIV, and vice versa, be carried out in all countries (239).  
Unfortunately, many European countries lack access to reliable data for HIV-
tuberculosis co-infection and remain unaware of the current epidemiology of HIV-
tuberculosis co-infection (238, 240). In many European countries major gaps in HIV 
and tuberculosis surveillance result in the prevalence of co-infection being reported as a 
rough estimate (241, 242).  
5.5.1 Incidence of tuberculosis among HIV-diagnosed persons 
In section 5.3, I reported rates and trends in tuberculosis incidence among HIV-
diagnosed heterosexuals in England and Wales. Similar rates and trends among HIV-
diagnosed persons have been reported elsewhere in Europe. In Western Europe as a 
whole, the incidence of tuberculosis among HIV-diagnosed persons declined between 
1994 and 2003 before stabilising between 2004 and 2010 (243). In Denmark, the 
incidence of tuberculosis among HIV-diagnosed persons decreased from 37 per 1,000 
person-years in 1995/1996 to 6.5 per 1,000 person years between 2000 and 2007 (244). 
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Between 1987 and 2006, the incidence of tuberculosis among HIV-diagnosed persons in 
Spain decreased from 200 per 1,000 person-years to fifty per 1,000 person-years (245). 
This decline was observed to continue up to 2010 (246).  
Despite a decline over time, the incidence of tuberculosis among HIV-diagnosed 
persons in Spain greatly exceeds that in the UK and Denmark. It has been suggested 
that rates of tuberculosis among HIV-diagnosed persons are elevated in countries where 
the prevalence of tuberculosis in the general population is high (243). After Portugal, 
Spain has been reported to have the second highest overall tuberculosis incidence rate in 
Western Europe (247). It is not clear from the literature why the prevalence of 
tuberculosis is high in Spain. In Spain’s neighbour Portugal, elevated prevalence of 
tuberculosis has been linked with historic failure in integrating tuberculosis prevention 
programmes into the primary healthcare system, slow economic recovery during the 
1970’s and 1980s, and migration into overcrowded city areas (248). 
In France, the incidence of tuberculosis among HIV-diagnosed persons between 1997 
and 2008 was four per 1,000 patient-years (249). In contrast to the UK, Denmark and 
Spain, the incidence of tuberculosis among HIV-diagnosed persons in France has 
increased in recent years (249).  
The increase observed in France has partially been put down to an increased proportion 
of the HIV-infected population being born in sub-Saharan Africa where there is a high 
prevalence of tuberculosis (249). Conversely, I suggest in paper 5.1 that the decline in 
tuberculosis incidence among HIV-diagnosed heterosexuals in England and Wales was 
partially explained by a fall in the number of heterosexuals in the UK acquiring HIV in 
sub-Saharan Africa. It is possible that the decline in tuberculosis incidence observed 
among HIV-diagnosed persons in Denmark and Spain are also partly related to fewer 
migrants acquiring HIV in countries where the prevalence of HIV and tuberculosis is 
high. In both countries approximately four in ten HIV diagnoses are among migrants 
(181). 
In addition to highlighting the impact of migration on the declining incidence of 
tuberculosis among HIV-diagnosed heterosexuals I also emphasise in paper 5.1 an 
association between falling incidence and increased uptake of antiretroviral therapy 
among HIV-diagnosed persons. In the UK, the incidence of tuberculosis among all 
HIV-diagnosed persons has been shown to decline in response to the commencement of 
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antiretroviral therapy (250). A similar association has been observed in Spain (251). In 
Denmark a decline in tuberculosis incidence after HIV diagnosis has been attributed, in 
part, to antiretroviral therapy related immunological restitution (244). 
There is evidence that the impact of antiretroviral therapy in reducing the incidence of 
tuberculosis among HIV-infected populations is limited. In a UK study, the incidence of 
tuberculosis remained substantial among HIV-diagnosed persons of non-white ethnicity 
even after 24 months of treatment (250). The authors of the study suggested their 
finding was explained by a higher risk of previous tuberculosis exposure and lower CD4 
cell count among black African migrants both at study entry and after the start of 
antiretroviral treatment (250). Among twelve cohorts from Europe and North America 
of HIV-diagnosed persons commencing antiretroviral therapy, a considerable risk of 
tuberculosis was reported, even among those with a good response to treatment (252). 
In a subsequent study of these twelve cohorts, a reduction of 44% in tuberculosis 
incidence among all HIV-diagnosed persons commencing antiretroviral therapy was 
observed (253). However, when focusing on HIV-diagnosed persons aged 50 years or 
above, or with a CD4 cell counts <50 cells/ml, no reduction was observed (253).  
A recent study, based on the same data I presented in paper 5.1, found tuberculosis 
incidence among HIV-diagnosed black Africans (the majority of whom acquired HIV 
heterosexually) in receipt of antiretroviral therapy for five years or longer to be similar 
to that among HIV-negative black Africans (254). However, among white HIV-
diagnosed persons in receipt of long-term treatment, tuberculosis incidence remained 
elevated as compared to the HIV-negative white population (254). The authors of the 
study suggested additional social risk factors for tuberculosis, difficult to measure on a 
population-level, may explain this finding (254). 
It has been argued that due to limitations in antiretroviral therapy reducing the incidence 
of tuberculosis among HIV-infected populations additional interventions are required 
(252). In contrast to this viewpoint, it has been suggested efforts be made to improve the 
impact of antiretroviral therapy through the promotion of earlier HIV diagnosis 
allowing treatment to be commenced when clinically indicated rather than at advanced 
immunodeficiency (253). It has also been proposed that tuberculosis incidence could be 
further reduced simply by effectively implementing existing recommendations to 
prevent tuberculosis in early HIV infection (255). 
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5.5.2 Characteristics of persons co-infected with HIV and tuberculosis 
In paper 5.1, I reported the annual incidence of tuberculosis to be elevated among HIV-
diagnosed heterosexuals aged 35 year and above at HIV diagnosis, men, persons born 
and / or infected abroad, and those not on antiretroviral therapy or with a CD4 cell count 
<200 cells/ml at HIV diagnosis. Although I did not find ethnicity to be associated with 
an elevated annual incidence of tuberculosis I did report in paper 5.1 that co-infected 
heterosexuals were more likely to be of black African or Indian, Pakistani and 
Bangladeshi ethnicity than those without tuberculosis. 
It has been proposed that the ethnic distribution of HIV-tuberculosis co-infected persons 
reflects the wider HIV-infected population in the UK rather than the tuberculosis 
infected population (256). This makes sense, as many co-infected persons will have 
acquired tuberculosis as a result of their HIV infection but not vice versa. As such, the 
characteristics of co-infected persons will be determined by risk factors for HIV 
infection and not tuberculosis. 
In England and Wales between 1993 and 1998 black Africans were shown to constitute 
a substantially larger proportion of the co-infected population than persons born in the 
Indian sub-continent (256). Among tuberculosis patients found to be co-infected with 
HIV in the UK between 1999 and 2003, seven in ten were black African, one in ten 
were white, and one in fifty were Indian, Pakistani or Bangladeshi (257). 
Similar associations to those I reported in paper 5.1 in relation to elevated tuberculosis 
incidence have been observed elsewhere in Europe. In Switzerland, persons diagnosed 
with HIV up to 1994 from countries with a high prevalence of tuberculosis had a 
significantly greater risk of co-infection than those from low prevalence countries (258). 
African and Asian origin, low CD4 cell count at HIV diagnosis, and a lack of 
antiretroviral therapy have been identified as risk factors for tuberculosis co-infection 
among HIV-diagnosed persons in Denmark (244). In France, a higher incidence of 
tuberculosis has been observed among HIV-diagnosed persons born abroad, not in 
receipt of antiretroviral therapy, and with a low CD4 cell count (249). Between 1997 
and 2008, the incidence rate of tuberculosis among HIV-diagnosed migrants in France 
was ten per 1,000 whereas among non-migrants the figure was two per 1,000 (249). In 
Spain, tuberculosis co-infection among HIV-diagnosed persons has been associated 
with low education level, being “sub-Saharan African”, not being in receipt of 
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antiretroviral therapy, and having a CD4 cell count <200 cells/ml (259). The incidence 
of tuberculosis among HIV-diagnosed persons in Spain was elevated among migrants in 
all years between 1987 and 2006 (245). In 2006, almost half of all new cases of HIV-
tuberculosis co-infection were among migrants to Spain, and migrants were 
significantly more likely than “Spaniards” (83% versus 17%) to be diagnosed with HIV 
and tuberculosis in the same year (245).  
The association with African or Asian origin and co-infection in Denmark has been put 
down to persons from high tuberculosis burden countries being at greater risk of 
infection due to reactivation of latent tuberculosis (244). It is likely that reactivation of 
latent tuberculosis partly explains the associations between HIV-tuberculosis co-
infection and non-white ethnicity, being born abroad, and / or being a migrant seen 
elsewhere in Europe.  
In paper 5.1, my study population consisted of only persons who had acquired HIV 
heterosexually. I therefore did not include probable route of HIV infection in my 
analysis. Probable route of HIV infection has been analysed in studies conducted in 
Denmark and Spain. In both countries acquiring HIV heterosexually or through 
injecting drug use were shown to be risk factors for tuberculosis (244, 245).  
In relation to HIV co-infection among tuberculosis patients, males, persons born abroad, 
injecting drug users, young adults (aged 25 to 30 years), urban residents, the homeless 
and prisoners represent high-risk groups across Europe (260). Of this list, the first three 
are also risk factors for tuberculosis among HIV-diagnosed persons (see above). 
Information on urban residency, homelessness and prison stay are not routinely 
considered in HIV risk analysis or collected through HIV surveillance.  
The finding that tuberculosis patients aged 25 to 30 years are at increased risk of HIV is 
difficult to interpret. In paper 5.1, I reported that HIV-diagnosed heterosexual in 
England and Wales aged 35 years or above at HIV diagnosis to be at increased risk of 
tuberculosis. The contrasting findings may reflect differences between the two study 
populations. The disparity in age would also be expected if, as compared with 
tuberculosis diagnoses in HIV settings, a greater proportion of people diagnosed with 
HIV in tuberculosis setting were identified through routine screening rather than waiting 
for presentation of disease. I discuss testing policies in sections 5.6.1 and 5.6.2. 
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Late HIV diagnosis may partly explain the association between older age and elevated 
annual incidence of tuberculosis. In Chapter 3, section 3.6.1, I report late HIV diagnosis 
among heterosexuals to be associated with older age at diagnosis. I also report late HIV 
diagnosis to be associated with male sex. Late HIV diagnosis may, therefore, also partly 
explain the association I report in paper 5.1 between men and elevated annual incidence 
of tuberculosis. 
5.6 HIV-tuberculosis service provision in the UK and elsewhere in Europe 
How should HIV-tuberculosis co-infection be managed? To reduce the burden of HIV 
and tuberculosis in populations affected by both diseases, the World Health 
Organisation recommends the implementation of collaborative co-infection activities 
based on effective national HIV and tuberculosis control strategies (38, 237). In the UK, 
close cooperation in the clinical management and accurate notification of HIV and 
tuberculosis cases has been described as being essential for providing appropriate care 
to persons infected with both diseases (257). Close cooperation would be guaranteed, it 
has been argued, if HIV-tuberculosis co-infected patients in the UK were managed, 
where possible, in dedicated co-infection clinics (261). Despite support from the Chief 
Medical Officer for joint HIV-tuberculosis patient services, a national audit of HIV and 
tuberculosis services in 2007/2008 found the dominant mode of care for co-infected 
patients was liaison between HIV and tuberculosis clinicians with each managing their 
own aspect of care (262). 
Several obstacles to implementing collaborative co-infection activities have been 
identified. These include parallel HIV and tuberculosis control systems and a lack of a 
national coordination body or national policy on co-infection (242).  
In 2005, only four in ten European countries reported having a national body 
responsible for coordinating HIV-tuberculosis activities and only one in three reported 
having a national plan for collaborative activities (242). Although no single body co-
ordinates HIV-tuberculosis activities in the UK, there are guidelines for collaborative 
working practice. In 1998, the UK Department of Health published guidance on the 
prevention and control of transmission of HIV-related tuberculosis (263). In 2007, the 
Department of Health suggested tuberculosis clinicians share the management of 
tuberculosis patients found to be co-infected with HIV with HIV specialists and, 
similarly, HIV clinicians only treat HIV/AIDS patients who develop tuberculosis in 
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consultation with tuberculosis clinicians (47). In addition to Department of Health 
guidance, the British HIV Association and National Institute for Health and Clinical 
publish updated guidelines for the testing and treatment of HIV-tuberculosis co-
infection (236, 264).  
Stigma and a lack of financial support also act as obstacles to implementing 
collaborative co-infection activities. It has been argued that the social effect of 
combining two highly stigmatising diseases adversely affects health-seeking behaviour 
thereby reducing the effectiveness of co-infection activities (265). Despite persons 
diagnosed with HIV in Eastern Europe being at a substantially greater risk of 
developing tuberculosis compared to HIV-diagnosed persons in Western Europe, it has 
been suggested Eastern European countries struggle to attract much needed international 
research and financial support for managing HIV-tuberculosis co-infections (265). This 
is because when compared to many African countries those in Eastern Europe are still 
seen as low priority (265).  
Notwithstanding obstacles, in the UK and elsewhere in Europe efforts are being made to 
reduce the burden of tuberculosis among persons living with HIV and vice versa. A 
common approach to achieving this is the promotion of tuberculosis testing in HIV 
settings and HIV testing in tuberculosis settings. 
5.6.1 Testing for tuberculosis among HIV-diagnosed persons 
In paper 5.1, I reported a substantial number of heterosexuals being diagnosed with 
tuberculosis more than six months subsequent to their HIV diagnosis. It is highly likely 
that a number of these persons could have been prevented from progressing to active 
tuberculosis had they been tested and treated for latent tuberculosis at the time of their 
HIV diagnosis.  
Preventing progression from latent to active tuberculosis through prescribing 
chemoprophylaxis (a therapeutic measure for the prevention of tuberculosis or to avoid 
development of disease in tuberculosis infected persons) has been shown to be 
achievable among the following groups of HIV-diagnosed people in the UK: from sub-
Saharan Africa and on antiretroviral therapy for less than two years; from middle 
tuberculosis incidence countries on antiretroviral therapy less than two years and with a 
CD4 cell count <500 cells/ml; from low tuberculosis incidence countries on 
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antiretroviral therapy for less than six months and with a CD4 cell count <350 cells/ml 
(236). It is among these three groups of HIV-infected persons that the British HIV 
Association recommends screening for latent and active tuberculosis (236). The 
National Institute for Health and Clinical Excellence combines these three groups in its 
broader recommendation for tuberculosis screening among all HIV-infected persons 
with a CD4 cell count <500 cells/ml (264). The institute also recommends treatment of 
latent tuberculosis be considered for all persons living with HIV (264).  
In a London-based study, testing HIV patients for tuberculosis was shown to identify 
more cases of latent and active tuberculosis than typically found during contact tracing 
(266). The same study also showed tuberculosis preventive treatment among those 
diagnosed to be acceptable, with 85% of patients completing their tuberculosis 
chemotherapy regimen (266). 
In the UK and elsewhere in Europe effective interventions, tests and treatments for 
tuberculosis among persons living with HIV are available (236, 242, 252, 264). Despite 
this, the incidence of tuberculosis remains elevated among HIV-diagnosed populations 
and a high number of tuberculosis associated deaths still occur among persons living 
with HIV (250, 252, 254). It has been argued that the underlying reason for this paradox 
has nothing to do with the effectiveness of diagnostic tests or preventive therapies but 
rather a lack of adherence by clinicians to existing guidelines (267). 
5.6.2 Testing for HIV among tuberculosis patients 
In addition to highlighting missed opportunities for earlier testing for tuberculosis, I also 
presented evidence in paper 5.1 of missed chances to diagnose HIV more promptly. In 
paper 5.1, I report a small number of HIV-diagnosed heterosexuals to be diagnosed with 
tuberculosis six or more months prior to HIV. As HIV often remains undiagnosed for 
several years it is probable that some of these persons were living with HIV when 
diagnosed with tuberculosis.  
Previous studies have presented evidence of potential missed opportunities for earlier 
HIV testing in tuberculosis setting. Among tuberculosis patients in Greater London 
between 2003 and 2004, almost half were not offered an HIV test (117). In the West 
Midlands, less than half of tuberculosis patients seen in 2008/2009 were tested for HIV 
(118). The authors of a study of tuberculosis among Africans living in London 
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suggested symptom misinterpretation and HIV-related stigma may result in reducing 
HIV test uptake in tuberculosis settings (116).  
To promote HIV testing, the British HIV Association in 2008 recommended universal 
HIV testing in healthcare services for persons diagnosed with tuberculosis (138). 
Subsequent to this, the National Institute for Health and Care Excellence recommended 
all tuberculosis patients in the UK receive a risk assessment for HIV (264). It is possible 
that these recommendations are having some impact. In 2013, among persons diagnosed 
with tuberculosis in the UK and for whom information was available, nine in ten were 
offered and received HIV testing (268). 
As in the UK, many other European countries recommend HIV testing in tuberculosis 
settings. Amongst European countries surveyed in 2005, four in ten had a national 
surveillance system to monitor HIV among tuberculosis patients and nine in ten had a 
national policy offering HIV testing and counselling to tuberculosis patients (242). Of 
25 European countries participating in a 2010 survey, 22 reported having a national 
recommendation for testing tuberculosis patients for HIV infection (241). Despite such 
recommendations, missed opportunities persist. Among the 22 European countries with 
a national recommendation, HIV testing among tuberculosis patients ranged from 5% to 
90% (241). 
The benefit of testing tuberculosis patients for HIV has been questioned. In 2003, it was 
suggested universal HIV testing among tuberculosis patients in chest clinics within the 
UK was unlikely to significantly reduce the number of people living with undiagnosed 
HIV (269). Among HIV-diagnosed persons starting treatment for active tuberculosis in 
the UK between October 2007 and April 2008, four in ten had their HIV infection 
diagnosed as part of their investigation for tuberculosis or as a direct result of their 
tuberculosis diagnosis (262). In 2011, 326 people diagnosed with tuberculosis in the UK 
were found to be co-infected with HIV (270). If we assume four in ten of these 326 
people had their HIV infection diagnosed in 2011 as a result of investigations for 
tuberculosis this would result in 130 people living with undiagnosed HIV having been 
found. In 2011, an estimated 22,600 people were living in the UK with undiagnosed 
HIV (271).  
Even if the potential yield from HIV testing among tuberculosis patients is small, the 
promotion of testing is essential as it is likely that those presenting with undiagnosed 
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HIV in tuberculosis settings will be in need of antiretroviral therapy (i.e. they are 
presenting with an AIDS defining illness). Between 2010 and 2012, tuberculosis was 
the second most common AIDS defining illness among all HIV-diagnosed people, after 
Pneumocystis jirovecii pneumonia (3).  
5.7 Impact of published research and recommendations  
In paper 5.1, I explored the incidence of tuberculosis among heterosexuals living with 
diagnosed HIV in England and Wales. In the paper I highlighted how, despite a decline 
in tuberculosis incidence between 2002 and 2010, the rate among HIV-diagnosed 
heterosexuals in 2010 still greatly exceeded the rate in the general UK population. I also 
provided evidence in paper 5.1 of missed opportunities for earlier testing of tuberculosis 
and HIV. 
To conduct the analysis for paper 5.1, I linked national HIV surveillance data with 
national tuberculosis surveillance data and sought guidance from both HIV and 
tuberculosis surveillance and clinical specialists. The bringing together of these 
specialists for the purpose of discussing my analysis was the beginning of the UK 
Tuberculosis and HIV Research Epidemiology and Development group (UK-THRED). 
The original membership of the group is reflected in the list of authors on paper 5.1. 
The group continues to meet on a six monthly basis.  
Discussions during UK-THRED meetings have guided three subsequent analyses of the 
wider dataset I created (i.e. includes persons infected with HIV through all routes). In 
May, 2015, Dr Rishi Gupta had a paper entitled “Does antiretroviral therapy reduce 
HIV-associated tuberculosis incidence to background rates? A national observational 
cohort study from England, Wales, and Northern Ireland” published in the Lancet HIV  
(254). In March, 2015, Dr Rishi Gupta also had a paper entitled “CD4 cell count 
responses to anti-retroviral therapy are not impaired in HIV-infected individuals with 
tuberculosis co-infection” accepted for publication in AIDS. Also in March, 2015 Dr 
Dominik Zenner had a paper entitled “Impact of tuberculosis on the survival of people 
living with HIV infection in England, Wales and Northern Ireland, 2000-2008” 
published in Thorax (272).  
Based on the results presented in paper 5.1, I recommended the universal offer of an 
HIV test to all persons diagnosed with tuberculosis be extended to all relevant 
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healthcare settings to promote optimal care for patients with tuberculosis and ensure 
antiretroviral therapy is initiated appropriately. I highlighted the importance of initiating 
antiretroviral therapy on time to reduce the incidence of active tuberculosis among HIV-
diagnosed people and concluded that integrated tuberculosis and HIV services were key 
to ensuring the recommendation for screening and possibly treating HIV-infected 
patients for latent tuberculosis was followed. The most recent national guidelines for the 
treatment of TB/HIV co-infection were published in 2011 prior to the publication of 
paper 5.1 in 2013 (39, 236). The recommendations of paper 5.1 have not, to date, been 
adopted. 
From the literature search I conducted for this chapter it is clear that a lack of adherence 
to existing guidelines is a major underlying reason for why the incidence of tuberculosis 
remains elevated in HIV-diagnosed populations. To improve the impact of antiretroviral 
therapy on reducing tuberculosis incidence, and to promote earlier diagnosis of HIV, it 
is essential that existing UK Department of Health, British HIV Association, and 
National Institute for Health and Clinical recommendations are effectively implemented 
and adhered to. In addition, it is essential that close cooperation is fostered in the 
clinical management and accurate notification of HIV and tuberculosis cases. To 
monitor and evaluate the impact of existing recommendations and interventions, 
accessible, reliable and comprehensive surveillance data on HIV-tuberculosis co-
infection are required. 
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6. HIV testing 
Summary 
In this chapter, I explore HIV testing among black Africans living in E,W&NI. The 
paper accompanying this chapter is called “HIV testing among black Africans living in 
England” (40).  
In the paper I presented results from the Mayisha II study, a community-based cross-
sectional survey of HIV prevalence, sexual attitudes and lifestyles among black African 
adults attending commercial and social venues in London, Luton, and the West 
Midlands in 2004 (41, 48). In Mayisha II less than half (44%) the participants had ever 
tested for HIV. The percentage was similar for those who were HIV-negative (44%) and 
those living with undiagnosed HIV (45%) (40). 
In this chapter I investigate HIV testing among black Africans living in E,W&NI. I 
describe the uptake of HIV testing and rates of undiagnosed HIV among black Africans. 
I also consider the benefits of reducing the number of black African adults living with 
undiagnosed HIV. I then examine barriers to HIV testing and discuss current strategies 
for promoting HIV testing in this population. 
Based on the published paper and my review of the literature I recommend that HIV 
testing be promoted among black African women and men in a range of healthcare and 
community settings and that the 2008 and 2011 national guidelines on HIV testing be 
adhered to. I also recommend further research into the frequency of HIV testing among 
black Africans. 
6.1 Introduction 
Heterosexual men and women living with HIV in E,W&NI, the majority of whom are 
black African, have elevated rates of late diagnosis and undiagnosed HIV infection 
(268). In Chapter 3, I reported that the percentage of heterosexuals diagnosed late in 
E,W&NI changed little between 2002 and 2011. It is important to reduce the number of 
people living with undiagnosed HIV in order to maximise the benefits of earlier 
detection (by improving a person’s health and life expectancy through treatment), and to 
minimise the risk of onward transmission (through antiretroviral treatment and 
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behavioural change).  Increasing HIV testing rates among heterosexuals, particularly 
among black Africans in E,W&NI, is central to achieving this. 
In this chapter, I present a paper, published in a peer-reviewed journal, in which I 
examine the uptake of HIV testing among black Africans living in England prior to the 
introduction of national testing guidelines in 2008. After summarising the key findings 
from the paper, I investigate the uptake of HIV testing, undiagnosed HIV and the 
benefits of reducing the number of black Africans living with undiagnosed HIV in 
E,W&NI. I also consider current strategies to promote HIV testing in this country. 
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6.2 The published paper: Rice et al., Epidemiology & Infection 2012 
HIV testing in black Africans living in England 
http://www.ncbi.nlm.nih.gov/pubmed/23040613  
Summary: We examined the uptake of HIV testing in black Africans living in England 
before the introduction of national testing guidelines. Analyses were conducted using 
data from an anonymous self-completed questionnaire linked to oral ﬂuid samples to 
establish HIV status in black Africans attending community venues in England in 2004. 
Of 946 participants, 44 % had ever been tested for HIV and 29 % had been tested in the 
previous 24 months. Of those with undiagnosed HIV, 45 % had previously had a 
negative HIV test. Almost a third of people tested in the UK had been at general 
practice. Uptake of HIV testing was not associated with perceived risk of HIV. These 
ﬁndings highlight the need for the implementation of national HIV testing guidelines in 
the UK, including the promotion of testing in general practice. Regular testing in black 
Africans living in the UK should be promoted regardless of their HIV test history. 
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6.3 Research findings from my published paper 
My published paper in this chapter is called “HIV testing among black Africans living in 
England” and was published in the journal Epidemiology and Infection in 2012 (40). In 
this chapter, I refer to it as paper 6.1. 
In paper 6.1, I presented results from the Mayisha II survey. Mayisha II was a 
community-based cross-sectional survey of HIV-prevalence, sexual attitudes and 
lifestyles among black Africans aged 16 years and over attending community-identified 
commercial and social venues in London, Luton and the West Midlands in 2004 (see 
Chapter 2 (section 2.2.2)) (41, 48). The overwhelming majority of the black African 
participants were born in Africa (94%) and were heterosexual (92%) (41). 
In the paper, I reported that among the 1,006 black African Mayisha participants for 
whom a valid HIV laboratory test result was available 865 (86%) were HIV negative, 
48 (5%) were living with diagnosed HIV infection, and 93 (9%) were living with 
undiagnosed HIV infection. Less than half (44%) of the black African study participants 
had ever tested for HIV. The proportion of participants who had ever tested was similar 
among those who were HIV negative (44%) and those living with undiagnosed HIV 
(45%). Among participants living with undiagnosed HIV infection who had previously 
tested negative for HIV, the overwhelming majority had had an HIV test in the previous 
24 months in the UK. 
In this chapter, I explore the uptake of HIV testing among black Africans in E,W&NI, 
rates of undiagnosed HIV and the benefits of reducing the number of black Africans 
living with undiagnosed HIV through improved uptake of testing. I also consider 
barriers to HIV testing and discuss current strategies to promote HIV testing in this 
country. 
6.4 Literature search 
I conducted a computerised literature search in relation to two topics raised by the 
published paper in this chapter. These were: (i) HIV testing among black Africans in 
E,W&NI; (ii) undiagnosed HIV among black Africans in E,W&NI. I also conducted a 
related computerised literature search on barriers to, and triggers for, HIV testing among 
black Africans living in E,W&NI. The searches also included the term “heterosexuals” 
in general. Appendix iii lists details of the searches conducted for this chapter. 
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6.5 Uptake of HIV testing among Black Africans in E,W&NI 
In paper 6.1, I reported that 44% of Mayisha II black African participants in 2004 had 
ever tested for HIV (after excluding participants living with diagnosed HIV infection). 
The uptake of testing was similar among HIV-negative participants (44%) and those 
living with undiagnosed HIV (45%). Among women, 47% reported having ever tested 
for HIV whereas, among men, the figure was lower at 41%, although this difference 
was not statistically significant (40).  
The rates of testing I reported in paper 6.1 were higher than those reported in the 
Mayisha I study conducted six years earlier. Between 1997 and 1999, 30% of female 
migrants and 34% of male migrants from five sub-Saharan African communities 
resident in London reported having ever tested for HIV (273).  
Between the two Mayisha studies, the increase in testing was greater among women 
(17% increase) than men (7% increase). The introduction in 1999 of the routine offer 
and recommendation of an HIV test to all antenatal clinic attendees probably explains 
why a greater increase in the uptake of testing was observed among women than men. A 
similar pattern was seen in France where sub-Saharan African women living in Paris 
were more likely to have ever tested for HIV than sub-Saharan African men (172). This 
was also explained by the acceptance of free screening tests systematically offered in 
France to all women during their first prenatal visit. 
In the second National Survey of Sexual Attitudes and Lifestyles (Natsal) conducted in 
Britain between 1999 and 2001, among black African residents aged 16 to 44 years, 
44% of women and 36% of men reported ever having had an HIV test (274). These 
percentages are similar to those reported in Mayisha II in 2004. 
Since 2004, rates of HIV testing among black Africans have continued to increase. 
Repeated studies of black Africans living in England have shown that the percentage of 
participants ever testing for HIV has increased from 52% in 2007 to 60% in 2008/2009 
and up to 65% by 2013/2014 (204, 275, 276). Figure 6.1 presents rates of HIV testing 
among black Africans in England or Great Britain. 
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Figure 6.1: Rates of HIV testing among black Africans living in England or Great 
Britain  
*Conducted in England by Health Protection Agency (Fenton et a l , 2002; Health Protection Agency, 2005)
***Conducted in England by Sigma Research (Sigma Research, 2008; Sigma Research, 2009; Bourne et a l , 2014)
**Conducted in Britain by University College London, the London School of Hygiene & Tropical Medicine 
and  NatCen Social Research (Burns et a l , 2005)
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Reasons for the increase in the rate of HIV testing between 2007 and 2008/2009 are not 
clear as it is unlikely that the introduction in 2008 of national HIV testing guidelines 
targeting people from countries with a high prevalence of HIV would have had an 
immediate effect. However, the introduction of the 2008 guidelines, and subsequent 
testing guidelines in 2011 targeting black Africans, may partially explain the increase 
between 2008/2009 and 2013/2014 (I discuss the 2008 and 2011 guidelines in section 
6.7). 
The National Surveys of Sexual Attitudes and Lifestyles (stratified probability sample 
surveys conducted in 1990 to 1991, 1999 to 2001, and 2010 to 2012) have shown rates 
of HIV testing among British male and female respondents (the majority of whom were 
heterosexual) to have also increased over the past twenty years. The percentage of males 
reporting having had an HIV test in any setting in the previous five years increased from 
7% in 1990-1991 to 9% in 1999-2001 and to 17% in 2010-2012 (277). Among females, 
there was an initial slight decline in the percentage reporting having had an HIV test in 
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any setting in the previous five years (1990-1991: 10.5%; 1999-2001: 9%) followed by 
a substantial increase (2010-2012: 28%) (277).  
In the 2010-2012 Natsal survey among the British population, rates of HIV testing were 
highest among women and black Africans (277). It is likely that the success of the 
universal offer of an HIV test to women attending antenatal care explains the higher rate 
of testing among British women as compared to men. It is also likely that the success of 
national HIV testing strategies in promoting the routine offer of an HIV test to people 
born in high prevalence countries and / or black Africans (see section 6.7) explains the 
higher rate of testing among black Africans. Among black Africans living in England 
two of the most common reasons for having had an HIV test were antenatal screening 
(for women) or that it was part of routine health screening (276). 
Despite increases over time, the uptake of HIV testing in England among black Africans 
remained lower than among MSM in the Natsal survey. Between 2010 and 2012, 52% 
of men who had had sex with a man in the past five years reported having had an HIV 
test (also in the past five years) compared with 44% of Black Africans (277). 
6.6 Undiagnosed HIV among black Africans in E,W&NI 
6.6.1 Rates of undiagnosed HIV 
In paper 6.1, I reported that among the 1,006 black African Mayisha participants for 
whom a valid HIV laboratory test result was available, 9% were living with 
undiagnosed HIV infection. This means that among the 14% of Mayisha participants 
living with HIV, two thirds (66%; 93/141) were undiagnosed. It is likely that this 
proportion is an overestimate of the true population proportion because it is thought that 
Mayisha II participants previously diagnosed with HIV were less likely to provide a test 
sample than those who had previously tested negative. As a consequence people with 
diagnosed HIV were underrepresented in the laboratory sample (41). Nonetheless, in the 
country as a whole, rates of undiagnosed HIV are elevated among black African men 
and women. In 2012, an estimated 30% (6,300/21,200) of heterosexual men and 24% 
(7,700/31,800) of heterosexual women living with HIV in the UK remained 
undiagnosed (3). The majority of these people were black African. Among MSM living 
with HIV in the UK in 2012, the figure was 18% (7,300/41,000) (3).  
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6.6.2 Importance of reducing undiagnosed HIV 
In the UK, the overwhelming majority of persons diagnosed with HIV are linked into 
care within three months, and more than nine out of ten in need of treatment receive 
antiretroviral therapy (36, 98). Access to this high-quality care is dependent on a person 
living with HIV being diagnosed. The identification and linkage in to care of people 
living with HIV has been described as the entry point for a lifelong continuum of care 
and treatment (278). It has also been described as “The Holy Grail” in improving the 
cascade of care among people living with HIV (279). 
Reducing the number of black Africans living with undiagnosed HIV in E,W&NI would 
not only bring more people into treatment and care but would also reduce the risk of 
HIV transmission. It has been argued that, in low-prevalence heterosexual populations 
in high income countries, HIV transmission could be reduced by tackling undiagnosed 
HIV alone (280).  
In the USA, it is estimated that half of all new HIV infections are attributable to the one 
in five people living with HIV who are undiagnosed (17). As improvements are made in 
retaining HIV-diagnosed persons in care and providing them with antiretroviral therapy 
earlier in the course of disease it is estimated that the proportion of new HIV infections 
attributable to those living with undiagnosed HIV will increase (17). It has been 
estimated that for every 100 persons newly diagnosed with HIV in the USA eight new 
HIV infections would be averted (17). Transmission would be averted through a 
combination of behaviour change and a reduction in infectivity through treatment.  
If all people living with undiagnosed HIV in the USA were diagnosed, behavioural 
change would lead to an estimated 57% decline in unprotected anal and vaginal 
intercourse among this group (281). This decline in unprotected sex could result in the 
annual number of new HIV infections acquired through sexual contact in the USA 
falling by a third (281). 
New sexually acquired HIV infections could also be averted by treating people who 
were previously undiagnosed. Persons diagnosed with HIV who are in receipt of 
treatment can attain undetectable viral loads (<50 copies/ml) (19). Those who attain 
undetectable viral loads have a negligible risk of transmitting their infection to others 
through unprotected sex (19). In light of this evidence, international HIV treatment 
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guidelines were revised to recommend antiretroviral therapy among all persons with a 
CD4 cell count <500 cells/ml (282). Treatment was previously recommended among 
persons with a CD4 cell count <350 cells/ml.  
The benefits of reducing the number of people living with undiagnosed HIV through 
HIV testing may outweigh the benefits of expanding treatment among persons already 
diagnosed with HIV. Expanding treatment to all diagnosed persons with a CD4 cell 
count <500 cells/ml in the UK, as opposed to only those with a count <350 cells/ml, 
would decrease the percentage of all persons living with HIV with detectable viral loads 
(>50 copies/ml) from an estimated 42% to 38% (130). In contrast, halving the size of 
the undiagnosed population would decrease this percentage from an estimated 42% to 
28% (130). In 2013, a coalition of HIV experts in the UK called for the percentage of 
people living with HIV who were undiagnosed to be halved by 2015 (283).  
Between 2005 (the first year national estimates of undiagnosed HIV were available) and 
2013 the estimated percentage of heterosexuals living with HIV in the UK who were 
undiagnosed only declined from 31% (10,500/33,600) to 27% (14,100/53,000) (3, 284). 
The majority of these people were black African. It should be noted that the 2005 
estimate considered heterosexuals aged between 15 and 59 years whereas the 2013 
estimate considered heterosexuals of all ages. Despite this caveat, it remains clear that 
more needs to be done in improving the uptake of HIV testing among black Africans in 
E,W&NI if the percentage of people living with undiagnosed HIV is to be halved. 
6.7 HIV testing strategies among black Africans in E,W&NI 
Currently in the UK a combination of targeted and population-based strategies are 
employed to promote HIV testing among black Africans and to reduce the prevalence of 
undiagnosed HIV. The shared goal of many current strategies is to normalise HIV 
testing. Normalised HIV testing is where HIV is treated like any other infectious disease 
and where all doctors are confident and competent at HIV testing and diagnosis (101). 
A review into the effectiveness of interventions to increase the uptake of HIV testing 
among black Africans living in England found that the uptake of HIV testing increased 
among migrant and black and minority ethnic groups in England when the provision of 
testing was normalised (285). 
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Across Europe attempts have been made to normalise HIV testing among heterosexuals 
at risk of HIV. A 2010 review of HIV testing policies and practices in migrant and 
ethnic minority populations across Europe found that HIV testing strategies were 
broadly categorised into general population approaches, targeted approaches, and a 
combination of the two (for example, offering routine testing in healthcare settings to 
the most affected communities) (286). 
For HIV testing strategies to be successful in promoting testing among migrant and 
ethnic minority populations at risk of HIV it is important that HIV-related stigma and 
discrimination is addressed. A study of all HIV-positive patients attending a London 
hospital in 1999 and 2000 found the level of concern about a range of practical, social, 
and emotional issues relating to HIV testing to be high among black Africans as 
compared to other groups (113). African HIV community informants in the UK have 
also identified stigma and issues relating to confidentiality as major barriers to 
accessing HIV testing and other HIV services (119). A study of black Africans living in 
England in 2008/2009 found that only half of the participants who had never tested for 
HIV were willing to do so (204). To reduce barriers to testing, public health guidance 
was published in 2011 highlighting the need for staff offering HIV tests to black 
Africans to emphasise that testing is confidential and to be aware of, and sensitive to, 
the cultural issues facing black Africans (139). 
Central to the approach of normalising HIV testing is the routine offer of an HIV test by 
healthcare providers. The routine offer of an HIV test may be targeted at specific groups 
at risk of HIV infection or based on attendance at a specific healthcare service. It may 
also be based on disease presentation or HIV population prevalence. 
6.7.1 Targeted HIV testing 
In an attempt to increase HIV testing among at-risk heterosexuals, national HIV testing 
guidelines in 2008 introduced testing criteria based on country of origin. In addition to 
recommending the routine offer of an HIV test to all sexual partners of a known positive 
person, the guidelines recommend routine testing of all people from a high HIV 
prevalence country (the majority of whom are from sub-Saharan Africa), and all people 
reporting sexual contact abroad or in the UK with individuals from high prevalence 
countries (138). In 2011, public health guidance was released with the specific intention 
of increasing HIV testing among black Africans in the UK. The guidance recommends 
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testing in a range of healthcare and community settings frequented by black Africans, 
recruiting members of local black African communities to act as champions, and 
making available promotional material tailored to the needs of black Africans (139).  
Both the 2008 and 2011 guidelines consider cost effectiveness. The 2008 guidelines 
suggest that by reducing late HIV diagnoses costs to healthcare services will be reduced 
(138). The guidelines also refer to modelling conducted in the USA which showed 
routine screening for HIV infection to be cost effective where the prevalence of HIV 
exceeds 0.05 percent (138). The 2011 guidelines conclude that testing and treating 
people before they become symptomatic is likely to be cost effective as it is likely to 
lead to fewer infections over time through treatment as prevention (139). 
Targeted testing may also be based on indicator diseases. In 2008, it was recommended 
that healthcare professionals in the UK, and elsewhere in Europe, recommend an HIV 
test to all patients presenting with diseases recognised to be associated with HIV (for 
example, tuberculosis) (102, 287). In particular, it was recommended that general 
practitioners, dentists, dermatologists, gynaecologists, sexual health clinicians and 
emergency physicians should be aware of the range of diseases where the prevalence of 
HIV is high as they were likely to be the providers who first encountered HIV-infected 
patients presenting with comorbid conditions (287). 
However, the effectiveness of targeted testing strategies has been questioned. In 2009, it 
was suggested that testing strategies in the UK based on risk were not reducing high 
rates of undiagnosed HIV and late diagnosis (288). One reason for why targeted testing 
may not have had the intended impact on undiagnosed HIV is stigma. Targeted, risk-
based strategies based on ethnicity have been seen as being judgemental and as a 
potential cause of stigma (120). To reduce stigma, and further promote testing among 
at-risk groups, a broader approach to testing has been called for (120, 288).  
6.7.2 Population-based HIV testing 
National HIV testing guidelines recommend an HIV test be offered to everyone 
attending contraceptive, sexual health, termination-of-pregnancy and antenatal services, 
drug-dependency programmes, and services for tuberculosis, lymphoma and hepatitis B 
and C. In addition, it is recommended that all people with symptoms consistent with 
primary HIV infection or presenting with a clinical indicator condition should be 
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offered an HIV test (100, 138). Additionally, in areas of E,W&NI where the prevalence 
of diagnosed HIV exceeds 2 in 1,000 (based on SOPHID data and referred to as high 
prevalence areas) an HIV test is recommended for all people admitted for secondary 
general medical care or registering with a general practice (100, 138). 
Antenatal clinics 
In the UK, antenatal clinics have routinely offered and recommended an HIV test to all 
patients since 1999 (18). In 2012, 675,800 pregnant women in England, representing 
98% of all pregnant women, were screened for HIV (3). The success of opt-out testing 
in antenatal clinics has resulted in a substantial decline in both the number of women 
remaining undiagnosed post-delivery and mother-to-child transmissions (289).  
The effectiveness of the antenatal screening programme probably explains why rates of 
undiagnosed infection are higher among heterosexual men than heterosexual women 
(see section 6.6.1). The authors of a study of HIV service utilisation among Africans in 
Britain concluded that, unlike women who may access antenatal services, African men 
lacked a front door to HIV services (119). Antenatal screening may, however, provide a 
back door to HIV services for men. A London-based study of HIV-positive African 
born heterosexual men found that many of the participants had only tested after 
discovering their female partners were HIV positive (290).  
Reaching men through women was identified as one of the few HIV testing strategies 
implemented in European countries to encourage migrant and ethnic minority 
heterosexual men to test (286). Men could be reached via women through partner 
testing or couple testing during antenatal care (286). In 2012, the British HIV 
Association recommended that people living with HIV be offered support from staff 
competent in partner or contact notification to enable personal contacts at risk of HIV to 
access testing (100). 
Sexual health clinics 
In 2001, the National Strategy for Sexual Health and HIV recommended that all sexual 
health clinic attendees in the UK be offered an HIV test (291). By 2008, the majority of 
sexual health clinics had adopted a universal opt-out approach to testing (138). 
Universal opt-out testing is where all attendees are routinely offered and recommended 
to have an HIV test and the individual has the option to refuse. 
122 
 
The introduction of opt-out testing in a sexual health clinic in Amsterdam in January 
2007 had a substantial effect on HIV test uptake. Among at-risk heterosexuals of all 
ages, HIV test uptake increased from 64% in 2006 to 94% by the end of 2007 (292). 
Evidence for the need for opt-out testing in The Netherlands was presented in a 2003 
study which found that among migrants to the Netherlands who had previously tested 
for HIV, only one third had actively requested their test (293). 
It has been suggested in the UK that an opt-out approach to testing in sexual health 
clinics and other healthcare facilities could detect many previously undiagnosed 
infections and help reduce the stigma associated with testing (120). However, it has also 
been suggested that the potential for opt-out HIV testing in healthcare facilities, such as 
sexual health services, to further promote testing and reduce rates of undiagnosed HIV 
may be limited due to stigma and a lack of information preventing people at risk from 
accessing these services (115). While this may be true for some sexual health services it 
appears that the introduction of routine HIV testing in antenatal clinics has been highly 
successful in this country (see section above).  
Primary care, and acute and general medical admissions 
In high prevalence areas of E,W&NI where diagnosed HIV prevalence exceeds two in 
1,000 population aged 15 to 59 years it is recommended that HIV testing be considered 
for all people registering in general practice and for all general medical admissions 
(138). A diagnosed prevalence of 2 in 1,000 or more is a proxy for an undiagnosed 
prevalence of 1 in 1,000 or more, the threshold at which routine testing in the UK is 
assumed to be cost effective (138). This cost effective threshold is based on data from 
the USA. 
In the USA, routine HIV screening of all persons aged 13 to 64 years in health-care 
settings with a prevalence of undiagnosed HIV infection of at least 1 in 1,000 was 
introduced in 2006 (294). In the USA, hospital emergency departments have been 
described as the cornerstone of the HIV screening approach in identifying persons 
living with undiagnosed infection (295). In E,W&NI, I would argue primary care should 
be the cornerstone of strategies aiming to reduce undiagnosed HIV among 
heterosexuals. 
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In the past, primary care has often been a setting for missed opportunities for early HIV 
diagnosis. Among Africans attending HIV treatment centres in London between April 
2004 and February 2006, three quarters had seen their general practitioner in the year 
prior to their HIV diagnosis (101). It is highly likely that a sizeable proportion of these 
black African attendees were living with undiagnosed HIV when they saw their general 
practitioner 12 months before HIV diagnosis. It is estimated that half of the people 
living with undiagnosed HIV in the UK have been living with their infection for 
between three and five years (130).  
Prior to the 2008 recommendation to normalise HIV testing in primary care in high 
prevalence areas, African HIV community informants in the UK reported a lack of trust 
in general practitioners due to HIV-related ignorance and breaches of confidentiality 
(119). Research conducted since 2008 appears to show a change in attitude towards opt-
out testing in primary care. A pilot study conducted in Lewisham in 2010 found opt-out 
testing of all patients aged 18 to 59 years newly registering at primary care services to 
be highly acceptable, to reduce the administrative burden of testing, and to help 
normalise testing (296). The authors of a 2011 study conducted in Brighton reported 
that nearly all study participants felt that registering with a general practice was a 
suitable opportunity for opt-out testing and more acceptable than testing on hospital 
admission (289). Thirty percent of respondents to a 2013/2014 online survey of black 
Africans living in England identified a general practitioner’s surgery as the location 
where they would like to take an HIV test in the future, making it the most preferred 
setting (276).  
The routine offer of an HIV test in both acute medical admissions and general medical 
services (such as where blood tests are routinely conducted for medical admissions) has 
also been shown to be acceptable to patients, feasible to establish, and effective in 
detecting previously undiagnosed infection (296). It is therefore disappointing that a 
2012 study of sexual health commissioners in forty high prevalence areas found that 
only half had commissioned HIV testing in the community and/or in general practice 
and only one third had commissioned HIV testing in hospital departments (297). Only 
one in ten areas had commissioned HIV testing in all three settings, and in areas where 
HIV testing in general practice was taking place it was typically in less than one in five 
of practices (297). If the number of black Africans living with undiagnosed HIV is to be 
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reduced, let alone halved, it is essential that existing testing strategies are widely 
implemented. The support of sexual health commissioners is critical in achieving this. 
6.7.3 Self-sampling and testing  
Stigma, discrimination, and a lack of privacy may partially explain why people living 
with undiagnosed HIV do not access facility-based testing (114). Self-sampling and 
testing may partially address these concerns. 
Self-sampling is where a person takes a blood finger prick or saliva sample and 
forwards it to a laboratory for testing, from which a test result is subsequently received. 
Self-sampling HIV test kits are already available in the UK.  
Self-testing is where a person takes and tests a sample themselves and obtains a result 
immediately. In 2014, the UK law was amended to allow the sale of HIV self-test kits in 
England, Scotland and Wales (298). In April, 2015 the first legally approved HIV self-
test kit went on sale in England, Scotland and Wales. 
Although self-testing for HIV has been shown to be acceptable among groups of 
heterosexuals at risk of HIV there are some concerns about this approach (299). It has 
been suggested that linkage into HIV services of people testing HIV positive with self-
testing kits will be a major challenge (299). Also, most currently available HIV self-test 
kits are third generation. As compared to fourth generation tests used in healthcare 
settings, third generation tests have a longer window period (time between becoming 
infected with HIV and the infection being detectable). This may result in a person who 
has recently acquired HIV testing positive with a fourth generation test but negative 
with a third generation test. Due to a lack of literature, it is difficult to predict the extent 
to which self-sampling and testing will help reduce the number of heterosexuals living 
with undiagnosed HIV. 
6.7.4 Repeat testing 
In paper 6.1, I estimated that almost half of the 93 black African study participants 
living with undiagnosed HIV infection in the Mayisha study had previously tested 
negative for HIV, the overwhelming majority of whom had tested negative in the UK in 
the previous 24 months. This finding provides evidence of HIV transmission among 
black Africans living in England and the need not to see testing as a one-off event. In 
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paper 6.1, I recommended that regular HIV testing in black Africans be promoted. In 
my recommendation, however, I did not define what I meant by “regular testing”. 
In 2006 in the USA, it was recommended that all persons at high risk for HIV infection 
be tested for HIV at least annually (294). Following the introduction of repeat testing, 
the authors of a study in the USA reported median initial CD4 cell count to be higher 
among patients diagnosed through repeat testing than among those identified through 
first time testing (300). The study authors concluded that both the diagnosis of prevalent 
HIV among those who have never tested and repeat testing of target populations for 
incident infection were important (300). 
In 2011, the National Institute for Health and Clinical Excellence recommended repeat 
testing be encouraged among black Africans living in England who had previously 
tested negative for HIV but who remained at risk of infection (139). As with the 
recommendation I made in paper 6.1, no time period was included in this 
recommendation. It is only in relation to repeat testing among MSM that a time period 
has been recommended. It is recommended that sexually active MSM in the UK have an 
HIV test at least annually, and more frequently if clinical symptoms are suggestive of 
seroconversion or if there is on-going high risk exposure (138, 301). However, to date, 
no recommendation has been made as to how often black Africans in E,W&NI should 
test for HIV. 
6.8 Recommendations  
In paper 6.1, I examined the uptake of HIV testing in black Africans living in England 
before the introduction of national testing guidelines in 2008. In the paper, I reported 
that less than half the black African study participants in 2004 had ever tested for HIV. 
In the paper, I recommended that HIV testing should not be seen as a one-off event but 
rather regular testing in black Africans should be promoted. I also recommended further 
research into the frequency of HIV testing. 
In the literature search I conducted for this chapter I found evidence of a 
disproportionate number of new HIV infections being attributable to persons living with 
undiagnosed HIV and of rates of HIV testing among black Africans in E.W&NI being 
lower than among MSM. It appears that the routine offer of an HIV test through 
targeted and population-based strategies in traditional and non-traditional settings may 
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have increased the uptake of HIV testing among black Africans in E,W&NI. 
Nonetheless, there remains much room for improvement. 
I recommend that regular HIV testing be promoted among black African women and 
men in a range of healthcare and community settings in this country, but particularly in 
primary care. I also emphasise the need for research into the frequency of HIV testing. 
Any future recommendation on testing frequency should include African community 
input and take into account HIV-related stigma among black Africans. I also 
recommend that the 2008 and 2011 national guidelines on the offering of an HIV test be 
adhered to. To promote adherence to national testing guidelines in high prevalence areas 
in E,W&NI, it is essential that the support of sexual health commissioners is secured.  
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7. Conclusion 
Summary 
In this concluding chapter, I revisit my research question and the approach that I have 
taken to answer it. Focusing on my research findings and methodological innovations, I 
summarise the six peer-reviewed published papers and the accompanying texts that are 
in Chapters 3, 4, 5 and 6. I then assess the public health importance and impact of my 
research and discuss the strengths and limitations of using national HIV surveillance 
data to examine how the epidemiology of heterosexually-acquired HIV in E,W&NI has 
evolved. Finally, I make recommendations based on my published papers and 
accompanying texts. My key recommendation is that regular HIV testing be promoted 
among black African women and men in E,W&NI in a range of healthcare settings, 
particularly in primary care. 
7.1 Rationale for the PhD  
In 2002, I joined the HIV and sexual transmitted infections department of the Public 
Health Laboratory Service as an HIV scientist. In my first few years as an HIV scientist 
a rapid increase in HIV diagnoses among heterosexuals in E,W&NI was observed (1). 
Despite this rapid increase little had been, or was being, published on the epidemiology 
of heterosexually-acquired HIV in E,W&NI at the time. Having developed an interest in 
this area, and recognising a gap in the research literature, I submitted an application for 
a part-time research degree to City University London in 2008 to examine the 
epidemiology of heterosexually-acquired HIV in E,W&NI in greater detail. 
7.2 Research question and objectives 
The overarching research question of my thesis is “How is the epidemiology of 
heterosexually-acquired HIV infection evolving, particularly among black Africans, in 
England, Wales and Northern Ireland?”. To answer this question, I analysed national 
HIV surveillance data and undertook literature searches. My specific objectives were to: 
1. analyse epidemiological data and undertake literature searches to highlight who is at 
risk of heterosexually-acquired HIV in E,W&NI;  
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2. consider challenges in accurately ascertaining epidemiological trends in 
heterosexually-acquired HIV, and design new methods to improve precision; 
3. explore the quality of HIV care provided to HIV-diagnosed heterosexuals in 
E,W&NI by examining key indicators of care available from routine HIV 
surveillance data; 
4. examine the impact of migration on the heterosexual transmission of HIV in 
E,W&NI and consider whether a “home-grown” epidemic has developed among 
both heterosexuals born abroad and those born in the UK;  
5. conduct research into HIV tuberculosis co-infection among heterosexuals in 
E,W&NI and consider the role of testing for HIV in tuberculosis clinics and vice-
versa; 
6. investigate HIV testing trends among heterosexuals in E,W&NI and why high rates 
of undiagnosed HIV and late presentation persist in this group. 
7.3 How I answered the research question 
To answer the research question I conducted a quantitative analysis of national 
surveillance datasets. Most of my analysis was based on data from the three national 
HIV surveillance systems which constitute the HIV and AIDS Reporting System. The 
three systems are the New HIV Diagnoses database, the Survey of Prevalent HIV 
Infections Diagnosed, and the CD4 Surveillance Scheme (42). I also analysed data from 
the national Enhanced Tuberculosis Surveillance system and the Mayisha II 
community-based survey of sexual attitudes and lifestyles among black African 
communities in England, as well as information from national death registrations and 
the Index of Multiple Deprivation (41, 46, 48-51, 53, 54). 
I analysed the three HARS datasets independently and in combination. I analysed 
Enhanced Tuberculosis Surveillance data in combination with merged HARS data. I 
analysed death registrations as part of the New HIV Diagnoses database and the Index 
of Multiple Deprivation rankings as part of the SOPHID dataset. I analysed the Mayisha 
II dataset, which I cleaned and validated for the purpose of my thesis, independently of 
the other data sources.  
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I published the results of my analyses in six peer-reviewed papers between 2007 and 
2014. I also presented the results of my analyses at conferences, workshops, and 
advisory group meetings (see Appendix iv). Guided by topics raised in the six published 
papers, I undertook computerised literature searches to explore these topics in greater 
detail. I applied key terms to search article titles and abstracts for papers published in 
the English language, which I then reviewed. I also conducted a manual internet key 
word search using Google Scholar to identify relevant grey literature. I have presented 
the findings from the six papers, together with the results of my literature searches, in 
four empirical chapters in this thesis (Chapters 3 to 6). 
7.4 New research findings  
7.4.1 Impact of migration  
In my thesis I estimated that one third of heterosexual adults born abroad and diagnosed 
with HIV in E,W&NI between 2004 and 2010 had acquired HIV whilst living in the 
UK, increasing from one quarter in 2004 to almost a half in 2010. The overwhelming 
majority of the study population were black African. My overall estimate of one third 
was three times higher than that ascertained via clinic reports, based on an assessment 
of a person’s sexual history.  
Focusing on 2010 (the latest year for which results were presented), I estimated that 543 
heterosexuals born abroad (mostly in sub-Saharan Africa) and diagnosed with HIV in 
E,W&NI that year had acquired their HIV infection whilst living in the UK. The 
equivalent number according to clinic-based assignment was 224. My analysis clearly 
highlights that the heterosexual transmission of HIV within E,W&NI among persons 
born abroad is greater than previously thought. My analysis also highlights the need for 
targeted HIV prevention among black-African communities in E,W&NI. 
7.4.2 Loss to follow-up from HIV care  
In exploring annual patterns of attendance at HIV services in E,W&NI I reported, on 
average, one in twenty adults attending HIV services in any one year were subsequently 
lost to follow-up from care. Cumulatively, over a nine year period, I reported one in five 
adults seen for HIV care being lost to follow-up. The groups most likely to be lost to 
follow-up from care were black Africans (the overwhelming majority of whom acquired 
HIV heterosexually), those who acquired HIV outside of the UK, those not receiving 
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antiretroviral therapy, and those recently diagnosed with HIV in E,W&NI. Based on my 
analysis and literature review, I suggested that outward migration from the UK may 
explain why these groups were more likely to be lost to follow-up from HIV care. 
7.4.3 Improved quality of HIV care  
For the period 2002 to 2011, I found an increase in the proportion of newly diagnosed 
heterosexuals in E,W&NI promptly integrated into HIV care (having a CD4 cell count 
within 28 days of HIV diagnosis) and receiving antiretroviral therapy within one year of 
diagnosis. The majority of these patients were of black African ethnicity. During the 
same period, I reported a reduction in the proportion of HIV-diagnosed heterosexuals 
(a) diagnosed beyond the point when treatment should have started (CD4 cell count 
<350 cells/ml), (b) diagnosed with an AIDS defining illness, or (c) having died of any 
cause within one year of HIV diagnosis. Despite a slight decrease over time, the 
proportion of heterosexuals diagnosed late with HIV remained unacceptably high. This 
was particularly true among black African heterosexuals. 
7.4.4 Decreased incidence of tuberculosis  
I reported a decline in the annual incidence rate of tuberculosis among HIV-diagnosed 
heterosexuals (the majority were of black African ethnicity) in England and Wales. The 
incidence of tuberculosis declined from 30 per 1,000 HIV-diagnosed heterosexuals in 
2002 to nine per 1,000 in 2010.  
The decline I reported in tuberculosis incidence coincided with a decline in the overall 
number of HIV-diagnosed heterosexuals in E,W&NI, including black Africans, 
acquiring HIV in sub-Saharan Africa (the prevalence of HIV and tuberculosis is high in 
many sub-Saharan Africa countries) and an increase in the uptake of antiretroviral 
therapy among persons diagnosed late (antiretroviral therapy can reduce a person’s 
susceptibility to HIV-related infections). Nonetheless, despite the decline over time, I 
reported the incidence of tuberculosis among HIV-diagnosed heterosexuals to remain 
substantially higher than in the general UK population. 
7.4.5 HIV testing among black Africans  
Among black Africans in England participating in a 2004 community-based study (the 
overwhelming majority of participants were born abroad), 44% had ever tested for HIV. 
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Nine percent of the study population were living with undiagnosed HIV infection. 
Among those living with undiagnosed HIV, almost half had previously tested negative 
for HIV, the majority of whom had had an HIV test in the UK in the preceding 24 
months. This finding highlighted that new infections had been acquired while the 
participants were already living in England. 
7.4.6 Summary of my research findings 
In response to the question “How is the epidemiology of heterosexually-acquired HIV 
infection evolving, particularly among black Africans, in England, Wales and Northern 
Ireland?” my key findings are that, over the last ten years: 
(i) an increasing proportion of black African heterosexual men and women, born abroad 
but diagnosed with HIV in the UK, acquired their HIV infection whilst living in the 
UK; 
(ii) outward migration from the UK may explain why some black African heterosexual 
men and women were lost to follow-up from HIV care; 
(iii) the proportion of black African heterosexual men and women diagnosed late with 
HIV in E,W&NI has not changed substantially; 
(iv) the uptake of HIV testing among black African heterosexual men and women in 
E,W&NI has increased but remains low compared with that among MSM. 
7.5 Methodological innovations 
7.5.1 Objectively assigning likely country of HIV infection 
Heterosexuals born abroad and diagnosed with HIV in E,W&NI may have acquired 
their infection before or after their arrival in the UK. To accurately consider the impact 
of migration on the heterosexual transmission of HIV in E,W&NI, I developed and 
applied, with my colleagues Dr Valerie Delpech and Dr Zheng Yin, a new method to 
assign likely country of infection based on objective, routinely collected surveillance 
data. The method assigns likely country of infection according to whether the estimated 
year of infection (ascertained by modelling rates of CD4 cell count decline) for a 
heterosexual born abroad is before or after their year of arrival in the UK. 
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Prior to the application of this method, assignment of likely country of HIV infection 
among persons born abroad was based on a clinic-based assessment of a patient’s sexual 
history. This method probably overestimated the number of heterosexuals acquiring 
HIV before arriving in the UK. This was due to clinic staff underestimating the risk of 
HIV transmission in the UK as compared to abroad (particularly in countries with a 
high prevalence of HIV), the underreporting of high-risk sexual behaviours in the UK 
due to social desirability bias or associated stigma, complex sexual and migration 
histories, and the difficulty of taking a complete sexual history in a clinical setting.  
7.5.2 Creating a cohort of adults seen for HIV care  
I created, with my colleague Dr Valerie Delpech, a cohort of adults attending NHS 
services for HIV-related care in E,W&NI. This was achieved by linking records across 
annual cross-sectional SOPHIDs on full identifiers (a four character coding of an adults 
surname, sex, date of birth, and postcode of residence) and by applying a deterministic 
matching algorithm which takes into consideration a variety of possible matches based 
on part identifiers.  
Prior to this methodological change, only aggregate, population-level trends in care 
could be monitored over time. These population-level trends were monitored by simply 
combining data from each annual survey in a single dataset (these data were referred to 
as stacked data). Data from each annual SOPHID remained independent of data 
collected in other years, therefore prohibiting the monitoring of trends across time at the 
individual level. By creating a cohort of people diagnosed with HIV we could monitor 
at the individual level patterns of HIV service attendance over time as well as 
developing quality of HIV care indicators.  
7.5.3 Linking national HIV and tuberculosis surveillance datasets 
To conduct research on the incidence of tuberculosis among HIV-diagnosed 
heterosexuals in E,W&NI, HIV surveillance data were linked with Enhanced 
Tuberculosis Surveillance data. To link these data I, along with colleagues from the 
HIV and tuberculosis surveillance teams at Public Health England, developed and 
applied a method of probabilistic matching. This method considers the frequency and 
uniqueness of data and expresses, as a percentage, the probability of two or more 
records belonging to the same person. 
133 
 
7.6 Public health impact of my research  
My work is of public health importance since I have published new research findings 
that have improved our understanding of heterosexually-acquired HIV in E,W&NI. In 
particular, I have enhanced our understanding of the impact of migration on 
heterosexually-acquired HIV in this country. Before I did the research for my PhD 
relatively little was known about the epidemiology of heterosexually acquired HIV in 
this country. I have also developed new methods which have improved the accuracy and 
validity of national HIV surveillance outputs. 
7.6.1 Accurately measuring the impact of migration on heterosexual HIV 
transmission 
Ascertaining whether HIV has been acquired before or after arrival in the UK is of 
critical public health importance. Accurate information on the number of people 
acquiring HIV whilst living in the UK helps public health professionals design and 
implement HIV prevention activities to scale. Colleagues and I designed and applied a 
new model to assign likely country of infection among persons born abroad and 
diagnosed with HIV in E,W&NI based on objective, routinely collected surveillance 
data.  
The new model is now routinely used in national HIV surveillance to objectively assign 
likely country of infection among all persons diagnosed with HIV in E,W&NI who are 
born abroad. It replaces a previous method which relied on sexual histories and clinic-
based risk assessment which underestimated the number of foreign-born people 
acquiring HIV after their arrival in the UK. 
Confident that the estimates derived from the new model were robust, I recommended 
that the new method be adopted in other countries where the number of HIV diagnoses 
among migrants is high. The European Centre for Disease Prevention and Control 
supported my recommendation (234). The revised European HIV/AIDS dataset, hosted 
by ECDC, has been designed to improve the capturing of information to allow for 
probable country of HIV infection to be ascertained for persons born abroad and 
diagnosed with HIV using the model.  
Following a workshop organised by Dr Valerie Delpech and myself from Public Health 
England and Teymur Noori of the ECDC, the model is being piloted in Sweden, 
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Belgium and Italy. In November 2014, I presented preliminary results based on 
Belgium’s national HIV surveillance data to the Belgian Research on AIDS and HIV 
Consortium in Brussels. In February, 2015, preliminary results based on Swedish and 
Italian national HIV surveillance data were shared with the respective countries. 
7.6.2 Monitoring patterns of HIV service attendance and quality of HIV care 
The creation of a cohort of adults seen for HIV care allowed for patterns of care and 
treatment to be observed over time among HIV-diagnosed adults. The ability to analyse 
trends over time at the individual level facilitated the design and implementation of a 
national set of quality of care indicators.  
Currently, seven indicators of the uptake of HIV testing and quality of HIV care are 
routinely monitored in E,W&NI. Two of these indicators are directly related to my 
analysis on loss to follow-up from HIV care. These two indicators monitor retention in 
care (the flipside of loss to follow-up). One of the indicators monitors retention in care 
among new patients (seen for care after 12 and 24 months of diagnosis) and the other 
retention in care among all patients (seen for care in the current and previous year).  
The two indicators on retention in care have been incorporated into British HIV 
Association quality standards to promote equity of access to care in the UK and to 
ensure people living with HIV can access the care they need (100). They form part of 
BHIVA Standard Two which monitors access to, and retention in HIV treatment and 
care. In 2013, the British HIV Association, in association with the Health Protection 
Agency (predecessor of PHE), adopted the methods I used to measure loss to follow-up 
to conduct a clinic-based audit of people seen for HIV care in the UK in 2010 but not in 
2011 (228, 235). 
7.6.3 Facilitating further research on HIV-tuberculosis co-infection 
In conducting my analysis of the incidence of tuberculosis among HIV-diagnosed 
heterosexual adults living in England and Wales I sought guidance from HIV and 
tuberculosis surveillance and clinical specialists. The bringing together of these 
specialists was the beginning of the UK Tuberculosis and HIV Research Epidemiology 
and Development group. This group, which continues to meet on a six monthly basis, 
has guided subsequent analysis of the combined HIV and tuberculosis dataset I helped 
create. In addition to the paper I published on the incidence of tuberculosis (included in 
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this thesis), three other papers have subsequently been published, or accepted for 
publication, in peer-reviewed journals. I am a co-author on all three papers. 
7.7 Strengths and limitations of my analysis  
I described in section 7.4 how the majority of my analysis was based on data from the 
three national surveillance systems which constitute HARS. There are both strengths 
and limitations in using established, already-collected surveillance data to answer my 
research question. In my discussion of the strengths and limitations of my analysis I 
refer to HARS as a combined system (i.e. I will not refer specifically to the three 
separate systems within HARS). 
7.7.1 Strengths 
An evaluation of all HIV and Sexually Transmitted Infections national surveillance 
systems in E,W&NI was conducted in 2007 and 2008 by internal and external 
stakeholders. It was concluded that HARS data were both comprehensive and valid 
(62). 
Only laboratory-confirmed cases of HIV are reported to HARS. To reduce the potential 
for underreporting, all diagnosing laboratories, diagnosing healthcare facilities, and 
facilities offering HIV care and treatment are encouraged to report. Each year, reporting 
sites that either have not reported, or have reported fewer patients than might be 
expected based on previous reports, are identified, contacted and encouraged to report.  
The reporting of HIV-diagnosed adults seen for care to SOPHID is linked to the local 
commissioning of HIV services. Underreporting could result in the underfunding of 
services in subsequent years. It is likely that this acts as an incentive to report all adults 
seen for HIV care in this country. 
The reporting of a first AIDS diagnosis at the time of an HIV diagnosis is likely to be 
comprehensive as first HIV and AIDS diagnoses can be reported to HARS jointly. The 
reporting of deaths among HIV-infected persons is also likely to be comprehensive as 
notifications reported directly by clinics to HARS are supplemented by death 
notifications from the Office of National Statistic (50). 
All HARS data are checked for duplicate records and missing or inaccurate information. 
Through routine data linkage within and between the three HARS constituents, 
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duplicate records are identified and removed from final amalgamated datasets. Data 
linkage and routinely run validation checks, within and between the three systems, 
identify missing and inaccurate information. Where possible, missing and inaccurate 
information in one system is populated or corrected by equivalent available and 
validated information in another. Where information is still missing or inaccurate, 
follow-up is undertaken by telephone and / or email with clinicians, health advisors, or 
data managers. Data completion exceeds 90% for most variables. 
In addition to completeness and validity, an advantage of using HARS data for my 
analysis was that they were readily available. It would not have been feasible for me to 
assemble from scratch a comparable dataset for my thesis. Also, analysing data I am 
familiar with (I have worked with HARS data since 2002) enabled me to recognise and 
understand the strengths and limitations of the data. It also meant that I was able to 
introduce methodological change to improve the validity of my analyses. These changes 
included linking annual cross-sectional surveys to create a cohort of adults seen for HIV 
care and developing a new method to assign likely country of infection among persons 
born abroad. 
7.7.2 Limitations 
To promote reporting and encourage clinician co-operation the number of variables in 
the HARS dataset is kept to a minimum as well as being standardised and fixed. The 
HARS data I used in my analysis were therefore limited and inflexible.  
It is likely that, in my analysis, I overestimated the number of HIV-diagnosed 
heterosexuals in E,W&NI. My definition of heterosexually-acquired HIV is based on 
probable route of HIV infection as reported by clinics. There is a potential for 
misclassification here. Due to social stigma, some men who have acquired HIV through 
sex with other men may report having acquired HIV heterosexually (66, 67). In 
particular, this may be the case for some black African men (69).  
Data from HARS relate only to HIV-diagnosed heterosexuals. In the UK, an estimated 
one in four heterosexuals living with HIV remain undiagnosed (3). Therefore, results 
relating to HIV-diagnosed heterosexuals underestimate the true number of heterosexuals 
living with HIV. 
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It is probable that my estimates of heterosexuals acquiring HIV after their arrival in the 
UK included some people who had acquired their infection whilst travelling abroad 
from the UK. Travel abroad after arrival in the UK may also have introduced error in 
my analysis on HIV testing among black Africans living in England. In my analysis of 
Mayisha II data, I classified black Africans born abroad who had ever been tested for 
HIV as having been tested in the UK if their year of arrival was before the year of their 
last test. It is possible that I misclassified some people as having tested in the UK when 
they actually tested while travelling abroad. I believe this misclassification will be 
limited as, unlike in many other countries, in the UK voluntary and confidential HIV 
testing is available free of charge in open access clinics. 
It is possible that error crept into some of my results due to the challenges of linking 
data within and between datasets. For example, if a person is reported over time to 
SOPHID under a different surname or date of birth linkage between these records may 
not occur. As a consequence, it is possible that my estimates of loss to follow-up from 
HIV care in E,W&NI were inflated. To reduce the potential for overestimation, I 
increased the likelihood of matching records in my analysis on loss to follow-up by 
using a matching algorithm that included variations in surname and date of birth. 
Limitations in data linkage between the national HIV and tuberculosis datasets may also 
have resulted in the incidence of tuberculosis among HIV-diagnosed heterosexuals in 
England and Wales being underestimated. To increase the likelihood of linking records 
relating to the same adult in both datasets probabilistic matching was applied. All 
possible matches were subsequently reviewed by me or another member of the research 
team. 
In summary, HARS data are complete, valid and readily available. The most important 
limitation of my analysis is the potential for misclassification due to some men who 
have acquired HIV through sex with other men reporting having acquired HIV 
heterosexually. However, it is likely that such misclassification is limited (as explained 
in Chapter 2 (section 2.4.2)). 
138 
 
7.8 Recommendations  
7.8.1 Review and roll-out the new method of assigning likely country of HIV 
infection 
To widen the application of the method I introduced in my thesis to assign likely 
country of HIV infection, I recommended additional analyses to assess the level of 
disaggregation at which the outputs of the model remain robust. For example, providing 
outputs at the sub-national level or according to sex, age, region of birth and ethnicity. 
To improve our understanding of the outputs from the new model I also recommended 
further research to investigate the extent to which heterosexuals born abroad acquire 
HIV whilst travelling away from the UK. Following the piloting of the new method in 
Sweden, Belgium and Italy, I also recommended that it be adopted in other countries 
where the number of HIV diagnoses among migrant populations is high. To enable roll-
out, national HIV surveillance systems should routinely collect information on CD4 cell 
count at diagnosis and year of arrival among persons born abroad.  
7.8.2 Consider the impact of inward and outward migration 
To improve precision, I recommended that predictive models of heterosexually-acquired 
HIV incorporate estimates of migration patterns based on the International Passenger 
Survey and the Labour Force Survey (146-148). I also recommended that national 
estimates of loss to follow-up from HIV care and objective estimates of likely country 
of HIV infection continue to be incorporated into routine surveillance outputs. I base 
my recommendations on the evidence that I presented on HIV transmission among 
migrants in E,W&NI, on persons being lost to follow-up from HIV care, and on 
potential outward migration of previously diagnosed persons 
7.8.3 Increased uptake of HIV testing  
In my analysis and literature review I presented evidence of heterosexual transmission 
of HIV among migrants in E,W&NI and of a disproportionate number of HIV infections 
being attributable to persons living with undiagnosed HIV. I highlighted late diagnosis 
among heterosexuals, particularly among black Africans, and that AIDS diagnoses and 
deaths were strongly associated with late diagnosis.  
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To reduce HIV transmission and late diagnosis, it is essential that the number of black 
Africans living with undiagnosed HIV in E,W&NI is greatly reduced. To achieve this I 
recommended that regular HIV testing be promoted among black African women and 
men in a range of healthcare and community settings, particularly in primary care. 
However, further research on the frequency of testing is warranted (please see section 
3.8).  
I also recommended that national guidelines on the offering of an HIV test to all persons 
in specific settings be adhered to. These guidelines recommend that an HIV test be 
offered to everyone attending contraceptive, sexual health, termination-of-pregnancy 
and antenatal services, drug-dependency programmes, services for tuberculosis, 
lymphoma and hepatitis B and C. In addition, all people with symptoms consistent with 
primary HIV infection or presenting with a clinical indicator condition should be 
offered an HIV test (100, 138). They also recommend that in areas where the prevalence 
of diagnosed HIV exceeds 2 in 1,000, an HIV test should be offered to all people 
admitted for secondary general medical care or registering with a general practice (100, 
138). Gaining the support of sexual health commissioners is critical for ensuring that 
these HIV testing strategies are widely implemented. As discussed in section 3.8, it is 
important that HIV testing be viewed as part of a wider HIV prevention strategy that 
includes the provision of condoms and lubricant as well as health promotion and 
outreach work. 
7.8.4 Maintain regular service engagement with HIV-diagnosed heterosexuals 
Based on the evidence I presented on loss to follow-up from HIV care I recommended 
that national and NHS trust-specific strategies be developed to maintain regular service 
engagement among black Africans, those who acquired HIV abroad, those not in receipt 
of antiretroviral therapy, and those recently diagnosed with HIV. I also recommended 
research on bi-national approaches to ensure efficient and effective pathways of care 
among HIV-diagnosed people leaving the UK on a permanent or semi-permanent basis. 
Evidence of heterosexual transmission of HIV within E,W&NI also highlights the need 
for maintaining regular service engagement with HIV-diagnosed heterosexuals to 
optimise treatment and reduce the risk of on-going transmission (19). 
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7.8.5 Reduce the incidence of tuberculosis among HIV-diagnosed heterosexuals 
Despite reporting a decline over time in the annual incidence rate of tuberculosis among 
HIV-diagnosed heterosexuals in England and Wales, I highlighted that incidence among 
this group remains substantially higher than in the general UK population. In my 
analysis I presented evidence of missed opportunities to diagnose HIV earlier in 
tuberculosis settings and to diagnose latent tuberculosis in HIV settings. I also 
highlighted the importance of initiating antiretroviral therapy on time to reduce the 
incidence of active tuberculosis among HIV-diagnosed people. 
It is essential that the recommendation for an HIV test to be offered to everyone 
attending services for tuberculosis should be followed (100, 138). British HIV 
Association, Department of Health, and National Institute for Health and Clinical 
Excellence guidelines on screening and possibly treating HIV-infected patients for 
latent tuberculosis infection should also be adhered to fully (47, 236, 264). I 
recommended close cooperation between tuberculosis and HIV services in the clinical 
management and accurate notification of HIV and tuberculosis cases. Finally, I 
recommended that the HIV and tuberculosis surveillance teams at Public Health 
England review, modify (if necessary), and repeat data linkage between the HIV and 
tuberculosis datasets to ensure reliable and comprehensive surveillance data on HIV-
tuberculosis co-infection are available to monitor and evaluate the impact of 
interventions. 
7.8.6 Improve data quality 
The strengths and limitations of national HIV surveillance data need to be considered 
when utilising these data to describe the evolving epidemiology of heterosexually-
acquired HIV. To reduce or account for potential bias in the reporting of probable route 
of HIV infection, I recommend that research be conducted to assess the extent to which 
social stigma results in men who have acquired HIV through sex with other men being 
classified as having acquired HIV heterosexually. To improve accuracy in time trend 
analysis, I recommend an on-going review of methods used to link records within and 
between the national HIV surveillance systems. 
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7.8.7 Categorise migrants according to ethnicity and country of birth 
I presented evidence for the utility of categorising migrants according to their ethnicity 
and country of birth to highlight heterogeneity in risk of acquiring or living with HIV. I 
therefore recommended migrants be categorised in HIV research according to their 
ethnicity and country of birth. To ensure heterogeneity in risk is more readily 
highlighted by these two variables I recommended that they be combined in HIV 
research with HIV prevalence estimates according to country of birth and / or ethnicity.  
7.8.8 Key recommendation 
Throughout my thesis I have presented evidence of the epidemiology of heterosexually-
acquired HIV infection in E,W&NI being shaped by black African migrants. I also 
presented evidence of high rates of undiagnosed HIV and late diagnosis, as well as HIV 
transmission occurring within this population in E,W&NI. To minimize the risk of HIV 
transmission and to maximise the benefits of earlier detection my key recommendation 
is to promote regular HIV testing among black African women and men in a range of 
healthcare and community settings, but particularly in primary care in E,W&NI. 
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Appendices 
Appendix i: co-author contributions on published papers 
Paper 3.1: Rice BD, Sinka K, Patel B, Chadborn T, Delpech V. The changing 
epidemiology of diagnosed prevalent HIV infections in England: greatest impact 
on the London environs. Epidemiol & Infect 2007; 135:151-158 
Brian D Rice: HIV Epidemiological Scientist. Co-ordinated the 2002 and 2003 
SOPHID surveys and first author. Carried out majority of the analyses and writing. 
Katy Sinka: Lead Scientist of the HIV and AIDS Reporting Section at CDSC, and 
second author. Provided input into the data analyses, layout and writing of the paper. 
Co-ordinated the 2001 SOPHID survey and the 1998 to 2001 London SOPHID surveys.  
Bela Patel: SOPHID (London) Scientist. Collected data shown in results and provided 
guidance as to the structure of the paper. 
Timothy Chadborn: SOPHID co-ordinator. Provided input into the writing of the paper. 
Valerie Delpech: Lead Consultant for SOPHID and person to whom correspondence 
should be forwarded. Provided input into the writing of the paper. 
Paper 3.2: Rice B, Elford J, Yin Z, Croxford S, Brown A, Delpech V. Trends in 
HIV diagnoses, HIV care and uptake of antiretroviral therapy among heterosexual 
adults in England, Wales and Northern Ireland. Sex Transm Dis 2014; 41(4): 257-
265 
Brian D Rice: HIV Epidemiological Scientist. Conceived the paper, carried out 
majority of the analyses and writing.  
Jonathan Elford: Professor. Contributed to data analysis, interpretation and drafting the 
paper.  
Zheng Yin: Epidemiological HIV scientist. Contributed to data analysis, interpretation 
and drafting the paper. 
Sara Croxford: Epidemiological HIV scientist. Contributed to data analysis, 
interpretation and drafting the paper. 
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Alison Brown: Principal HIV Scientist. Contributed to data analysis, interpretation and 
drafting the paper. 
Valerie Delpech: Lead HIV Consultant. Contributed to data analysis, interpretation and 
drafting the paper. 
Paper 4.1: Rice BD, Elford J, Yin Z, Delpech D. A new method to assign country of 
HIV infection among heterosexuals born abroad and diagnosed with HIV in the 
UK. AIDS 2012; 26(15): 1961-1966 
Brian D Rice: HIV Epidemiological Scientist. Conceived the paper, carried out majority 
of the analyses and writing. 
Jonathan Elford: Professor. Contributed to data analysis, interpretation and drafting the 
paper. 
Zheng Yin: Epidemiological Scientist. Contributed to data analysis, interpretation and 
drafting the paper. 
Valerie Delpech: Lead HIV Consultant. Contributed to data analysis, interpretation and 
drafting the paper. 
Paper 4.2: Rice BD, Delpech VC, Chadborn TR, Elford J. Loss to follow-up among 
adults attending HIV-services in England, Wales and Northern Ireland. Sex 
Transm Dis 2011; 38(8):685-690 
Brian D Rice: HIV Epidemiological Scientist. Conceived the paper, carried out 
majority of the analyses and writing. 
Valerie Delpech: Lead Consultant for SOPHID and new HIV diagnoses. Contributed to 
data analysis, interpretation and drafting the paper. 
Timothy Chadborn: Epidemiological Scientist leading on SOPHID. Contributed to data 
analysis, interpretation and drafting the paper. 
Jonathan Elford: Professor. Contributed to data analysis, interpretation and drafting the 
paper. 
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Paper 5.1: Rice BD, Elford J, Yin Z, Kruijshaar M, Abubakar I, Lipman M, et al. 
Decreasing incidence of tuberculosis among HIV diagnosed heterosexuals in 
England and Wales. AIDS 2013; 27(7):1151–1157 
Brian D Rice: HIV Epidemiological Scientist. Conceived the paper, carried out 
majority of the analyses and writing. 
Jonathan Elford: Professor. Contributed to data analysis, interpretation and drafting the 
paper.  
Zheng Yin: Epidemiological Scientist SOPHID. Contributed to data analysis, 
interpretation and drafting the paper. 
Michelle Kruijshaar: Principal TB Scientist: Contributed to data analysis, interpretation 
and drafting the paper. 
Ibrahim Abubakar: Lead TB Consultant. Contributed to data analysis, interpretation and 
drafting the paper. 
Marc Lipman: Consultant Physician. Contributed to data interpretation and drafting the 
paper. 
Anton Pozniak:  Consultant Physician. Contributed to data interpretation and drafting 
the paper. 
Meaghan Kall: Epidemiological Scientist HIV and AIDS New Diagnoses. Contributed 
to data analysis and interpretation. 
Valerie Delpech: Lead Consultant for SOPHID and HIV and AIDS New Diagnoses. 
Contributed to data analysis, interpretation and drafting the paper. 
Paper 6.1: Rice BD, Delpech V, Sadler KE, Yin Z, Elford J. HIV testing among 
black Africans living in England. Epidemiol & Infec 2012; 141:1741–1748 
Brian D Rice: HIV Epidemiological Scientist. Conceived the paper, carried out 
majority of the analyses and writing. 
Valerie Delpech: Lead HIV Consultant. Contributed to data analysis, interpretation and 
drafting the paper. 
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Katharine Sadler: Research Director at NATCEN and lead scientist on Mayisha II. 
Contributed to data analysis, interpretation and drafting the paper. 
Zheng Yin: Epidemiological Scientist SOPHID. Contributed to data analysis, 
interpretation and drafting the paper. 
Jonathan Elford: Professor. Contributed to data analysis, interpretation and drafting the 
paper. 
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Appendix iii: Literature search strategy 
Resources used 
 Ovid MEDLINE and EMBASE by means of City University London’s Health and 
Society E-Resource Databases. 
 Ovid EMBASE AutoAlert (SDI) feeds. 
 Reference lists of key review articles. 
 Conference abstract databases of the International AIDS Society and British HIV 
Association. 
 Google, Google Scholar and PubMed Central. 
Literature review 
In Chapter 2.8, I describe my methods for conducting computerised and manual 
literature searches. In summary, I undertook computerised literature searches using 
Ovid MEDLINE and EMBASE. I applied key terms to search article titles and abstracts 
for papers published in the English language. Publications with relevant titles were 
selected for abstract screening. The reference lists of key publications were reviewed 
and publications of interest were obtained through title and author searches using 
Google Scholar and PubMed Central. To identify grey literature, I conducted manual 
Internet key word searches using Google. 
Literature search strategy specific to each chapter 
Chapter 1: Introduction 
Information on the history of the HIV epidemic and of heterosexually-acquired HIV in 
E,W&NI was obtained from a review of Health Protection Agency / Public Health 
England publications (1985-2015). The references of key papers were reviewed. 
Chapter 2: Methods 
A description of each of the datasets I utilise for the purpose of my thesis was obtained 
from a review of Health Protection Agency / Public Health England publications and 
web-based documents. I conducted computerised and manual literature searches on the 
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following key words: data confidentiality; surveillance strengths; surveillance 
weaknesses. 
Chapter 3: Trends in heterosexually-acquired HIV in England, Wales and 
Northern Ireland 
I conducted computerised and manual searches on the following topics: (i) HIV trends 
and predicting trends; (ii) quality of HIV care; (iii) late HIV diagnosis; (iv) older age at 
HIV diagnosis. The following key words were applied: HIV; AIDS; predictions; quality 
of care; surveillance; late diagnosis; HIV older adults; United Kingdom; Europe; USA.  
Computerised literature searches 
 Heterosexually-acquired HIV - MEDLINE 
1. MEDLINE; HIV.ti,ab [Limit to: English Language and Humans and Publication Year 
2000-Current]; 107085 results. 
2. MEDLINE; heterosexual.ti,ab [Limit to: English Language and Humans and 
Publication Year 2000-Current]; 4074 results. 
3. MEDLINE; 1 AND 2 [Limit to: English Language and Humans and Publication Year 
2000-Current]; 1980 results. 
4. MEDLINE; europe.ti,ab [Limit to: English Language and Humans and Publication 
Year 2000-Current]; 25653 results. 
5. MEDLINE; 3 AND 4 [Limit to: English Language and Humans and Publication Year 
2000-Current]; 76 results. 
Following review, 76 papers published on heterosexually-acquired HIV between 
January 1990 and August 2014 were selected for abstract screening. Of these, 27 were 
included for extraction and review. 
 Epidemiological trends in heterosexually-acquired HIV - Embase 
1. HIV.mp. or Human immunodeficiency virus/ 
2. HIV.mp. or Human immunodeficiency virus/ 
3. limit 2 to (human and english language and yr="1990 -Current") 
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4. heterosexual.mp. or heterosexuality/ 
5. limit 4 to (human and english language and yr="1990 -Current") 
6. 3 and 5 
7. epidemiology/ 
8. limit 7 to (human and english language and yr="1990 -Current") 
9. 6 and 8 
10. trend study/ or trend.mp. 
11. limit 10 to (human and yr="1990 -Current") 
12. 6 and 11 
Following review, 210 papers published on epidemiological trends in heterosexually-
acquired HIV between January 1990 and August 2014 were selected for abstract 
screening. Of these, 79 were included for extraction and review. 
 Quality of HIV care – Embase 
1. hiv.mp. or Human immunodeficiency virus/ 
2. limit 1 to (human and english language and yr="2000 -Current") 
3. heterosexual.mp. or heterosexuality/ 
4. limit 3 to (human and english language and yr="2000 -Current") 
5. quality.m_titl. 
6. limit 5 to (human and english language and yr="2000 -Current") 
7. cascade.m_titl. 
8. limit 7 to (human and english language and yr="2000 -Current") 
9. continuum.m_titl. 
10. limit 9 to (human and english language and yr="2000 -Current") 
11. 2 and 4 and 6 
12. 2 and 4 and 8 
13. 2 and 4 and 10 
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Following review, 30 papers published on quality of HIV care among heterosexuals 
between January 2000 and August 2014 were selected for abstract screening. Of these, 
18 were included for extraction and review. 
 Late HIV diagnosis - Embase 
1. hiv.mp. or Human immunodeficiency virus/ 
2. limit 1 to (human and english language and yr="2000 -Current") 
3. late diagnosis.mp. or delayed diagnosis/ 
4. limit 3 to (human and english language and yr="2000 -Current") 
5. late diagnosis.m_titl. 
6. limit 5 to (human and english language and yr="2000 -Current") 
7. 2 and 4 
8. 2 and 6 
Following review, 50 papers published on late HIV diagnosis between January 2000 
and August 2014 were selected for abstract screening. Of these, 39 were included for 
extraction and review. 
 Older adults and HIV- Embase 
1. hiv.mp. or Human immunodeficiency virus/ 
2. limit 1 to (human and english language and yr="2000 -Current") 
3. heterosexual.mp. or heterosexuality/ 
4. limit 3 to (human and english language and yr="2000 -Current") 
5. older.m_titl. 
6. limit 5 to (human and english language and yr="2000 -Current") 
7. elderly.m_titl. 
8. limit 7 to (human and english language and yr="2000 -Current") 
9. "50".m_titl. 
10. limit 9 to (human and english language and yr="2000 -Current") 
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11. 2 and 4 and 6 
12. 2 and 4 and 8 
13. 2 and 4 and 10 
Following review, 67 papers published on HIV among older adults between January 
2000 and August 2014 were selected for abstract screening. Of these, 33 were included 
for extraction and review. 
Chapter 4: Migration 
I conducted computerised and manual literature searches in relation to the following 
topics: (i) Heterosexually-acquired HIV and migration (ii) challenges of HIV 
surveillance; (iii) CD4 decline; (iv) HIV, migrants and migration; (v) HIV and 
migration in Europe; (vi) HIV and migration in the USA. The following key words were 
applied: HIV; AIDS; migration; migrants; surveillance; United Kingdom; Europe; USA; 
Australia.  
Based on the Embase search entitled “HIV, migrants and migration” (see below), I set 
up monthly EBSCOhost Auto Alert Notifications via EPNET.com to my personal 
Yahoo email account. Alerts were reviewed on receipt for new and relevant papers on 
HIV, migrants and migration. Relevant papers were selected for abstract screening. 
Computerised literature searches 
 Heterosexually-acquired HIV and migration - MEDLINE 
1. MEDLINE; diagnosis.ti [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 52991 results. 
3. MEDLINE; hiv.ti [Limit to: Publication Year 2000-2011 and Humans and English 
Language]; 63952 results. 
7. MEDLINE; heterosexual.ti,ab [Limit to: Publication Year 2000-2011 and Humans 
and English Language]; 3613 results. 
8. MEDLINE; 1 AND 3 AND 7 [Limit to: Publication Year 2000-2011 and Humans 
and English Language]; 22 results. 
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9. MEDLINE; diagnosis.ti [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 52991 results. 
10. MEDLINE; hiv.ti [Limit to: Publication Year 2000-2011 and Humans and English 
Language]; 63952 results. 
15. MEDLINE; 9 AND 10 AND 14 [Limit to: Publication Year 2000-2011 and Humans 
and English Language]; 22 results. 
16. MEDLINE; migrant.ti,ab [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 1696 results. 
17. MEDLINE; 1 AND 3 AND 16 [Limit to: Publication Year 2000-2011 and Humans 
and English Language]; 1 results. 
18. MEDLINE; 3 AND 16 [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 182 results. 
21. MEDLINE; migrant.ti [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 595 results. 
22. MEDLINE; 3 AND 21 [Limit to: Publication Year 2000-2011 and Humans and 
English Language]; 77 results. 
Following review, 77 papers published on heterosexually-acquired HIV and migration, 
between January 2000 and October 2011 were selected for abstract screening. Of these, 
42 were included for extraction and review. 
 Challenges of HIV surveillance - MEDLINE 
1. MEDLINE; surveillance.ti [Limit to: Publication Year 1990-Current and Humans]; 
15526 results. 
2. MEDLINE; hiv.ti [Limit to: Publication Year 1990-Current and Humans]; 105094 
results. 
3. MEDLINE; 1 AND 2 [Limit to: Publication Year 1990-Current and Humans]; 625 
results. 
4. MEDLINE; criteria.ti,ab; 290528 results. 
5. MEDLINE; 3 AND 4 [Limit to: Publication Year 1990-Current and Humans]; 12 
results. 
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6. MEDLINE; challenges.ti,ab; 90590 results. 
7. MEDLINE; 3 AND 6 [Limit to: Publication Year 1990-Current and Humans]; 15 
results. 
Following review, 27 papers published on the criteria for, and challenges of, HIV 
surveillance, between January 2000 and October 2011 were selected for abstract 
screening. Of these, 12 were included for extraction and review. 
 CD4 decline - MEDLINE 
1. MEDLINE; CD4.ti [Limit to: Publication Year 1990-Current and Humans]; 12292 
results. 
2. MEDLINE; progression.ti,ab [Limit to: Publication Year 1990-Current and Humans]; 
176155 results. 
3. MEDLINE; HIV.ti,ab [Limit to: Publication Year 1990-Current and Humans]; 
166116 results. 
4. MEDLINE; decline.ti,ab [Limit to: Publication Year 1990-Current and Humans]; 
59931 results. 
5. MEDLINE; 1 AND 2 AND 3 [Limit to: Publication Year 1990-Current and 
Humans]; 617 results. 
6. MEDLINE; 1 AND 3 AND 4 [Limit to: Publication Year 1990-Current and 
Humans]; 331 results. 
7. MEDLINE; markov.ti,ab; 9368 results. 
8. MEDLINE; 6 AND 7 [Limit to: Publication Year 1990-Current and Humans]; 4 
results. 
9. MEDLINE; seroconversion.ti,ab; 10281 results. 
10. MEDLINE; 6 AND 9 [Limit to: Publication Year 1990-Current and Humans]; 41 
results. 
Following review, 45 papers published on CD4 decline between January 2000 and 
October 2011 were selected for abstract screening. Of these, 14 were included for 
extraction and review. 
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 HIV, migrants and migration - Embase 
1. *Human immunodeficiency virus/ 
2. (HIV or AIDS).ab. 
3. 1 or 2 
4. *migration/ or *population migration/ 
5. (migrat* or migrant).ab. 
6. 4 or 5 
7. 3 and 6 
8. limit 7 to (human and yr="2000 -Current") 
9. limit 8 to (english and (adult <18 to 64 years> or aged <65+ years>)) 
10. (migrat* or migrant).ti. 
11. 4 or 10 
12. 3 and 11 
13. limit 12 to (human and yr="2000 -Current") 
14. limit 13 to (english and (adult <18 to 64 years> or aged <65+ years>)) 
Following review, 281 papers published on HIV, migrants and migration between 
January 2000 and June 2014 were selected for abstract screening. Of these, 95 were 
included for extraction and review. 
 HIV and migration in Europe - Embase 
1. HIV.mp. or Human immunodeficiency virus/ 
2. limit 1 to (human and english language and yr="2000 -Current") 
3. migration/ 
4. limit 3 to (human and english language and yr="2000 -Current") 
5. 2 and 4 
6. europe.mp. or Europe/ or Eastern Europe/ or Western Europe/ or Southern Europe/ 
7. limit 6 to (human and english language and yr="2000 -Current") 
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8. 5 and 7 
9. from 8 keep 1-2,4,6-8,10-11,13,15-16,19-20,23-24,34-36,39-40 
Following review, 42 papers published on HIV and migration in Europe between 
January 2000 and June 2014 were selected for abstract screening. Of these, 20 were 
included for extraction and review. 
 HIV and migration in the USA - Embase 
1. HIV.mp. or Human immunodeficiency virus/ 
2. limit 1 to (human and english language and yr="2000 -Current") 
3. migration/ 
4. limit 3 to (human and english language and yr="2000 -Current") 
5. 2 and 4 
6. United States/ 
7. 5 and 6 
8. from 7 keep 7,9-10,16,18,20-21,37,48-50,74,76,78,98,148 
Following review, 173 papers published on HIV and migration in the USA between 
January 2000 and June 2014 were selected for abstract screening. Of these, 16 were 
included for extraction and review. 
Chapter 5: HIV and Tuberculosis co-infection 
I conducted computerised and manual literature searches in relation to the following 
topics: (i) the incidence of active tuberculosis among HIV-diagnosed heterosexuals in 
the UK and elsewhere in Europe; (ii) HIV-tuberculosis service provision in the UK and 
elsewhere in Europe. The following key words were applied: HIV; AIDS; heterosexual; 
tuberculosis; co-infection; surveillance; integrate; missed; United Kingdom; Europe.  
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Computerised literature search 
 HIV and tuberculosis co-infection -Embase 
1. hiv.m_titl. 
2. limit 1 to (human and english language and yr="1990 -Current") 
3. tuberculosis.m_titl. 
4. limit 3 to (human and english language and yr="1990 -Current") 
5. 2 and 4 
6. europe.mp. or Europe/ or Eastern Europe/ or Western Europe/ or Southern Europe/ 
7. limit 6 to (human and english language and yr="1990 -Current") 
8. 5 and 7 
9. united kingdom.mp. or United Kingdom/ 
10. limit 9 to (human and english language and yr="1990 -Current") 
11. 5 and 10 
12. spain.mp. or Spain/ 
13. limit 12 to (human and english language and yr="1990 -Current") 
14. 5 and 13 
15. germany.mp. or Germany/ 
16. limit 15 to (human and english language and yr="1990 -Current") 
17. 5 and 16 
18. france.mp. or France/ 
19. limit 18 to (human and english language and yr="1990 -Current") 
20. 5 and 19 
21. heterosexual.mp. or heterosexuality/ 
22. limit 21 to (human and english language and yr="1990 -Current") 
23. 5 and 22 
24. from 8 keep 2-3,9-12,15-20,23,25-27,29,31,33-34,38 
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25. from 11 keep 1,7-9,12-14,17-18,20-21,23,29-30,34,38,40,43,45,47-48,50-51 
26. from 23 keep 10,13,17-18 
27. integrate.mp. 
28. limit 27 to (human and english language and yr="1990 -Current") 
29. 5 and 28 
30. services.m_titl. 
31. limit 30 to (human and english language and yr="1990 -Current") 
32. 5 and 31 
33. 10 and 32 
34. 7 and 32 
35. missed.m_titl. 
36. limit 35 to (human and english language and yr="1990 -Current") 
37. 5 and 36 
Following review, 241 papers published on HIV and tuberculosis between January 2000 
and October 2014 were selected for abstract screening. Of these, 57 were included for 
extraction and review. 
Chapter 6: HIV testing 
I conducted computerised and manual literature searches in relation to the following 
topics among heterosexuals and black Africans: (i) undiagnosed HIV; (ii) HIV testing; 
(iii) testing barriers and triggers. The following key words were applied: HIV; AIDS; 
heterosexual; black African; testing; barriers; stigma; discrimination; United Kingdom; 
Europe; USA. 
Computerised literature searches 
 Undiagnosed HIV among heterosexuals and black Africans –Embase 
1. hiv.m_titl. 
2. limit 1 to (human and english language and yr="2002 -Current") 
3. undiagnosed.m_titl. 
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4. limit 3 to (human and english language and yr="2002 -Current") 
5. 2 and 4 
6. heterosexual.mp. or heterosexuality/ 
7. limit 6 to (human and english language and yr="2002 -Current") 
8. 5 and 7 
9. black.mp. or Black person/ 
10. limit 9 to (human and english language and yr="2002 -Current") 
11. 5 and 10 
Following review, 16 papers published on undiagnosed HIV among heterosexuals or 
black Africans between January 2000 and February 2015 were selected for abstract 
screening. Of these, 11 were included for extraction and review. 
 HIV testing among heterosexuals and black Africans –Embase 
1. hiv.m_titl. 
2. limit 1 to (human and english language and yr="2002 -Current") 
3. heterosexual.mp. or heterosexuality/ 
4. limit 3 to (human and english language and yr="2002 -Current") 
5. black.mp. or Black person/ 
6. limit 5 to (human and english language and yr="2002 -Current") 
7. test.m_titl. 
8. limit 7 to (human and english language and yr="2002 -Current") 
9. testing.m_titl. 
10. limit 9 to (human and english language and yr="2002 -Current") 
11. 2 and 4 and 8 
12. 1 and 3 and 10 
13. 1 and 6 and 10 
14. UK.mp. or United Kingdom/ 
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15. limit 14 to (human and english language and yr="2002 -Current") 
16. 12 and 15 
17. 13 and 15 
18. USA.mp. or United States/ 
19. limit 18 to (human and english language and yr="2002 -Current") 
20. 12 and 19 
21. 13 and 19 
22. Europe.mp. or Europe/ or Western Europe/ or Southern Europe/ 
23. limit 22 to (human and english language and yr="2002 -Current") 
24. 12 and 23 
25. 13 and 23 
Following review, 171 papers published on undiagnosed HIV among heterosexuals or 
black Africans between January 2000 and February 2015 were selected for abstract 
screening. Of these, 65 were included for extraction and review. 
 Barriers to HIV testing among heterosexuals and black Africans - Embase 
1. hiv.m_titl. 
2. limit 1 to (human and english language and yr="2002 -Current") 
3. heterosexual.mp. or heterosexuality/ 
4. limit 3 to (human and english language and yr="2002 -Current") 
5. black.mp. or Black person/ 
6. limit 5 to (human and english language and yr="2002 -Current") 
7. testing.m_titl. 
8. limit 7 to (human and english language and yr="2002 -Current") 
9. barrier.m_titl. 
10. limit 9 to (human and english language and yr="2002 -Current") 
11. 2 and 4 and 8 and 10 
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12. 2 and 6 and 8 and 10 
13. barriers.mp. 
14. limit 13 to (human and english language and yr="2002 - 2015") 
15. 2 and 4 and 8 and 14 
16. 2 and 4 and 6 and 14 
17. stigma.m_titl. 
18. limit 17 to (human and english language and yr="2002 - 2015") 
19. 2 and 4 and 18 
20. 2 and 6 and 18 
Following review, 62 papers published on barriers to HV testing among heterosexuals 
and black Africans between January 2000 and February 2015 were selected for abstract 
screening. Of these, 32 were included for extraction and review. 
Chapter 7: Conclusion 
Not applicable. 
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